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 Healing is a matter of time, but it is sometimes also a matter of opportunity.  
Hippocrates
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i PrologueThe skin is to our body what a wall is to a house, it protects us from invaders and controls temperature and water balance of the inside environment. Damage to the wall 
of a house needs to be reconstructed as fast as possible to ensure the wall maintains its 
function, which is also the case for our skin. However, if the house is old and the original 
building elements are no longer available, the reconstruction of the wall will be difficult. 
Especially when there are no skilled construction workers available and there is no 
knowledge of how the wall was built. In this situation, the wall will be restored in a way 
it is able to maintain its function, but, the damaged part will be distinguishable from the 
rest of the wall, both in composition and performance. This also holds true for our skin 
where damaged sites are distinguishable by the scars that have formed. Although scars 
can fulfill the main functions of our skin, they are also distinguishable in composition 
and performance. For example, a scar is not as elastic and not as strong as our skin [1].
However, in the case of a newly built house, damage to the wall will be reconstructed much 
faster and easier. Especially when construction workers are still on site and building 
materials are still available. In that case, the damaged part might be fully restored and 
will be undistinguishable from the rest of the wall. Although this situation might be a 
bit uncommon, it is comparable with the situation in the developing fetal skin. Up until 
the third trimester of pregnancy, the skin of the developing fetus has the intrinsic ability to heal without scarring [2, 3]. However, the exact mechanisms that underlie this scarless 
healing are not clear yet. In this thesis, I studied healthy human fetal and adult skin to 
gain more insight into the mechanisms that are involved in human skin development 
and fetal wound healing. Because, just as a construction plan of a wall is of great interest 
for people rebuilding an old wall, the processes involved in the development of fetal 
skin are interesting for researchers searching for strategies to improve wound healing. 
Currently, several differences between fetal and adult skin have been described and 
these might contribute to the different healing capacities. First, the fetal skin is built 
from different materials than the adult skin as it contains fibronectin, hyaluronic 
acid but no elastin and has a higher ratio of collagen Type-III to collagen Type-I [4]. 
Remarkably, these materials that are present in the fetal skin are also produced during 
wound healing in the adult skin. This indicates that these materials are necessary 
for the build-up of the skin.  Again, we can compare this to the building of a wall, the 
materials present in the fetal skin and during wound healing are like a construction 
scaffolding which is necessary to build a high wall. Upon wounding, these materials are 
already available in the fetal skin which is not the case in the adult skin. In the adult 
skin construction scaffolding has to be ordered and assembled before reconstruction 
of the wall can start, while in the fetal skin the construction scaffolding is already there. 
Therefore, reconstruction of the fetal skin can start faster compared to the adult skin. 
Second, the dermal part of our skin contains construction workers who are called 
fibroblasts. These fibroblasts exist in both the fetal and the adult skin, but they differ 
in various ways. In this thesis, I compared the fetal and adult fibroblasts to gain insight 
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iinto their behavior and factors that influence that behavior. This is comparable with the observation of employees of two construction companies, one that is successful and one that is not. From the behavior of the employees at both companies one can, on one hand, learn how to successfully build a wall, and, on the other hand, learn what better 
not to do. 
Third, the immune system is also important during wound healing, as it protects us from 
invaders and regulates inflammation. Although the inflammatory response is important 
during wound healing, a reduced inflammation is shown to improve wound healing [5-7]. 
This is comparable with a neighborhood watch, you want them to protect your house, 
but if you live in a safe environment, you don’t want them to cause too much panic and 
hinder construction workers. In literature, it is often suggested that the inflammatory 
response is reduced during fetal wound healing [8, 9]. However, this can not be a result of 
an undeveloped immune system, as the fetal immune system is already fully developed 
during the second trimester of wound healing. Therefore, I studied immune cells and 
chemokines that attract immune cells in healthy adult and fetal skin to verify if the fetal 
skin indeed has low levels of immune cells.
Altogether, I studied molecular and cellular mechanisms that are involved in scarless 
wound healing in the fetal skin. The ultimate aim of these studies was to find methods 
to influence, control, and optimize adult wound healing. In comparison, one could say 
I studied the methods and materials necessary for the construction of a new wall, in 
order to find methods to restore and improve an old wall. 
Aim and outline of thesis
The main aim of my thesis is to unravel the cellular and molecular mechanisms involved 
in scarless fetal wound healing. Insight into these scarless healing mechanisms will give 
us strategies to control and improve adult wound healing. 
Significant numbers of adult wounds still heal with hypertrophic scars due to a 
derailment in wound healing processes. These pathological scars have a thick and 
rigid composition, and often cause pain, pruritus, and contraction [10, 11]. As a result, 
hypertrophic scars significantly affect the patient’s quality of life, both physically and 
mentally [12]. At present, no clinical satisfactory approaches are available to prevent 
pathological scarring or improve quality of life [13, 14].  In contrast to hypertrophic scarring 
in adult skin, fetal skin is able to heal without scarring during the first two trimesters 
of fetal development. It was shown that this scarless healing is an intrinsic capacity of 
the fetal skin, which is independent of the intra-uterine environment [2, 3]. Altogether, 
the ultimate purpose of my thesis is to find leads on how to improve the outcome of 
pathological scarring in the adult skin.
Several factors that might contribute to scarless healing in the fetal skin have already 
been described. First, the extracellular matrix (ECM) of the fetal skin is different in 
structure compared to the adult skin. It has high levels of fibronectin, lacks elastin, 
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i has different levels of glycosaminoglycans, among which high levels of hyaluronic acid, and has a higher ratio of collagen Type-III versus collagen Type-I [4, 15-18]. Second, fetal fibroblasts are also different since they are reported to have higher production of ECM proteins, higher proliferation, and enhanced migration compared to adult fibroblasts 
[19-22]. Third, the inflammatory response upon wounding is weak in fetal skin, and 
low numbers of immune cells are present in fetal wounds [23-25]. In addition, levels of 
inflammatory chemokines are low in fetal wounds as well [25]. Fourth, levels of growth 
factors differ between fetal and adult skin, and cytokine production also differs between 
fetal and adult skin cells –both fibroblasts and keratinocytes- [26-28].
Despite these differences, the exact mechanisms underlying scarless healing in fetal 
skin are not clear. The main difficulty to study fetal wound healing mechanisms arises 
from the lack of appropriate material, as no wounded human fetal skin is available. 
As a result, most data come from a plethora of wound healing models developed in a 
wide range of animals, such as fish [29, 30], mouse [31-33], rabbit [34], sheep [35], and monkeys 
[36]. As wound healing differs between species, results from different models are often 
inconclusive or contradictory, which makes translation to the human situation difficult 
[37, 38]. To optimize interpretation of data, all studies in this thesis were performed with 
human skin or fibroblasts isolated from human skin.
The cellular and molecular mechanisms studied in this thesis can be divided in three 
themes, although some chapters overlap from one theme into the other. The first three 
chapters of this thesis focus on transforming growth factor-β (TGF-β), a growth factor 
that is important during fetal development but also plays a detrimental role in wound 
healing. Chapter 1 is a literature review that summarizes the current knowledge on 
fetal wound healing and TGF-β. The review discusses the differences between fetal and 
adult wound healing, gives an overview of the canonical TGF-β signaling pathway, and 
describes the differences in this signaling pathway between fetal and adult fibroblasts. 
Accordingly, this chapter can be read as a general introduction. In chapter 2 the 
different components of the canonical TGF-β pathway were studied in healthy fetal and 
adult skin. This study shows that fetal skin, like adult skin, contains all components of 
the canonical TGF-β pathway, but that there are differences in gene expression, protein 
levels, and protein localization of these components between fetal and adult skin. In 
chapter 3 the cells from the dermis -the fibroblasts- were cultured in vitro to study 
their response to TGF-β. As fibroblasts differentiate in myofibroblasts under stimulation 
with TGF-β, this method is often used as an in vitro model to study wound healing and 
fibrosis. This study shows that fetal fibroblasts have the ability to differentiate into 
myofibroblasts, despite their scarless healing capacities. 
The second part of this thesis partially overlaps with chapter 3 as it also focuses on 
the fibroblasts. However, in this part the interactions of the fibroblasts with their 
environment were studied. In chapter 4, adhesion and migration of fibroblasts from 
fetal and adult skin were compared and mechanisms underlying these processes were 
studied. We show that fetal fibroblasts have a migratory phenotype that contains low 
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levels of certain integrins. Further, this study demonstrates that blocking of integrin 
receptors can affect adhesion and migration, and could be a promising strategy to 
improve wound healing. In chapter 5 differences in myofibroblast-associated gene 
expression were studied between fibroblast from different origin, i.e. fetal fibroblasts, 
adult dermal fibroblasts and adult fibroblast from a fibrotic burn wound environment, 
i.e. eschar fibroblasts. In addition, we studied the effects of mechanical stretch on 
myofibroblast-associated characteristics in these fibroblasts from different origin. This 
study shows that fibroblasts from fibrotic environments have higher gene expression 
of myofibroblast-associated genes compared to fetal and adult dermal fibroblasts. 
However, it did not give conclusive evidence for the beneficial effects of mechanical 
stretch on myofibroblast de-differentiation.
The third part of this thesis contains chapter 6, a study into the immune system in 
the healthy fetal and adult skin. This study shows that fetal skin contains low levels of 
immune cells and cytokines compared to adult skin. This deficiency in immune cells 
is not a result of an underdeveloped immune system, and could underlie a reduced 
inflammatory response during wound healing.
Finally, this thesis is concluded with chapter 7, a chapter in which the results are 
summarized and discussed. This chapter also contains remarks on implementation of 
these findings and suggestions for future research.
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Abstract
Scarless wound healing is a unique and intrinsic capacity of the fetal skin that is not fully 
understood. Further insight into the underlying mechanisms of fetal wound healing may 
lead to new therapeutic approaches promoting adult scarless wound healing. Differences 
between fetal and adult wound healing are found in the extracellular matrix, the 
inflammatory reaction and the levels of growth factors present in the wound. This review 
focuses specifically on transforming growth factor-β (TGF-β) since this growth factor is 
prominently involved in wound healing and fibroblast to myofibroblast differentiation. 
Although fetal fibroblasts do respond to TGF-β, they lack a proliferative and a contractile 
response and display a short-lived myofibroblast differentiation, autocrine response and 
collagen upregulation in comparison with adult fibroblasts. Curiously, prolonged TGF-β 
activation is associated with fibrosis and therefore, this short-lived response in fetal 
fibroblasts might contribute to scarless healing. This review gives an overview of the 
current knowledge on TGF-β signaling and the intracellular TGF-β signaling pathway in 
fetal fibroblasts. Furthermore, this review also describes the various components that 
regulate the cellular TGF-β response and hypothesizes about the possible roles these 
components might play in the altered response of fetal fibroblasts to TGF-β.
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TGF-β signaling in fetal fibroblasts
Introduction
Cutaneous scarring is the end result of a complex healing process that starts directly 
after the skin is wounded. Approximately 100 million people a year acquire a scar 
as a result of trauma, surgical procedures, burns or infection [1, 2]. A significant part 
of these scars will develop into pathological scars due to an imbalance in the healing 
process. Pathological scars, such as hypertrophic scars or keloids, are characterized by 
overproduction of extracellular matrix and tissue contraction. These kinds of scars are 
responsible for a decrease in quality of life due to functional and cosmetic impairment 
[3, 4]. In the field of burn wounds, for example, reported rates of pathological scarring 
range from 30% to 91% and patients with extensive burns have a poorer quality of life 
compared to the general population due to physical, social and emotional problems [3, 5, 6].
In contrast to pathological scars, fetal skin is reported to heal without scarring. Until the 
third trimester of pregnancy, scarless healing has been seen in fetal skin, independent 
of the presence of amniotic fluid or the intrauterine environment [7, 8]. Understanding 
the differences between scarless wound healing and pathological wound healing is 
important to gain more insight into these complex mechanisms which may eventually 
lead to the development of new wound healing therapies to promote scarless healing. 
Therefore, this review will summarize the known differences between adult and fetal 
wound healing with a special focus on transforming growth factor-β (TGF-β) as this 
growth factor is clearly an interesting target for wound healing studies.
Fetal wound healing
Early- to mid-gestation fetal skin can heal without scarring and this scarless healing 
seems to be an intrinsic capacity of the fetal skin since it is independent of the intrauterine environment [9]. In 1979, Rowlatt noted that no acute inflammatory process and no 
granulation tissue formation were seen in a 20-week human fetus with intrauterine limb 
amputations [10]. In the following decades, similar findings of scarless cutaneous healing 
were reported in various animal models [11, 12]. Unfortunately, differences in cutaneous 
wound healing between animal models cause discrepancies in reported data and make 
extrapolation to the human situation difficult. Nevertheless, results from human fetal 
skin transplanted on nude mice as presented by Lorenz et al. demonstrate the intrinsic 
ability of the human fetal skin to heal without scarring [9, 13]. Despite these results the 
mechanisms behind the scarless healing in the human fetal skin are still not known.
The main question in most studies on fetal scarless healing is how this kind of wound 
healing differs from the scarring seen in adult skin. Several distinctions between fetal 
and adult skin have been found that may contribute to the differences in wound healing. 
Although it is outside the scope of this review to discuss in detail all these distinctions 
and their possible roles in scarless healing, this paragraph will mention the most 
pronounced differences nowadays known.
First, differences between adult and fetal skin are found in the composition, especially 
in the extracellular matrix (ECM). Collagen type I is the main ECM component in both 
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fetal and adult skin, although the ratio of type III to type I is higher in fetal skin in both human and animal models [14-16]. Elastin, another important ECM molecule in human 
postnatal skin, is not detected in human fetal skin till up to 22 weeks’ gestation [17]. In 
contrast, in both humans and animals, the fetal ECM has a higher presence of hyaluronic 
acid, fibronectin, chondroitin sulfate and glycosaminoglycans [17-20]. These differences in 
ECM molecules may contribute to scarless healing because ECM affects cell behavior 
and has been shown to play a role in wound healing [17, 21, 22].
Second, differences in the inflammatory reaction and the immune system are observed 
between fetal and adult wound healing. These differences might also contribute to 
scarless wound healing as the duration and severity of these processes influence 
wound healing. In fetal wound healing a mild inflammatory reaction and an altered 
immune response are observed in comparison with adult wound healing, regardless of 
the species studied [23-25]. The depressed inflammatory response is partially due to the 
low production of Th1 polarizing cytokines in order to avoid an alloimmune reaction 
between mother and fetus [26, 27]. Furthermore, the fetal adaptive immune system is 
relatively naive due to the sterile intrauterine environment and therefore depends 
highly on the innate immune system [26]. Recruitment of immune cells to fetal wounds 
has been studied in both murine and rabbit models and in both species lower numbers 
of macrophages are present in fetal wounds and also less B and T lymphocytes are recruited to the wound [2 4, 28]. Fetal platelets have been studied in a porcine model, where 
it was shown that these platelets degranulated and aggregated poorly and consequently 
released less inflammatory cytokines in the wound bed [23, 29, 30]. Altogether, these data 
show that the inflammatory reaction and the immune response in fetal cutaneous 
wounds differ from the reactions seen in adult cutaneous wounds.
Third, besides difference in the immune response, differences are also found in the 
growth factor profiles present during fetal and adult wound healing. Variations in 
growth factor levels are known for platelet-derived growth factor (PDGF), fibroblast 
growth factor (FGF), vascular endothelial growth factor (VEGF) and TGF-β. In mice, 
PDGF is present in both adult and fetal cutaneous wounds but it was found to disappear 
more rapidly in the fetal wounds [31]. In addition, overall FGF expression and signaling in 
fetal wounds is reported to be diminished in a rat model [8, 32]. Contradicting results exist 
on the VEGF expression in fetal cutaneous wounds. Wilgus et al. reported basal protein 
expression in scarless wounds, while the expression was increased 4 fold in scarring wounds [33]. On the other hand, Colwell et al. reported elevated VEGF gene expression 
in scarless wounds, while gene expression was reduced in scarring wounds [34]. These 
contradicting results were both established at 72h after wounding but may be due to 
differences in animal models (rat vs. mice) or read-out parameters (PCR vs. ELISA). 
However, the growth factor with the most prominent differences in expression profile 
is from one of the major growth factor families involved in wound healing, TGF-β. Levels 
of TGF-β1 and TGF-β2, the so-called profibrotic isoforms of TGF-β, are reported to be 
lower, whereas levels of TGF-β3, the so-called anti-fibrotic isoform, are reported to be 
higher in both rodent and human fetal wounds [35-37].
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Altogether, this paragraph summarized briefly the known differences between fetal 
and adult wound healing. To date, it is still unclear which of these differences may 
contribute to the phenomena of scarless healing. Nevertheless, these differences could 
be interesting targets for the development of anti-fibrotic therapies. TGF-β is clearly 
the most prominent target and has already been studied in a number of in vivo wound 
healing studies and clinical phase I and II trials [38-41]. Further insight into this complex 
growth factor and its possible role in scarless wound healing might eventually lead 
to new therapeutic strategies. Therefore, the following paragraphs of this review will 
discuss in detail the role TGF-β and TGF-β signaling might play in fetal scarless healing.
TGF-β
TGF-β is a multifunctional growth factor family that includes various TGF-β isoforms, 
activins and inhibins that are involved in a variety of cellular processes such as growth, 
differentiation, ECM synthesis and cell migration. This growth factor family is also 
involved in multiple other physiological processes, including wound healing [1, 42]. In 
all stages of wound healing TGF-β plays a key role: directly after wounding TGF-β is 
released by platelets and it attracts neutrophils, macrophages and fibroblasts into 
the wound, at later stages TGF-β stimulates angiogenesis and fibroplasia and in the 
final stages of wound healing TGF-β is involved in ECM remodeling [1, 43]. TGF-β can be 
produced by almost all cells of the body, including fibroblasts, keratinocytes, endothelial 
cells and immune cells. As depicted in figure 1, cells secrete inactive TGF-β that is non-
covalently bound to a latency-associated peptide (LAP) that can associate with latent 
TGF-β binding proteins (LTBP) to form the large latent complex (LLC). This complex 
can bind to ECM molecules, thus generating ‘storage’ of inactive TGF-β in the matrix. 
Activation of TGF-β occurs when LLC is released from the matrix and active TGF-β is 
liberated from LAP, several factors that influence this activation have been identified 
like mechanical force, proteases, matricellular proteins, integrins, ROS or pH [44-47]. 
In humans, three isoforms of TGF-β are present: TGF-β1, TGF-β2, and TGF-β3. These 
isotypes are encoded by different genes but share 60-80% homology and are thought to 
signal through the same intracellular signaling pathways [1, 42]. Expression and activity 
of these three isotypes are under strict transcriptional regulation by differential 
promoters. The TGF-β1 promoter is selectively activated by various factors involved 
in stress or disease and has a positive autoregulatory feedback loop [48]. The TGF-β2 
and TGF-β3 promoters, on the other hand, contain different sequences among which a 
cyclic AMP-responsive element/activating transcription factor (CRE-ATF) binding site 
suggesting hormonal and developmental control [49]. Furthermore, TGF-β1 and TGF-β3 
transcription are regulated by Sp1 transcription factor while TGF-β2 is unresponsive to 
Sp1 [50, 51]. These differences in transcription of the TGF-β isoforms indicate independent 
regulation and likely underlie the differential expression of the TGF-β isoforms during 
development and other physiological processes. 
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Indeed, overexpression of TGF-β1 and TGF-β2 is associated with various diseases 
including cancer and fibrosis, while TGF-β3 is associated with anti-fibrotic properties 
[1, 52, 53]. However, attempts to use TGF-β1 or TGF-β2 inhibitors or intradermal TGF-β3 
administrations have not led to licensed therapeutics so far [54-57], and thus further 
elucidation of the mechanisms behind the TGF-β signaling cascade is necessary. 
Noteworthy, the TGF-β isoforms appear to have overlapping functions in vitro despite 
the differences in expression patterns in vivo [50, 58, 59]. Insight into this TGF-β signaling 
in scarless fetal wound healing may result in methods to manipulate this cascade and 
eventually develop TGF-β based anti-fibrotic therapies.
TGF-β signaling in fibroblasts
The cells that play an important role in wound healing by production of ECM and 
contraction of the wound bed are the fibroblasts and their contractile phenotype, the 
myofibroblasts. TGF-β is one of the most potent inducers of fibroblast to myofibroblast differentiation and in vitro studies have shown that all three isoforms induce this 
myofibroblast differentiation [58]. As all three isoforms are thought to signal through 
the same intracellular Smad pathway, this paragraph will describe the TGF-β signaling 
cascade in fibroblasts and the regulatory mechanisms involved.
The actual TGF-β signaling in fibroblasts starts with the binding of activated TGF-β to 
a TGF- β receptor II (TGF-βRII). After binding of the isoform, this TGF-β receptor forms 
a serine/threonine kinase complex with a TGF-β receptor I (TGF-βRI), also known as 
activin receptor-like kinase 5 (ALK5). Formation of this complex leads to the activation 
of an intracellular Smad cascade, starting with phosphorylation of receptor-associated 
Smad2 and Smad3. These receptor-Smads are then released into the cytoplasm and form 
a heterodimeric complex with Smad4. This activated Smad complex translocates into 
the nucleus, where it regulates the transcription of target genes [60, 61]. Two other Smads, 
Smad6 and Smad7, are known to inhibit the activation of the receptor Smads thereby 
negatively regulating the TGF-β response. In addition to TGF-βRI and II, a third receptor 
(TGF-βRIII) has been described, also known as betaglycan. The exact function of this 
receptor is not completely understood, but it has been shown to promote binding of the 
TGF-β isoforms, especially TGF-β2, to the TGF-βRII thereby enhancing the TGF-β response 
[1, 54, 62, 63]. Furthermore, overexpression of this receptor in certain cell cultures has been 
shown to affect receptor endocytosis and extend the half-life of the TGF-βR complex [64].  
Besides the above-mentioned Smad-pathway, TGF-β1 can also activate mitogen-activated 
protein kinase (MAPK) pathways, either directly via receptor- or Smad interactions or 
indirectly via extracellular stimuli such as cytokine secretion [65]. TGF-β has been shown 
to activate three MAPK pathways in a number of cell types: the extracellular signal 
regulated kinase 1/2 (ERK1/2), the c-Jun N-terminal kinase (JNK) and the p38 pathway 
[1]. These MAPK pathways are involved in various wound healing mechanisms like 
fibroblast proliferation and ECM production [42, 61]. However, the exact interactions in 
fibroblasts remain to be clarified since these MAPK pathways can potentiate, synergize, 
or antagonize the canonical TGF-β pathway in various ways [65].
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Figure 1: A schematic overview of TGF-β signaling.
A) TGF-β isoforms are produced by a variety of cells including fibroblasts, keratinocytes and 
immune cells. TGF-β is secreted as an inactive form that is ‘stored’ in the ECM via its binding 
to the LTBP. B) Activation of TGF-β occurs via various stimuli for example specific proteases 
or integrins. C) Activated TGF-β can bind to a TGF-βRII after which a serine/threonine kinase 
complex is formed with TGF-βRI. D) The formation of this receptor-complex leads to activation 
and phosphorylation of the intracellular Smad cascade. E) The activated Smad heterodimer 
of R-Smad and Smad4 translocates into the nucleus, where it regulates the transcription of 
target genes. TGF-β activated gene transcription in fibroblasts eventually leads to proliferation, 
myofibroblast differentiation, contraction, ECM production and autocrine TGF-β1 upregulation. 
F) The TGF-βR complex internalizes via two pathways with different effects: clathrin-mediated 
endocytosis results in receptor recycling leading to prolonged signaling, while caveolin- mediated 
endocytosis leads to receptor degradation. G) TGF-β can also activate MAPK pathways either 
direct, via receptor or Smad interactions or indirect, via cytokine release. The exact role of these 
MAPK pathways in TGF-β signaling in fibroblast needs to be further clarified although it is known 
that these signaling pathways can affects Smad signaling and are involved in various cellular 
processes like cell proliferation, cell differentiation and ECM production.
Proefschrift_27jan2016_JAK_versie3b.indd   25 27-1-2016   21:43:37
501871-L-bw-Walraven
26
1
Besides the signal transduction pathways mentioned above, binding of ligand to 
the TGF-βRs also causes internalization of these receptors from the cell surface into 
internal vesicles. This so-called receptor-mediated endocytosis is regulated via 
two distinct internalization pathways, clathrin-mediated endocytosis or caveolin-
mediated endocytosis [66-68]. These endocytic pathways are not unique to TGF-β since 
other receptors, for example the Wnt-receptor complex [69] and the LDL receptor [70], 
are also internalized via clathrin- and caveolin-mediated pathways. Clathrin-mediated 
receptor endocytosis results in uptake of the TGF-βR in early endosome antigen-1 
(EEA-1) positive endosomes and sustains TGF-β signaling by recycling of the receptors 
back to the plasma membrane and promoting R-Smad phosphorylation [67, 68]. Caveolin-
mediated endocytosis, on the other hand, results in uptake of the receptors in caveolin 
positive endosomes and inhibits TGF-β signaling by degradation of the receptors, 
down-regulation of receptor expression and down-regulation Smad2 and Smad3 
phosphorylation [68, 71-73]. Moreover, caveolin is associated with cellular proliferation and cellular senescence [74, 75]. Caveolin is downregulated in rapidly dividing fibroblasts [75], 
while upregulation of caveolin expression may be involved in myofibroblast persistence via cellular senescence [76, 77]. Therefore, caveolin is involved in inhibition of the 
TGF-β response via multiple regulatory mechanisms: receptor degradation, receptor 
expression, Smad phosphorylation, cellular proliferation and cellular senescence.
Altered TGF-β response in fetal fibroblasts
Although myofibroblasts are strongly associated with hypertrophic scarring in the 
adult, fetal fibroblasts are also able to differentiate into this hypertrophic phenotype 
under influence of TGF-β. This response to TGF-β seems, however, to be different in 
fetal fibroblasts in comparison with adult fibroblasts. In the literature, five differences 
in response to TGF-β are described between fetal and adult fibroblasts.  First, addition 
of TGF-β to adult fibroblasts results in increased proliferation, while addition to fetal 
fibroblasts seems to result in no or decreased proliferation [78-80]. Pratsinis et al. showed 
that this inhibitory effect on fetal fibroblasts was isoform-independent but concentration-
dependent, with a maximal proliferative response at a concentration of 500 pg/mL [78]. 
In addition, mouse fibroblasts showed a similar dose-dependent TGF-β response with 
a mitogenic effect in adult fibroblasts, but no proliferative effect in fetal fibroblasts [80]. 
Second, both types of fibroblasts are able to differentiate into myofibroblasts, but this 
reaction seems to be more rapid and short-lived in fetal fibroblasts. Rolfe et al. studied 
induction of myofibroblast differentiation by TGF- β1 in human fetal and adult fibroblasts. 
Fetal differentiation peaked at 3d and ended at 8d, while adult differentiation peaked 
at 8d [81]. Another study of Moulin et al. examined the increase in myofibroblasts after 
7d of culture with TGF- β1 in human fibroblasts. In adult cultures the myofibroblast to 
fibroblast ratio increased from 2.3 to 3.8, whereas in fetal cultures this ratio remained 
between 0.9 and 1.1 during the period [82]. 
Third, the same study of Moulin et al. reported that stimulation with TGF-β isoforms 
decreased the contractile capacity of fetal fibroblasts. This effect was observed from the 
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first day of TGF- β treatment till up to two weeks, while under the same circumstances 
and in the same period the contractile capacity of adult fibroblasts increased [82]. 
Curiously, this study showed that myofibroblast differentiation and contraction were not 
necessarily associated and it indicated that other factors might be involved, for example, 
differences in cytoskeletal structure or integrin expression [82].  
Fourth, the autocrine effect of TGF-β1 seems to be more rapid and short-lived in fetal 
wound healing and in fetal fibroblasts. TGF-β1 gene expression in rat fetal wounds 
returned to baseline levels faster and expression was significantly lower in comparison 
with the expression in adult wounds [83]. This same rapid and short-lived TGF-β1 
expression in fetal wounds was observed immunohistochemically in both mice and rat 
dermis, with a weaker staining that returned to baseline faster [83, 84]. Furthermore, a 
study with human fibroblasts showed that fetal fibroblasts did not have an autocrine 
loop of TGF-β1 upregulation in response to TGF-β1 [85].
Fifth, upregulation of collagen type I gene transcription and the resulting collagen 
type I production in response to TGF-β1 differed between fetal fibroblasts and adult 
fibroblasts. Although the results vary with regard to time and expression levels, all 
studies reported shorter and less severe responses in fetal fibroblasts [80, 81, 85].
In conclusion, fetal fibroblasts lack a proliferative and a contractile response and 
they have short-lived myofibroblast differentiation, autocrine effect and collagen 
upregulation. These differences suggest a limited, transient response to TGF- β in fetal 
fibroblasts in comparison with adult fibroblasts. It is thought that prolonged activation 
of TGF-β signaling is one of the factors causing fibrosis, and therefore this short-lived 
response might contribute to the scarless healing seen in fetal skin. 
TGF-β signaling pathway in fetal fibroblasts
Knowledge of the mechanisms that cause a transient response to TGF-β may lead to 
the development of new anti-fibrotic therapies. Several groups have studied and 
hypothesized about the underlying processes that might cause a transient TGF-β 
response, although none of these hypotheses is confirmed yet. Therefore, this paragraph 
gives an overview of all that is currently known about similarities and differences 
in TGF-β signaling pathway between fetal and adult fibroblasts. The data on TGF-β 
signaling in fetal fibroblasts are further summarized in figure 1 and table 1.
TGF-β expression
In view of the fact that the three TGF-β isoforms play an important role during 
development, several studies have evaluated the differences in expression levels of these 
isoforms in fetal and adult skin. As mentioned before studies in mice, rabbit and human 
models have reported lower protein expression of TGF-β1 and TGF-β2 and higher 
expression of TGF-β3 in both healthy and wounded fetal skin [37, 83, 84, 86, 87]. Gene expression 
for TGF-β1 seemed to correspond with protein expression, as it increases both during 
development and after wounding [37, 88]. Remarkably, data on gene expression of TGF-β2 
and TGF-β3 did not correspond with protein data [37, 88, 89]. Since the various cellular 
Proefschrift_27jan2016_JAK_versie3b.indd   27 27-1-2016   21:43:37
501871-L-bw-Walraven
28
1
subsets of the skin have different roles during wound healing, it might be necessary to 
distinguish between these cells to gain more insight into their separate TGF-β expression 
profiles during wound healing. Several groups studied the expression of the different 
TGF-β isoforms in the different cellular subsets in mice, rat and human fetal skin by 
immunohistochemistry. These studies showed that healthy fetal skin contained TGF-β 
producing cells in the epidermis and the blood vessels but lacked TGF-β positive signal in 
the cells or ECM of the dermis. In contrast, adult skin contained TGF-β positive epidermal 
cells, fibroblasts, keratinocytes and endothelial cells throughout both epidermis and 
dermis and also showed signal in the ECM of the dermis for both TGF-β1 and TGF-β2 [37, 
84]. Nevertheless, in the first 48 h after wounding TGF-β positive inflammatory cells and 
fibroblasts are observed in fetal wounds as well, although the staining and number of 
positive cells remained low in comparison with adult wounds [83, 84].
Since fibroblasts do not seem to be the main TGF-β producing cells in fetal skin, studies 
into gene expression in full fetal skin might not be applicable for fetal fibroblasts. 
Remarkably, a study by Gosiewska et al. showed that fetal fibroblasts in vitro produced 
4- to 10-fold more latent TGF-β1 compared to neonatal fibroblasts, although the TGF-β1 
mRNA expression was only 1.5 times higher in these fetal fibroblasts [90]. This study 
also showed that the mRNA expression of LTBP-1, a protein involved in secretion and 
activation of latent TGF-β, was almost undetectable in fetal fibroblasts in contrast to 
neonatal fibroblasts. These results may indicate that in fetal skin, despite high latent 
TGF-β production by fibroblasts, active TGF-β might not be available in the dermis due 
to lack of LTBP. The studies in healthy fetal skin seem to support these data, since LTBPs 
are also involved in storage of TGF-β in the ECM and no TGF-β was observed in the ECM of fetal skin [37].
TGF-β receptor expression and endocytosis
TGF-β signaling is partially regulated at receptor level; the number and the type of 
receptors available to bind ligand will affect the duration and strength of the response. 
Fetal and adult fibroblasts are reported to express the same TGF- βRs (i.e. TGF-βRI, TGF-
βRII and TGF-βRIII) with similar binding affinities for the TGF-β isoforms: high affinity 
for TGF-β1, low affinity for TGF-β2, and an intermediate affinity for TGF-β3 [82]. However, 
these TGF-βRs are constantly turned over and their presence at the plasma membrane 
is controlled by gene transcription and receptor endocytosis. 
Downregulation of TGFβR gene expression will reduce the amount of TGFβRs available 
at the plasma membrane and, consequently, decrease the cellular response. Multiple studies have shown that receptor expression differs between fetal and adult skin. In 
vivo studies reported lower expression of TGF-βRI and TGF-βRII and higher expression 
of TGF-βRIII in the healthy fetal skin [36, 37]. After wounding, both fetal and adult skin 
showed upregulation of receptor expression on both RNA and protein level. Yet, this 
upregulation seemed to be short-lived in fetal fibroblasts, although data differ on the 
exact increase and the time period [82-84, 88]. As a result of these different findings some 
authors indicated that transcriptional TGF-βR control might be involved in scarless 
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Table 1: TGF-β signaling in fetal fibroblast. 
This table summarizes the data on TGF-β signaling in fetal fibroblasts discussed in the text and 
drawn schematically in figure 1. The letters in the first column of the table correspond with the 
numbers in figure 1. More information can be found in the corresponding references.
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wound healing [36, 84, 88], although others suggested no such influence [37,84]. Consequently, 
further studies are necessary to determine the exact chronology of TGF-βR gene 
expression in vitro after stimulation with TGF-β and in vivo after wounding. 
As discussed, variations in TGF-βR expression at the plasma membrane might also be 
due to differences in receptor-mediated endocytosis. A shift from clathrin-mediated 
endocytosis towards caveolin-mediated endocytosis leads to higher rates of receptor 
degradation and inhibited signal transduction [67, 68, 72]. Therefore, it could be promising 
to study whether such a shift towards caveolin-mediated endocytosis might contribute 
to the transient response in fetal fibroblasts. Unfortunately, up until now, no research on 
clathrin- or caveolin-mediated receptor endocytosis in fetal fibroblasts has been done.
Intracellular Smad signaling
The cellular response to TGF-β is also regulated by intracellular Smad signaling, which 
can be affected by the absolute amount and phosphorylation of these components. 
Only two groups have studied this intracellular Smad signaling in fetal fibroblasts after 
stimulation with TGF-β. 
First, Rolfe et al. observed increased phosphorylation of the Smad2/3 complex in 
response to TGF-β in both fetal and adult cells [81]. In fetal cells this response decreased 
to baseline levels 1 h after treatment and remained low, whereas in adult cells a second 
response was seen 6 to 8 h after treatment [81]. Localization of this Smad2/3 complex 
differed as well, as it was observed solely in the cytoplasm of fetal cells but in both 
the cytoplasm and nucleus of adult cells [81]. Further, this study also reported higher 
protein expression of Smad4 and Smad7 in fetal fibroblasts, and this higher expression 
lasted for respectively 2 h -Smad4- or 1 min -Smad7-, while adult fibroblasts showed 
no upregulation during this time period [81]. These findings led to the hypothesis that 
a shorter-lived phosphorylation of TGF-βRs in fetal fibroblasts negatively affects 
shuttling of Receptor-Smads (R-Smads) and thus leads to a shorter activation of the 
TGF-β signaling pathway. Although the hypothesis did not mention what might cause 
this short-lived receptor phosphorylation, we speculate that caveolin-mediated 
receptor endocytosis might be an explanation for this effect as it leads to receptor 
degradation and affects R-Smad phosphorylation.
Second, two other studies reported rapid phosphorylation of Smad2 and Smad3 in 
both human fetal and adult fibroblasts with maximum activation after 30 min and 
a reduced activation after 3 h. These studies found an equal protein expression and 
phosphorylation of Smad2 and this phosphorylation was followed by translocation 
of Smad2 into the nucleus in both cells [78, 79]. Curiously, the study by Giannouli et 
al. observed Smad3 expression as well and found higher protein expression and 
phosphorylation in fetal fibroblasts after stimulation with TGF-β1 [79]. 
Overall, these data indicate that there are differences in Smad expression and duration 
of the intracellular Smad response between fetal and adult fibroblasts after TGF-β 
treatment. Nevertheless, it is not clear what might cause these differences in expression 
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and duration. A detailed dissection of regulatory factors controlling the Smad signaling 
pathway in fetal fibroblasts might further elucidate the underlying mechanisms.
MAPK signaling
As noted earlier, TGF-β1 can also activate MAPK pathways. Giannouli et al. found that 
TGF-β1 stimulated protein kinase A (PKA) activity in fetal fibroblast and this finding 
together with their Smad3 findings led to the hypothesis that upregulated Smad3 
expression and phosphorylation stimulated PKA activation in fetal fibroblasts. This 
PKA activation in fetal fibroblasts would regulate transcription of two cyclin-dependent 
kinase inhibitors and eventually lead to growth arrest [79]. 
Besides the PKA activation in fetal fibroblasts, this study also found upregulated FGF2 
expression in adult fibroblasts. The resulting induced production and secretion of FGF2 
by these adult fibroblasts stimulated the Ras-Raf-MEK-ERK pathway and led to late 
upregulation of the phosphorylated ERK1/2 complex 3 to 6 h after TGF-β1 treatment [81]. 
Together, these results led to the hypothesis that fetal fibroblasts regulate proliferation 
via a PKA dependent mechanism whereas adult cells regulate proliferation via FGF2 
and the MEK-ERK pathway [79]. 
In contrast to these findings, Rolfe et al. found upregulation of phosphorylated ERK1 
and ERK2 in fetal fibroblasts, while adult fibroblasts showed no upregulation [81]. 
However, this increased ERK phosphorylation was only significant for ERK2 at 1 min 
after stimulation. In this study, fetal fibroblasts showed also a bimodal pattern of Jnk 
phosphorylation at 1 min and 4 h, while adult fibroblasts had only a response at 4 
h. Although these data indicate a role for early MEK/ERK and Jnk activation in fetal 
fibroblasts, it is not clear what the effects of such an early activation at 1 min might be.
Regardless of the rather contradictory findings, these studies showed that TGF-β 
stimulation might lead to direct or indirect activation of MAPK pathways in fetal and 
adult fibroblasts. Which MAPK pathways are exactly involved, how these pathways 
become activated, and what the effects of these pathways are on the TGF-β response in 
fibroblasts is not clear. The very early ERK response at 1 min after TGF-β stimulation 
in fetal fibroblasts and the late response at 3 to 6 h after TGF-β stimulation in adult 
fibroblasts should be confirmed. Furthermore, the effects of such early and late ERK 
activation should be further studied to determine if they might be involved in the altered 
response to TGF-β seen in fetal fibroblasts. 
Influence of keratinocytes and immune cells
Although this review mainly focuses on the differential response of fetal fibroblasts to 
TGF- β, keratinocytes and immune cells play an important role in wound healing as 
well. Keratinocytes are shown to closely interact with fibroblasts during wound healing 
by regulating myofibroblast differentiation and stimulating fibroblasts to synthesize growth factors [91]. Remarkably, keratinocytes also seem to be the main source of TGF-β 
in the healthy fetal skin, since all TGF-β expression was observed in the epidermis and 
no TGF-β producing cells were observed in the dermis [37, 84]. Hence, it would be useful 
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to study fetal keratinocytes, their response to TGF-β and their influence on the TGF-β 
response in fibroblasts as well. Colwell et al. showed an increased expression of TGF- β1, 
TGF- β2, TGF-βRs, Smad4 and collagen type-I with increasing age in rat keratinocytes 
[92]. This group also investigated the effects of adult keratinocytes on components of 
the TGF-β pathway in murine fetal and adult fibroblasts. Keratinocytes in co-culture 
induced TGF- β3 expression and decreased TGF- β1, TGF- β2, TGF- βRI and TGF- βRII 
in fetal fibroblasts [93]. In co-culture with adult fibroblasts, these keratinocytes had 
similar effects, except that TGF- β1 expression did not change. Effects on intracellular 
Smad signaling were reported as well, however, these data should be met with concern 
as the controls of this study contradict with another study of Colwell et al.. In 2006 
this group reported equal Smad3 and higher Smad7 gene expression in murine fetal 
fibroblasts [94], while in a study from 2007 they reported lower Smad3 and equal Smad7 
gene expression in murine fetal fibroblasts [93]. Thus, to conclusively elucidate the role 
of keratinocytes in fetal scarless healing, more studies have to be performed, such as 
studies into the role of TGF-β in fetal keratinocytes and studies using co-cultures of 
these cells with fibroblasts.
Immune cells also play an important role in wound healing and are reported to influence 
fibroblast behavior, for example macrophages are known to control fibroblast to 
myofibroblast differentiation and myofibroblast apoptosis [95, 96]. As mentioned before, 
fetal wounds showed less inflammatory infiltrate and an altered immune response. Soo et 
al. showed that fetal E16 wounds in rats have less inflammatory cells 24 h after wounding 
compared to scarring E19 wounds [83]. Curiously, the intensity of TGF-β1 staining in these 
E16 fetal inflammatory cells was higher compared to the E19 inflammatory cells, while 
increased TGF-β2 staining persisted up till 72 h in E19 inflammatory cells [83]. Olutoye 
et al. showed that porcine fetal platelets have decreased degranulation and aggregation 
and produced lower levels of growth factors including TGF-β [30, 97, 98]. Although, both 
adult and fetal serum contained much more latent TGF-β in comparison with active 
TGF-β, Olutoye et al. also showed that porcine fetal serum contained less active TGF-β1 
and TGF-β2 in comparison with porcine adult serum [97]. Other studies showed that 
both monocytes and macrophages are recruited to fetal and adult wounds but that the 
numbers and persistence of these cells are lower in fetal wounds [24, 29]. Both fetal and adult 
wound macrophages are shown to have TGF-β1 and TGF-β2 gene expression, although, 
expression levels differ over time [29]. Furthermore, fetal macrophages are shown to have 
a noninflammatory phenotype with tissue remodeling M2-like capacities [24, 99]. However, 
in vivo application of these fetal macrophages to murine postnatal wounds results in 
prolonged healing and excessive scar formation [100]. 
Altogether, these data indicate a reduced inflammatory response in fetal wounds with 
lower levels of TGF-β1 and TGF-β2. Although lower levels of TGF-β will affect fibroblast 
function it is not clear if the fetal immune cells have a direct influence on fetal fibroblast 
function or if fetal fibroblasts might have a direct function on immune cells. Thus again 
more studies have to be performed to conclusively elucidate the role of immune cells in 
fetal scarless healing.
Proefschrift_27jan2016_JAK_versie3b.indd   32 27-1-2016   21:43:39
501871-L-bw-Walraven
1
33
TGF-β signaling in fetal fibroblasts
Perspectives
The data described in the previous paragraph indicate that expression and 
phosphorylation of several components of the TGF-β signaling pathway differ in both 
intensity and duration between fetal and adult fibroblasts. It needs to be established if 
and how the differences contribute to the altered response of fetal fibroblasts to TGF-β. 
First, studies should further focus on the components involved in the TGF-β signaling 
cascade in fetal fibroblasts since conclusive data are lacking and available data are 
often contradictory. In most cases, these discrepancies in literature can be attributed 
to differences in species (human, sheep, rat and mice), TGF-β1 concentrations (range 
between 2.5 and 10 ng/mL), time points (ranging between 1 min and 16 h) and read 
out parameters (PCR, IHC or Western Blot). Preferably, an in vitro analysis of the cellular 
components of the TGF-β pathway and their interactions at different time points should 
be done to elucidate the regulatory mechanisms of TGF-β signaling in fetal fibroblasts. 
Q-PCR can be considered to determine gene expression of these components at various 
time points and elucidate the chronology of TGF-β signaling. However, protein expression 
studies should be done as well to show activation and phosphorylation of the intracellular 
mediators. Ultimately, co-cultures and in vivo experiments may allow further insight into 
the effects of the differential TGF-β response on scarless wound healing.
Second, analyses of TGF-β signaling in cells other than fibroblasts have revealed several 
alternative mechanisms of signal regulation such as receptor endocytosis. Variations 
in expression and phosphorylation of various components of the intracellular Smad-
pathway have been reported. Studies into these regulatory mechanisms are promising, 
and they might reveal differences in expression and phosphorylation. In this respect, 
caveolin could be an interesting target as upregulation of caveolin has an inhibitory 
effect on TGF-β signaling via different mechanisms: increased receptor degradation, 
downregulated receptor expression, reduced R-Smad phosphorylation, reduced 
proliferation and increased cellular senescence [67, 68, 74]. It may be useful to examine 
if one or more of these inhibitory effects of caveolin are involved in the short-lived 
response of fetal fibroblasts to TGF-β. In addition, proliferation of fetal fibroblasts 
has been shown to be reduced under influence of TGF-β1 and caveolin might also be 
involved in this process by reducing proliferation or stimulating cellular senescence. 
Together, studies into regulatory mechanisms of TGF-β signaling, including caveolin-
mediated endocytosis, may shed more light on the precise mechanisms involved in the 
more rapid and short-lived response to TGF-β1.
Third, besides studying TGF-β signaling in fetal fibroblasts it could also be interesting 
to study the processes of latent TGF-β storage and activation in the fetal dermis. Several 
studies have shown that the fetal dermis does not contain TGF-β1 or TGF-β2, and others 
have shown that fetal fibroblasts do produce latent TGF-β but lack LTBP-1, which is a 
protein involved in latent TGF-β storage and activation. Further insight into the storage 
and activation of latent TGF-β in the fetal dermis might therefore be promising and shed 
more light on fetal scarless wound healing. 
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Conclusion
Fetal scarless wound healing is a phenomenon that has been studied intensively, yet 
without a clear solution to finding potential targets for adult wound healing therapies. 
This summary of the presently known differences between fetal and adult wound 
healing takes a special focus on the TGF-β pathway. TGF-β is an important growth factor 
involved in wound healing and prolonged TGF-β activation is associated with fibrosis. 
Curiously, the response of fetal fibroblasts to this growth factor is shorter and less severe 
than the response seen in adult fibroblasts despite similar TGF-β signaling pathways 
with identical intracellular Smad-pathways and TGF-βRs. Nevertheless, Smads and 
TGF-βRs seem to play an important role in the altered response, because variations in 
expression and phosphorylation are found for TGF-βRs and several Smads. These data 
are thus far incomplete and contradictory and future studies should be conducted to 
establish the expression and phosphorylation profiles of the different components of the 
TGF-β signaling pathway more precisely. The underlying mechanisms that cause these 
variations in fetal fibroblasts should be further unraveled. More knowledge of these 
mechanisms in fetal fibroblasts will most likely shed light on the processes involved in 
scarless wound healing. Unraveling the fetal signaling pathway will hopefully lead to 
new therapeutic strategies to promote adult scarless wound healing. 
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Abstract
TGF-β plays an important role in growth and development but is also involved in scarring 
and fibrosis. Differences for this growth factor are known between scarless fetal wound 
healing and adult wound healing. Nonetheless, most of the data in this area are from 
animal studies or in vitro studies and, thus, information about the human situation is 
incomplete and scarce.
The aim of this study was to compare the canonical TGF-β signaling in unwounded 
human fetal and adult skin. 
Q-PCR, immunohistochemistry, western blot and Luminex assays were used to 
determine gene expression, protein levels and protein localization of components of this 
pathway in healthy skin. All components of the canonical TGF-β pathway were present in 
unwounded fetal skin. Compared to adult skin, fetal skin had differential concentrations 
of the TGF-β isoforms, had high levels of phosphorylated Receptor-Smads, especially 
in the epidermis, and had low expression of several fibrosis-associated target genes. 
Further, the results indicated that the processes of receptor endocytosis might also 
differ between fetal and adult skin. 
This descriptive study showed that there are differences in gene expression, protein 
concentrations and protein localization for most components of the canonical TGF-β 
pathway between fetal and adult skin. The findings of this study can be a starting point 
for further research into the role of TGF-β signaling in scarless healing.
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Introduction
The intriguing phenomenon of scarless healing in early fetal skin is a quest that is 
studied intensively for decades, but still remains unsolved. A significant part of the 
research in this area has focused on the role of transforming growth factor-β (TGF-β), 
as this growth factor has a key function in scarring and fibrosis. Intriguingly, differences 
between fetal and adult skin have been found for the three TGF-β isoforms. These 
findings led to the assumption that TGF-β3 has anti-fibrotic properties while TGF-β1 
and –β2 are pro-fibrotic [1, 2]. Although it is now known that the three isoforms have 
distinct functions during wound healing, all three isoforms have the ability to activate 
the fibrosis-associated canonical TGF-β pathway [3, 4]. Since all three isoforms activate 
the same pathway, the exact molecular mechanisms leading to their differential function during wound healing are not clear [5]. Thus, the role of TGF-β in scarless healing has not 
been elucidated yet and the quest still remains. 
The canonical TGF-β pathway consist of several extra- and intra-cellular components 
that, together, form a cascade of events that results in upregulation of fibrosis-related 
genes. The cascade starts with the activation of inactive TGF-β from the latent TGF-β 
binding protein (LTBP) complex which is bound to the extracellular matrix (ECM). Upon 
activation, TGF-β binds to TGF-β Receptor II (TGF-βRII) which subsequently forms a 
complex with TGF-βRI, the so called TGF-βR complex. Formation of this complex leads to 
activation and phosphorylation of the Receptor-Smads -i.e. Smad2 and Smad3 [6]. These 
phosphorylated Smads can then bind Smad4 and, as a complex, migrate to the nucleus 
to activate transcription. After activation and phosphorylation of the Receptor-Smads, 
the TGF-βR complex is taken up via Receptor endocytosis pathways; the receptors 
are either recycled back to the plasma membrane via clathrin-mediated endocytosis 
or degraded via caveolin-mediated endocytosis. Besides TGF-βRI and –βRII, another 
receptor, TGF-βRIII, is identified, but its function in wound healing and fibrosis still 
remains unknown. 
We recently described the potential role that the different components of the TGF-β 
pathway might play in fetal scarless wound healing in a review article [7]. In contrast to 
the extensive studies on the TGF-β isoforms in the fetal skin, only little information is 
available about the other components of the canonical TGF-β pathway such as the TGF-
βRs or the intracellular Smads. In human skin, one group studied the expression of both 
TGF-β and the TGF-βRs [8]. Several other groups studied some of the components of the 
pathway in rodents but little attention has been devoted to the intracellular part of the 
pathway. The only data available on this intracellular Smad-signaling are from in vitro 
studies in fibroblasts [9-12]. Therefore, only scarce information exists on the presence and 
function of most of the components of the canonical pathway in human fetal skin. 
The purpose of the present investigation was to evaluate all of the components of 
the canonical TGF-β pathway in unwounded human fetal and adult skin both on gene 
expression as well as protein levels and protein localization. Besides the TGF-β isoforms, 
the LTBP, the TGF-βRs, the receptor endocytosis markers, the Receptor-Smads, and the 
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inhibitory Smads were studied. Furthermore, expression levels of some direct target 
genes of the canonical TGF-β pathway were studied , i.e. TGF-β induced (TGF-βi) [13-15], 
connective tissue growth factor (CTGF) [16,17], and plasminogen activator inhibitor-1 
(PAI-1) [18]. Finally, expression levels of some ECM genes that are also known to be 
involved in this pathway were studied, i.e. Collagen Type-I (Col1), Collagen Type-III 
(Col3) [19, 20], Biglycan, Decorin and Fibromodulin [21-23].
Materials and methods
Tissue collection
Healthy human adult skin was obtained from fully informed, consenting donors 
undergoing abdominoplasty. Healthy human fetal skin was harvested from the limbs 
of aborted fetuses; patients undergoing elective terminations of pregnancy were fully 
informed and had given consent. Gestational age of the fetuses was estimated by last 
menstrual period. For an overview of samples used for the different assays, see table 1.
From all skin samples, subcutaneous tissue was carefully removed and two biopsies 
were taken. One biopsy was fixed in kryofix (50% ethanol, 3% PEG300) for at least 24 
hours (h) at 4°C, the other biopsy was snap-frozen and stored at -80°C. Samples that 
could not be snap-frozen immediately were preserved in RNAlater (Life Technologies, 
Bleiswijk, the Netherlands) on ice for a maximum of 24 h before processing.
RNA isolation and cDNA synthesis
Frozen skin samples were manually cut into small slices and lysed using TRIzol reagent 
(Life Technologies). Adult skin was further lysed in a Tissue Lyser LT (Qiagen, Venlo, 
The Netherlands) for 5 minutes (min) at 65 Hertz. During all procedures samples were 
kept on ice. RNA was extracted according to the manufacturer’s instructions. RNA was 
dissolved in Diethylpyrocarbonate (DEPC) treated water and RNA concentration and 
purity were measured (Nanodrop, Nanodrop Technologies, Wilmington, DE, USA). 
Agarose gel electrophoresis was used to asses RNA quality, only RNA samples with 
clear 28S and 18S bands were used for cDNA synthesis. From these samples, 500 ng of 
RNA was reverse transcripted using the QuantiTect Reverse Transcription Kit (Qiagen) 
following the manufacturer’s instructions. The resulting cDNA was diluted 5 or 10 times 
in DEPC-treated water and stored at -20°C upon use.
Table 1 (gest) Age Q-PCR (n, age) IHC (n, age) Luminex (n, age) 
Fetal 17-22 wks 18 (19.7 wks) 10 (19.6 wks) 10 (19.6 wks) 
Adult 16-56 yrs 11 (37 yrs, 2 male) 5 (46 yrs, 1 male) 10 (40 yrs, 1 male) 
 
Table 1: Sample information. 
Range of gestational (gest) age in weeks (wks) or age in years (yrs). Number of samples (n) for 
every analyses and the mean age and number of male samples. Sex of the foetuses was not known 
but equal distribution was assumed. 
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Quantitative Real-time polymerase chain reaction (Q-PCR)
Primers for the different components of the TGF-β pathway were designed based 
on National Center for Biotechnology Information (NCBI) and the primers were 
synthesized by Invitrogen (Life Technologies) (table 2). For the Q-PCR reaction, 2.5 
µL of diluted cDNA was incubated with 7.5 µL of mastermix containing 300nM of the 
primer-pair dissolved in 5.0 µL SYBRGreen DNA polymerase (Applied Biosystems, 
CA, USA) and DEPC-treated water. All samples were analysed in triplicate for every 
primer. Q-PCR reaction was performed on a StepOnePlus™ RT-PCR System (Applied 
Biosystems). First, SYBRGreen DNA polymerase was activated (1 min at 90°C) followed 
by 40 amplification cycles (15 seconds (sec) at 95°C, 1 min at 60°C) and a meltcurve 
analysis (stepwise reduction of temperature over time) was performed. StepOnePlus™ 
software was used to determine Ct-values and relative gene expression was calculated 
with the ddCt method as normalized ratios between the target gene and the average of 
three reference genes (supplement A).
Immunohistochemistry (IHC)
Kryofix-treated samples were processed for paraffin embedding and 5 µm sections were 
sliced. Slides were stained with antibodies from Abcam (Cambridge, UK), R&D systems 
(Abingdon, UK), BD Biosciences (Breda, The Netherlands), LSBio (Seattle, WA, USA) 
or Santa Cruz Biotechnology Inc (Heidelberg, Germany) (supplement B) and negative 
control slides were incubated in absence of the primary antibody. Appropriate secondary 
poly-horseradish peroxidase (poly-HRP) either goat-anti-mouse (1:400, P0260 clone) 
or goat-anti-rabbit (1:400, polyclonal) both from Dako (Glostrup, Denmark) were 
used followed by DAB substrate (Dako) incubation and Mayer’s Haematoxylin (Dako) 
as a counterstain. Localization and intensity of specific staining were evaluated and 
representative slides were photographed with a Zeiss BF microscope (Zeiss, Sliedrecht, 
The Netherlands). In case of p-Smad2/3, secondary donkey-anti-goat poly-biotin from 
Jackson ImmunoResearch (Suffolk, UK) was used followed by streptavidin Alexa-
Fluor-555 (Life Technologies), DAPI (Invitrogen) was used to envision the nuclei. Slides 
were photographed with a Leica CTR6000 microscope (Leica-microsystems, Wetzlar, 
Germany).
Luminex
Frozen skin samples were manually cut into small slices. Tissue was lysed in MILLIPLEX 
MAP Lysis Buffer (Millipore, Billerica, MA, USA), homogenized for 5 min at 65 Hertz in a 
Tissue Lyser LT and centrifuged to remove debris and excess lipids. Two Milliplex map 
kits were used, the TGF-β 1,2,3 Magnetic Bead Kit (TGF-β kit) and the Human TGF-β 
Signalling Magnetic Bead Panel 6-plex (6-plex kit) from Millipore. Assays were run 
following manufacturer’s instructions on a Bioplex 200 system (Biorad, Veenendaal, The 
Netherlands). For both kits, samples were analyzed in duplo. The TGF-β kit measured 
total protein levels (pg TGF-β/mg tissue) of TGF-β1,2,3. Inactive TGF-β was activated 
by lowering the pH under 3.0 (10 min, room temperature (RT)). Protein levels were 
corrected for the total protein levels of the sample, which were quantified by means 
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of a BCA assay (Pierce, Thermo Scientific, Rockford, IL, USA). The 6-plex kit measured 
protein levels (median fluorescence intensity (MFI)) of TGF-βRII and Smad4 and 
phosphorylated levels of Smad2 and Smad3. MFI-values were corrected for the amount 
of cells in these samples quantified by means of GAPDH with a Western Blot.   
Western Blot
Western Blot was performed to normalize for the amount of cells and to measure the 
receptor endocytosis markers in the Luminex samples. The lysis buffer samples (see 
Luminex) were loaded onto 10% sodium dodecyl sulphate polyacrylamide (SDS-PAGE) 
gels and the separated protein fractions were transferred to polyvinylidene difluoride 
(PVDF) membranes (Bio-Rad). The membranes were blocked with 1:1 PBS-Odyssey 
Blocking Buffer (LI-COR Biosciences, Bad Homburg, Germany) and stained with primary 
antibodies (supplement B) followed by incubation with a secondary antibody either 
fluorescently labelled goat-anti-mouse-800 or goat-anti-rabbit-680 (both from LI-COR 
Biosciences). An odyssey Infrared Imaging System (LI-COR Biosciences) was used to 
scan the blots and Odyssey V3.0 software was used to measure the bands. 
Statistics
Q-PCR, Luminex and Western Blot data were analyzed by IBM SPSS software version 
20 (IBM, Amsterdam, The Netherlands). All data were tested independently and non-
parametrically by means of a Mann-Whitney U statistical test, significance was set at 
p<0.05. Graphpad Prism 4 (Graphpad, La Jolla, CA, USA) was used to create graphs and 
Adobe Illustrator CS4 (Adobe, Barcelona, Spain) was used to create figures.
Results
Differential ratios of the TGF-β isoforms in fetal and adult skin
In this study the differential gene expression for the TGF-β isoforms in fetal skin was 
confirmed with low mRNA expression for TGF-β1 and high expression for TGF-β2 and 
-β3 (table 2) [8, 10, 11]. In line with observations of Chen et al. [8], strong IHC staining for 
TGF-β1 was observed in the adult epidermis and dermis while positive staining was 
mainly observed in the fetal epidermis and the staining in fetal dermis was weak. 
TGF-β3 staining was observed in both the epidermis and dermis in fetal and adult skin 
but the staining was weaker in adult skin. TGF-β2 staining was, in line with the gene 
expression, stronger in fetal dermis compared to adult dermis (figure 1).
Subsequently, we quantitatively measured the concentrations of total TGF-β for all three 
isoforms in human fetal and adult skin by means of a Luminex assay (TGF-β kit). This 
assay showed that the concentrations of all three TGF-β isoforms are higher in fetal skin 
when measured as pg/mg protein (table 3). The ratios of the isoforms are in agreement 
with the gene expression ratios, as in adult skin TGF-β1 contributes to more than 88% 
of the total TGF-β content while a negligible amount of TGF-β3 was measured. In fetal 
skin the ratio is more balanced with 60.2% TGF-β1 against 37.2% TGF-β2 and 2.6% 
TGF-β3 (table 3). 
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Table 2 
Gene expression 
Sample size Median (ddCt) Mean rank U value Sign. level F vs. A 
F A F A F A 
Is
of
or
m
s TGF-β1 18 11 0.0170 0.0294 11.33 21.00 33.000 0.002 < TGF-β2 18 11 0.0147 0.0069 18.89 8.64 29.000 0.001 > TGF-β3 18 11 0.0128 0.0048 18.22 9.73 41.000 0.008 > 
TG
F-
β
R RI 18 11 0.0065 0.0065 15.17 14.73 96.000 0.912 = RII 18 11 0.0355 0.0655 11.00 21.55 27.000 0.001 < RIII 18 11 0.0230 0.0461 11.33 21.00 33.000 0.002 < 
 LTBP-1 18 11 0.0194 0.0161 16.44 12.64 73.000 0.256 = 
 Caveolin 18 11 0.1544 0.3159 11.22 21.18 31.000 0.002 < Clathrin 18 11 0.0345 0.0324 15.39 14.36 92.000 0.774 = 
Sm
ad
s 
Smad 2 18 11 0.0163 0.0049 18.28 9.64 40.000 0.007 > Smad 3 18 11 0.0169 0.0194 14.06 16.55 82.000 0.465 = Smad 4 18 11 0.0266 0.0262 15.28 14.55 94.000 0.842 = Smad 6 18 9 0.0106 0.0060 16.33 9.33 39.000 0.031 > Smad 7 18 11 0.0144 0.0531 10.50 22.36 18.000 0.000 < 
Ef
fe
ct
or
 G
en
es
 
TGF-βi 18 10 0.0456 0.0974 9.78 23.00 5.000 0.000 < PAI-1 18 9 0.0012 0.0033 11.11 19.78 29.000 0.006 < CTGF 18 8 0.0096 0.0258 11.50 18.00 36.000 0.047 < Col 1 18 11 0.6165 0.2318 16.67 12.27 69.000 0.188 = Col 3 18 11 1.0768 0.1807 17.67 10.64 51.000 0.031 > Biglycan 18 10 0.0457 0.0266 14.50 14.50 90.000 1.000 = Decorin 18 10 0.2337 3.2140 9.50 22.50 0.000 0.000 < Fibromodulin 18 10 0.0253 0.0457 12.33 16.13 51.000 0.261 =  
Table 2 : Gene expression as measured by Q-PCR. 
Relative gene expression for factors involved in the canonical TGF-β pathway was calculated with 
the ddCt method. The Mann-Whitney U statistical test was used to calculate median, mean rank, 
U-value, significance level (exact two-tailed). The table shows the results of the test as well as 
sample size and the difference between fetal and adult skin. Lower gene expression (<) in the fetal 
skin compared with the adult skin, higher gene expression (>) or no difference in gene expression 
(=) are shown in the last column.
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Fetal and adult skin contain LTBP-1
The TGF-β isoforms are produced in an inactive form and are bound to the ECM via 
the LTBP-complex. In this manner, the ECM functions as storage for inactive TGF-β that 
can be activated upon wounding [24]. We studied mRNA expression and protein levels 
of LTBP-1 and observed no differences in mRNA expression between fetal and adult 
skin (table 2). Furthermore, fetal skin, regardless of the gestational age, and adult skin 
showed a diffuse staining for LTBP-1 throughout the dermis (data not shown).
Gene expression of TGF-βRII differs from protein levels
Beside the TGF-β isoforms, TGF-βRs play an important role in the TGF-β signaling 
cascade. In our study, differences in gene expression were observed for TGF-βRII and 
–βRIII which were both lower expressed in fetal skin. No differences in gene expression 
were observed for TGF-βRI (table 2). Positive staining for the three TGF-βRs was 
observed in the epidermis, the dermis and the blood vessels with the strongest staining 
for TGF-βRII (data not shown). The total protein levels of TGF-βRII, were quantified by 
means of a luminex assay (6-plex kit). No significant differences in the total amount of 
TGF-βRII were observed between fetal and adult skin (figure 2). 
Differences in receptor endocytosis
Post-translational processes involved in TGF-βR presence at the plasma membrane are 
the receptor endocytosis pathways with either caveolin-mediated or clathrin-mediated 
endocytosis. Gene expression of both markers was studied and caveolin-1 was found 
to be significantly higher expressed in adult skin. No differences for gene expression 
of clathrin (EEA-1) were observed between fetal and adult skin (table 2) Strong IHC 
staining was observed for both endocytosis markers in the blood vessels and positive 
but weaker staining in the dermis of both fetal and adult skin. Western Blot analysis 
showed no differences for caveolin-1 but significant higher levels of clathrin (EEA-1) in 
adult skin (figure 2).
High phosphorylation levels for the Receptor-Smads in fetal skin
In response to Receptor activation, Smad2 and Smad3 are phosphorylated which 
results in activation and allows binding to Smad4. Q-PCR data in this study showed 
higher mRNA expression for Smad2 in fetal skin and no differences for Smad3 and 
Smad4  (table 2).  
Since phosphorylation of the Receptor-Smads is necessary for signal transduction, 
phospho-levels of Smad2 (Ser 465/467) and Smad3 (Ser 423/425) and total protein 
levels of Smad4 were measured (6-plex kit). Significantly higher levels were observed 
in fetal skin for all three Smads (figure 2). Strong IHC staining for p-Smad2/3 (Ser 
423/425) was observed in the epidermis and hair follicles of fetal skin, weaker staining 
was observed in fibroblasts throughout the fetal dermis. In adult skin only weak staining 
was observed in the epidermis, hair follicles and dermis. Almost all staining, both in fetal 
and adult skin, was observed in the cytoplasm and not in the nucleus of cells (figure 3). 
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Figure 1: IHC of the three TGF-β isoforms in fetal and adult skin. 
Representative samples were chosen, gestational age of the fetal sample is 18 weeks. Staining for 
TGF-β1 was clearly higher in the adult dermis while the staining for TGF-β2 and –β3 seemed to 
be higher in fetal dermis. Positive staining was observed for all isoforms in both fetal and adult 
epidermis. 
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Besides the Receptor-Smads, the canonical pathway also contains two Inhibitory-
Smads, i.e. Smad6 and Smad7. For these Smads only gene expression was measured, 
which showed a significantly higher gene expression for Smad6 and a significantly 
lower gene expression for Smad7 in fetal skin (table 2). 
Gene expression of target genes
Gene expression of some direct target genes of the canonical TGF-β pathway was 
measured by means of Q-PCR. One of these target genes is TGF-βi which is known to be 
upregulated in several cells, among which keratinocytes and fibroblasts after TGF-β1 stimulation [15]. In our study, significantly higher gene expression was observed for this 
effector molecule in adult skin in comparison with fetal skin (table 2). Similar, gene 
expression of PAI-1 and CTGF, which are also induced by TGF-β1, were higher in adult 
skin (table 2). 
Furthermore, gene expression of Col1 and Col3 was measured, as well as gene expression 
of some proteoglycans that are known to be involved in the TGF-β pathway [21-23], i.e. 
Biglycan, Decorin and Fibromodulin. Gene expression for Col3 was significantly higher 
while gene expression of Decorin was significantly lower in fetal skin. No differences 
were observed for Col1, Biglycan and Fibromodulin (table 2).
Discussion
The role of TGF-β in scarless fetal healing has been a topic of investigation for decades, 
and it is often assumed that fetal skin has short-lived or inhibited TGF-β signaling [7]. The 
purpose of the present study was to evaluate the components of the canonical TGF-β 
pathway in healthy human fetal and adult skin. The results of our descriptive study 
provide some new information about TGF-β signaling in the human fetal skin and give 
propositions for future research. In the next section we will discuss the main findings.
Table 3 TGF-β1 pg/mg) TGF-β2 (pg/mg) TGF-β3 (pg/mg) Total (pg/mg) 
Adult 183.72 ± 50.52 23.24 ± 14.10 1.02 ±  0.94 207.98 
Fetal 258.21 ± 53.18 159.37 ± 85.85 11.13 ± 3.03 428.71 
Percentage TGF-β1 (%) TGF-β2 (%) TGF-β3 (%) Total (%) 
Adult 88.3 11.2 0.5 100% 
Fetal 60.2 37.2 2.6 100% 
 
Table 3: Concentrations of the TGF-β isoforms in fetal and adult skin. 
Concentrations are calculated as pg TGF-β/mg total protein. The total protein content of the 
samples was determined by a BCA assay. Mean concentrations and standard deviations within 
the group (n=10) are given.
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Figure 2: Protein levels of components of the TGF-β pathway as measured by Luminex and 
Western Blot. 
One grey square represents one fetal sample while one black square represents one adult sample 
(for both n=10 in total), significance is indicated with either one star (* p<0.05) or two stars 
(** p<0.01). Top row of the figure shows the results of the TGF-β kit for TGF-β1 (left), TGF-β2 
(middle) and TGF-β3 (right) in pg/mg protein. Middle row, two left plots show the results of the 
Western blot for caveolin (left) and clathrin (EEA-1) (middle) in protein levels in arbitrary units 
(a.u.). Last row and right plot of the middle row show the results of the 6-plex Luminex kit for 
TGF-βRII (middle row, right), pSmad 2 (low, left), pSmad 3 (low, middle) and Smad 4 (low, right) 
in protein levels (a.u.).
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First, it was suggested that fetal skin might lack LTBP-1, and, thus, might not have the 
ability to store inactive TGF-β [25]. Our study showed that both, fetal and adult skin, contain 
LTBP-1. Even more, our study was the first were total TGF-β levels were quantitatively 
measured in fetal and adult skin. By doing this, we showed that fetal skin has not only 
the ability to store inactive TGF-β, we also demonstrated that fetal skin has higher 
concentrations (in pg/mg protein) of all three TGF-β isoforms compared to adult skin. 
Furthermore, we demonstrated that the differential gene expression in fetal skin also 
results in differential protein levels, the ratio TGF-β2 and –β3 versus TGF-β1 is higher 
in fetal skin compared to adult skin on gene expression as well as on protein level. In 
conclusion, this study showed that fetal skin contains higher concentrations of all three 
TGF-β isoforms but the ratios of the isoforms are differential compared to adult skin that 
contains mainly TGF-β1.
Second, we hypothesized recently that caveolin-mediated receptor endocytosis, leading to 
receptor degradation, might play a role in scarless fetal wound healing [7]. Our data showed 
that there are significant differences in gene expression and protein levels of two markers 
of the receptor endocytosis pathways. Gene expression of caveolin-1 and protein levels 
of EEA-1, a marker for clathrin, were significantly lower in healthy fetal skin compared 
to healthy adult skin. These results indicate that the processes of receptor endocytosis 
might differ between fetal and adult skin. Given these differences, it should be interesting 
to further investigate these receptor-endocytosis processes in fetal and adult skin.  
Third, in line with literature, one might suppose that fetal fibroblasts have limited or 
short-lived TGF-β signaling with lower or fast fading phosphorylation of Smad2 and 
Smad3 [7, 26-28]. Yet, the results of our study showed that non-wounded healthy fetal skin 
compared to adult skin has higher levels of pSmad2, pSmad3 and Smad4. Strong IHC 
staining was observed in the fetal epidermis which indicates that the measured difference 
in p-Smad2/3 levels might be caused by keratinocytes rather than fibroblasts. Further, 
most of the staining was localized extranuclear while shuttling of the p-Smad complex to 
the nucleus is necessary to activate transcription [29]. Therefore, it is most probable that 
the high pSmad levels will not even lead to a functional outcome, at least not in the healthy 
skin. Altogether, these data indicate a certain activation of the intracellular Smad pathway 
in unwounded fetal skin that is an interesting area for further studies. Measuring protein 
levels of Smad6 and Smad7, distinguishing between pSmad2 and pSmad3 localization and 
studying pSmad translocation into the nucleus are the first steps to gain further insight 
into the Smad signaling in fetal skin. 
Fourth, since high levels of p-Smad were measured in fetal skin, we wondered if expression 
of target genes of the pathway, such as PAI-1, TGF-βi, CTGF and ECM genes, would be higher 
as well. Interestingly, gene expression of the three fibrosis-associated target genes and of 
one ECM gene was significantly lower in fetal skin compared with adult skin. Of the other 
ECM genes, Col3 was higher expressed in fetal skin while no difference in expression was 
observed for Collagen 1, Biglycan and Fibromodulin. However, all these ECM genes can 
also be activated via interplay with other growth factors and intracellular pathways [30, 31]. 
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Figure 3: IHC of the p-Smad2/3 (Ser 423/425) in fetal and adult skin. 
Representative samples were chosen, gestational age of the fetal sample is 18 weeks. The white 
dotted line indicates the basement membrane between epidermis and dermis. Strong staining 
for p-Smad2/3 was clearly observed in the fetal epidermis (insert A) while only a few fibroblasts 
were positive in both the fetal and adult dermis (insert B & D). The adult epidermis showed some 
positive cells as well (insert C). Staining was mostly located extranuclear in the cytoplasm of the 
cells (right inserts A-D). 
Proefschrift_27jan2016_JAK_versie3b.indd   53 27-1-2016   21:43:53
501871-L-bw-Walraven
2
54
Altogether these findings shed a new light onto TGF-β signaling in human fetal skin. 
The data of this study can be used as a starting point for further research into the role 
of TGF-β signaling in scarless healing. It should be noticed that the data of this study 
concern healthy unwounded skin as a whole. No distinction was made between the 
various subsets of cells present in the skin and no comparison was made with wounded 
skin. Several groups that immunohistochemically studied fetal skin have reported that the 
main TGF-β producing cells are located in the fetal epidermis [8, 11]. Indeed, in this study, 
the fetal epidermis showed strong IHC staining for TGF-β1 and p-Smad2/3 which was 
stronger than the staining in the adult epidermis and the staining in the fetal and adult 
dermis. Therefore, it seems TGF-β1 plays a role in the developing fetal epidermis. It would 
be interesting to study this role further and, in addition, study the canonical pathway in 
the separated fetal epidermis and dermis.
Finally, the results from this study show that, for most components of the TGF-β pathway, 
gene expression is not always reflected in protein expression. Several post-transcriptional 
processes do influence the production and activation of these components. For example, 
the higher gene expression of TGF-βRII in adult skin was not observed on protein level 
and the gene expression of the Receptor-Smads is no indication of their phosphorylation. 
Therefore, it is absolutely necessary to study not only gene expression of these components 
but also protein levels and protein phosphorylation.
In conclusion, this present study compared the components of the canonical TGF-β 
pathway in human fetal and adult skin and established that there are differences in gene 
expression, protein concentrations and protein localization for most components of the 
canonical TGF-β pathway. Fetal skin was shown to have differential concentrations of 
the TGF-β isoforms, to have high levels of phosphorylated Receptor-Smads, especially 
in the epidermis, and to have low expression of several fibrosis-associated target genes. 
Therefore, this study showed that there are differences in canonical TGF-β signaling 
between human fetal and adult skin. Insight into these differences might lead to new 
approaches for wound healing therapies. 
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Supplement A: Primer sequences. 
Primer sequences design was based on NCBI data. The genes that are marked as (Ref) are used 
as reference genes.
Appendix
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Supplement B: Antibody information. 
IHC procedure: Slides were deparaffinized, rehydrated and antigen retrieval (AR) with either 
Tris/EDTA (TE) Buffer (pH=9.0, 10 min at 70°C) or Citrate Buffer (CB) (pH=6.0, 15 min at 70°C) 
was done (see column AR). After AR, a 3% [v/w] hydrogen peroxide block (15 min, RT) and a 
20% [v/v] serum block (normal goat serum (Jackson ImmunoResearch Laboratories, Suffolk, 
UK)) were performed before incubation with primary antibody. Serum and antibodies were 
diluted in 1% [w/v] bovine serum albumin (Sigma-Aldrich, Zwijndrecht, The Netherlans) in 
MilliQ. After incubation, slides were washed thoroughly and incubated for 1 h with appropriate 
secondary poly-horseradish peroxidase (poly-HRP). DAB substrate (Dako) incubation was used 
to detect peroxidase activity and Mayer’s Hematoxylin (Dako) was used as a counterstain. Slides 
were dehydrated and embedded in Entellan (Merck Millipore, Amsterdam, The Netherlands). In 
case of pSmad2/3, normal donkey serum (Sanbio, Uden, The Netherlands) was used as block 
and secondary donkey-anti-goat poly-biotin from Jackson ImmunoResearch (Suffolk, UK) was 
used followed by streptavidin Alexa-Fluor-555 (Life Technologies), DAPI (Invitrogen) was used 
to envision the nuclei. Slides were embedded in glycergel (Dako) 
Western Blot procedure: PVDF membranes were blocked 1h at RT in 1:1 pbs-block buffer before 
incubation with the primary antibody. For Western Blotting, primary and secondary antibodies 
were diluted in 1:1 pbs:block buffer containing 0.1% Tween.
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Abstract
Transforming growth factor-β (TGF-β) is involved in development and wound healing. 
Enhanced and prolonged TGF-β signaling during adult wound healing result in 
myofibroblast differentiation and fibrosis. In contrast, the fetal skin contains high levels 
of TGF-β but still has the intrinsic capacity to heal without scarring. Therefore, insight 
into the regulation of TGF-β signaling during fetal wound healing might lead to methods 
to control TGF-β signaling during adult wound healing. 
The aim of this study was to gain insight into the regulation of TGF-β signaling in 
human fibroblasts from the adult and fetal dermis. We imitated wound healing in a 
simplified way as we stimulated in vitro cultured fibroblasts with TGF-β and examined 
myofibroblasts differentiation. 
TGF-β stimulation of adult and fetal fibroblasts resulted in upregulated expression of 
several myofibroblast associated genes. As similar or even more severe upregulation 
of myofibroblast-associated genes was observed in fetal fibroblasts, this shows that 
these fibroblasts are able to respond to TGF-β. In addition, stimulated fetal fibroblasts 
in collagen matrices had higher protein levels of the myofibroblast marker α-smooth 
muscle actin (α-SMA), produced more of the fibrotic protein fibronectin splice-variant 
EDA (FnEDA), and showed enhanced contraction compared to adult fibroblasts. 
Furthermore, fetal fibroblasts produced significant higher levels of TGF-β1 compared 
to adult fibroblasts. 
Altogether, these data show that in vitro cultured fetal fibroblasts are able to differentiate 
into myofibroblasts and are also able to produce a fibrotic environment. Although 
this appears to be in contrast with scarless healing, the developing fetal skin contains 
high levels of TGF-β and FnEDA as well. Therefore, more advanced in vitro models are 
necessary to distinguish between the regulation of these factors during development 
and wound healing.
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Introduction
Since the discovery that fetal skin has the intrinsic ability to heal scarless, extensive 
studies have focused on the role of TGF-β [1]. TGF-β is an important growth factor in 
development but also plays a detrimental role during wound healing, as this growth 
factor strictly controls fibroblast to myofibroblasts differentiation [2, 3]. Differences in the 
TGF-β signaling pathway between healthy adult and fetal skin support that the pathway 
is differentially regulated during fetal development [4]. The regulation of the pathway 
during fetal skin development and fetal wound healing is of great interest as this could 
give insight into mechanisms to control TGF-β signaling. Control of TGF-β signaling 
during adult wound healing might optimize wound healing and prevent detrimental 
scarring, i.e. fibrosis.
Recently, we quantified the components of the canonical TGF-β signaling pathway in 
healthy human adult and fetal skin. That study showed fetal skin has high concentrations 
of TGF-β and high levels of intracellular signaling-Smads, indicating active intracellular 
TGF-β signaling. Nevertheless, fetal skin also had low expression of several TGF-β 
responsive genes, such as connective tissue growth factor (CTGF), Plasminogen 
Activator Inhibitor-type 1 (PAI-1), and TGF-β induced (TGF-βi) [4]. 
To study if the observed differences in TGF-β1 signaling contribute to fetal scarless 
healing, wounded human skin is necessary. However, as wounded fetal skin is not 
available, an in vitro wound healing model is needed. The most simple and common 
method to study wound healing in vitro is to stimulate in vitro cultured fibroblasts 
with TGF-β. Stimulation results in myofibroblast differentiation and a fibrotic-like 
situation, as gene expression of α-SMA is enhanced, production of FnEDA is increased and contraction is initiated [5-7].
Several groups already studied the response of fetal fibroblasts to TGF-β1 using an 
in vitro culture system. Remarkably, all studies concluded fetal fibroblasts are able 
to differentiate in myofibroblasts [8-10], although this appears to be in contrast with 
the scarless healing capacity of the fetal skin. However, conflicting results exist, due 
to different study designs, methods and materials. For example, fetal fibroblasts 
proliferation is reported to be enhanced [10, 11], reduced [12], or not affected [8, 13] in 
response to TGF-β1, and, also collagen 1 production is reported to be enhanced [13], reduced [10] or not affected [11] upon TGF-β stimulation. Hence, the exact response of fetal 
fibroblasts to TGF-β1 is still unclear. For that reason, the aim of our present study was to 
gain more insight into the myofibroblast differentiation in fetal fibroblasts. Therefore, 
we examined the response to TGF-β1, and studied the processes that are involved in 
myofibroblast differentiation and fibrosis between human adult and fetal fibroblasts.   
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Materials and methods
Fibroblast isolation and culture
Human adult fibroblasts were obtained from skin of patients undergoing abdominoplasty 
(11 donors, ages ranged from 28 to 54 years) and fetal fibroblasts were obtained from 
skin of the limbs of aborted fetuses (12 donors, gestational ages ranged from 15 to 21 
weeks). Tissues were collected according to national and institutional guidelines and 
informed consent was given for all tissue. Fibroblasts were isolated from the dermis 
with an enzymatic treatment as described before [14]. Fibroblasts were cultured in 
fibroblast culture medium (FBM); Dulbecco’s Modified Eagle’s Medium (Gibco, Thermo 
Fisher Scientific, Waltham, MA) with 10% FCS (Hyclone, Thermo Fisher Scientific), 
1mM 1-glutamine, 100 ug/mL streptomycin and 100 IU/mL penicillin (Gibco, Thermo 
Fisher Scientific). Upon 80% confluence, fibroblasts were passaged by trypsinization 
and fibroblasts between passage 3 and 6 were used for experiments.
Before TGF-β treatment, cells were seeded in 24-well plates and left to attach overnight. 
For 3D-cultures, fibroblasts were seeded (300.000 cells/cm2) into Novomaix collagen 
scaffolds (Matricel, Herzogenrath, Germany) and allowed to attach overnight. To induce 
collagen remodeling, FBM in the Noviomaix cultures was supplemented with 65 μg/mL 
vitamin C. Upon TGF-β stimulation, medium was refreshed with standard FBM or FBM 
containing 5 ng/mL recombinant human TGF-β1 (Biovision, Milpitas, CA). For cultures 
longer than 3 days, medium was refreshed every 2 or 3 days. 
Quantitative Real-time polymerase chain reaction (Q-PCR)
Samples that were designated for Q-PCR were lysed with Trizol (Life Technologies, 
Thermo Fisher Scientific) and RNA isolation was performed as previously described [4]. 
Shortly, chloroform was used to precipitate RNA, followed by washings with isopropanol 
and 70% ethanol. Diethylpyrocarbonate (DEPC) treated water was used to solve RNA. 
Quantified RNA was reverted in cDNA by a Reverse Transcription System Kit (Promega, 
Madison, WI) following manufacturer’s instructions. Primers were designed based 
on the National Center for Biotechnology Information (NCBI) database and primer 
synthesize was done by Invitrogen (Life Technologies). Primer sequences are given in 
table 1. Q-PCR was performed on a Step One Real-Time PCR System (Life Technologies). 
Western Blot
Samples for Western Blot were lysed with RIPA buffer; 50 mM Tris-HCl (pH 7.4), 150 
mM NaCl, 10 mM EDTA, 10% Triton in MilliQ with 1 Protease Inhibitor tablet (cOmplete, 
Sigma-Aldrich, Saint Louis, MO) per 50 mL. Upon use samples were heated for 10 min 
at 95˚C in 5x sample buffer; 250 mM Tris-HCl (pH 6.8), 10% SDS, 30% glycerol, 0,02% 
bromophenol blue, 5% β-mercapitalethanol in MilliQ. Samples were loaded onto 
10% sodium dodecyl sulphate polyacrylamide (SDS-PAGE) gels and, subsequently, 
transferred to polyvinylidene difluoride (PVDF) membranes (Bio-Rad Laboratories, 
Hercules, CA). Membranes were incubated shortly with blocking-solution; 50% Odyssey 
Blocking buffer (LI-COR Biosciences, Bad Homburg, Germany) in phosphate buffered 
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saline. Membranes were stained overnight at 4˚C with mouse anti-human α-SMA (1A4 
clone, Abcam) or mouse anti-human EDA Fibronectin (IST-9 clone, Sirius Biotech, Genoa, 
Italy) in a 1:1000 dilution in blocking-solution with 0,1% Tween. Rabbit-anti-human 
GAPDH (14C10 clone, Cell Signalling, Leiden, The Netherlands) in a 1:1000 dilution 
(2h, RT) was used as reference protein. Goat-anti-mouse IRDye 800 CW or goat-anti-
rabbit IRDye 680 (both from LI-COR) were used as secondary antibodies in a 1:10,000 
dilution. Blots were scanned with Odyssey Infrared Imaging System and bands were 
analyzed with Odyssey V3.0 software (both LI-COR Biosciences). 
Immunohistochemistry (IHC)
Collagen matrices were treated for 24h at 4˚C with Kryofix; 50% ethanol, 3% PEG300 
in MilliQ. Fixed matrices were processed for paraffin embedding and cut in 5 μm 
sections. Sections were fixed on slides, deparaffinized, rehydrated, heated in Tris/
EDTA buffer (pH=9.0, 10 min at 70˚C), blocked with 20% normal goat serum (Jackson 
ImmunoResearch Laboratories, Suffolk, UK) and stained with the EDA Fibronectin 
antibody for 2h at RT in a 1:100 dilution in 1% [w/v] bovine serum albumin solution 
(Sigma-Aldrich). Negative control slides were incubated in absence of the antibody. The 
first incubation step was followed by washing steps and incubation for 1h at RT with a 
secundary goat anti-mouse AF-555 (Invitrogen) in a 1:500 dilution. DAPI (Invitrogen) 
was used to stain the nuclei and glycergel (Dako, Glostrup, Denmark) to mount slides. 
Slides were photographed with a Zeiss fluorescence microscope (Zeiss, Sliedrecht, The 
Netherlands).
TGF-β Elisa
Cell culture supernatants were collected and frozen at -80˚C. Upon use, inactive TGF-β 
was activated by lowering pH under 3.0 (10 min, RT) followed by neutralizing pH to 7.0. 
Levels of TGF-β1 were measured in the supernatants using a TGF-β1 Emax ImmunoAssay 
System (Promega, Madison, WI) following manufacturer’s instructions. Absorbance 
was determined at 450 nm on a 680 Microplate reader (Bio-Rad Laboratories)
Table 1 Primer Sequence 5’-3’ Reverse Sequence 5’-3’ Collagen 1a  AGAAAGGGGTCTCCATGGTG AGGACCTCGGCTTCCAATAG Collagen 3  CCAGGAGCTAACGGTCTCAG TGATCCAGGGTTTCCATCTC CTGF TGTGCACCGCCAAAGATG CAGACGAACGTCCATGCTG EF1a (Ref)  TCGGGCAAGTCCACCACT CCAAGACCCAGGCATACTTGA FnEDA CCCTAAAGGACTGGCATTCA CATCCTCAGGGCTCGAGTAG GAPDH (Ref)  CCATGTTCGTCATGGGTGTG GGTGCTAAGCAGTTGGTGGTG LH2b TTAAAGGAAAGACACTCCGATCAGAGATGA AATGTTTCCGGAGTAGGGGAGTCTTTTT PAI-1  AGTGAAGATCGAGGTGAACGA GACTGTTCCTGTGGGGTTGT TGF-βi  ATGACCCTCACCTCTATGTACC CACAGTTCACAGTTACAATCCCA YWHAZ (Ref)  AGCAGAGAGCAAAGTCTTC GCTTCTTGGTATGCTTGTTG  
Table 1: Primersequences. 
Primer sequences design was based on NCBI data. The genes that are marked as (Ref) are used 
as reference genes. 
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Statistical analysis
Graphpad Prism 4 (Graphpad, La Jolla, CA, USA) was used to perform statistical analyses, 
different analyses were used. Significance of 24h-gene expression between fibroblasts 
groups was calculated with Kruskall-Wallis followed by Dunn’s Multiple Comparisons 
test. Significance of TGF-β stimulation within fibroblasts groups was calculated with a 
two-way repeated measurement (RM) ANOVA which calculated if samples significantly 
differed over time compared to the unstimulated adult sample. Finally, differences in 
fold change between fetal and adult samples were calculated with a Mann-Whitney 
followed by Bonferonni correction. Every figure and table indicates which test was used.
Results
Fibroblasts respond to TGF-β1 by upregulation of myofibroblast-associated genes
To study myofibroblast differentiation, adult and fetal fibroblasts were cultured in 
monolayer and stimulated with TGF-β1 for 24 hours. Gene expression of several TGF-
β-responsive and myofibroblast-associated genes was observed. First, we studied 
myofibroblast-marker α-SMA [5, 15] and observed upregulation in the TGF-β1 treated 
samples. However, this upregulation was only significant in fetal fibroblasts. Moreover, 
stimulated fetal fibroblasts had significant higher levels of α-SMA compared to stimulated 
adult fibroblasts (figure 1A). Second, we observed expression of the TGF-β-responsive 
genes that were found to be lower expressed in healthy fetal skin compared to healthy 
adult skin, i.e. CTGF [16,17], PAI-1 [18,19], and TGF-βi [20,21]. In contrast to our findings in the 
skin, no significant differences in expression of these genes were observed between 
unstimulated fetal and unstimulated adult fibroblasts. Moreover, all of these genes were 
upregulated after 24h treatment with TGF-β1 in both adult and fetal fibroblasts. This 
upregulation was statistically significant for CTGF and TGF-βi in both fibroblast groups 
and for PAI-1 in the fetal fibroblast group (figures 1 B-D). 
Myofibroblasts are also known for excessive extracellular matrix production and 
crosslinking. TGF-β1 regulates several of these extracellular matrix molecules like 
collagen Type-I (Col1a), collagen Type-III (Col3), and FnEDA [22-24]. TGF-β1 stimulation 
resulted in a clear increase in expression of the FnEDA gene in both fibroblast groups, 
although the increase was only statistically significant in fetal fibroblasts (figure 1E). 
Also expression of Lysyl Hydroxylase 2b (LH2b), a gene that is involved in fibrosis-related crosslinking of collagen [25], was elevated upon stimulation with TGF-β1 (figure 
1F). In contrast to PAI-1 and FnEDA, the increase in LH2b expression was only significant 
in adult fibroblasts. Furthermore, the Col1a and Col3 genes were not affected after 24 
hours TGF-β1 stimulation (figure 1G-H). Like with the other TGF-β responsive genes, 
the expression of Col3 did not reflect the situation in the skin, as higher Col3 expression 
in fetal skin compared to adult skin [4] was not observed between the unstimulated fetal 
and adult fibroblasts (figure 1H).
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Figure 1: Fetal fibroblasts respond to TGF-β1 by upregulation of myofibroblast-associated 
genes.
Box-and-whiskers plots (represents median, hinges and end points) of gene expression of 
TGF-β responsive genes after stimulation with TGF-β1 for 24h in 5 adult and 6 fetal donors in 
unstimulated (-) and stimulated (+) conditions. Significance was calculated by  Kruskall Wallis 
followed by Dunns Multiple Comparisons tests, * p≤0.05, ** p≤0.01.
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In vitro cultured fetal fibroblasts have high α-SMA expression
The significant higher expression of myofibroblast-associated genes in fetal fibroblasts 
shows that these cells are capable of myofibroblast differentiation upon TGF-β1 
stimulation. As the differentiation in fetal fibroblasts is described to be short-lived 
[10], we investigated gene expression and protein levels of α-SMA at day 3, 7 and 10 
(figure 2A-D). At these time points, levels of α-SMA were higher in stimulated samples 
compared to unstimulated samples. At day 7, both gene expression and protein levels of 
α-SMA differed significantly in stimulated fibroblasts compared to unstimulated adult 
fibroblasts (figure 2A&B). Further, gene expression and protein levels in stimulated fetal 
fibroblasts significantly differed from unstimulated adult fibroblasts at all time points. 
Besides, protein levels in unstimulated fetal fibroblasts were significantly higher at day 
3 compared to unstimulated adult fibroblasts. Altogether, these results show a more 
severe response in fetal fibroblast compared to adult fibroblasts. 
A
C
B
D
Figure 2: In vitro cultured fetal fibroblasts have high α-SMA expression.  
A-D) Quantification of gene expression, protein levels, fold change in gene expression, and fold 
change in protein levels. A&B) Every dot represent mean ± SEM of unstimulated (-) or stimulated 
(+) adult or fetal fibroblasts. As two samples are missing on day 10, sample sizes are not equal 
over time and a two-way repeated measurement (RM) ANOVA could not be used. Therefore, 
significance was calculated with Kruskall-Wallis followed by Dunns Multiple Comparison Test, 
* p< 0.05,  ** p<0.01, or *** p<0.001 versus the unstimulated adult fibroblasts at that time point. 
C&D) Every bar represent mean ± SEM of fold changes between stimulated and unstimulated 
samples . Significance was calculated by Mann-Whitney tests between adult and fetal fibroblasts 
at the same time point. After Bonferonni correction for the use of multiple tests no samples were 
significantly different.
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As some studies have calculated fold change or ratio instead of using quantitative values 
[8, 10], we also calculated fold change between unstimulated and stimulated samples 
(figure 2C&D). With this method, we found a higher fold change in adult fibroblasts 
compared to fetal fibroblasts at day 7 for both mRNA expression and protein levels. 
However, this finding is caused by the difference in basal levels rather than differences 
in response.
Fetal fibroblasts have myofibroblast-associated characteristics 
As fibroblasts are sensitive to their environment [26, 27], the high α-SMA expression in 
fetal fibroblasts might be induced by the two-dimensional culture method on rigid 
plastic. Indeed, Moulin et al. reported a decrease in α-SMA levels when fibroblasts were 
cultured in collagen gels instead of in monolayer [8]. However, collagen gels that are not 
under isometric tension, i.e. matrices made of soluble collagen, can initiate fibroblast 
quiescence and apoptosis [26, 28], and impede myofibroblast differentiation [29].  Therefore, 
we cultured fibroblasts in artificial skin substitutes. Again, significantly higher protein 
levels of α-SMA were observed in TGF-β1 stimulated fetal fibroblasts at day 2 and day 3 
but not in stimulated adult fibroblasts (figure 3A). 
As myofibroblast differentiation is also shown to require FnEDA [15], we measured 
soluble levels of this protein by means of Western Blot. TGF-β1 treatment resulted in 
significant higher FnEDA levels at day 1 in fetal fibroblasts and at day 2 in both adult 
and fetal fibroblasts (figure 3B). By day 3 soluble protein levels were decreased, except 
for a slight increase in the unstimulated fetal fibroblasts. Nevertheless, IHC staining at 
this time point clearly showed that FnEDA was deposited as a network into the matrix 
with stimulated fibroblasts (figure 3D&F). Moreover, matrices with unstimulated fetal 
fibroblasts (figure 3E) had a FnEDA network similar to the stimulated adult fibroblasts 
(figure 3D) while this was not observed in matrices with unstimulated adult fibroblasts 
(figure 3C).
In addition to the high α-SMA and FnEDA levels in fetal fibroblast cultures, matrices 
started to contract (figure 3G). Contraction was already visible at day 1 in stimulated 
fetal samples by curling of the edges. At day 3, all stimulated fetal samples were severely 
contracted (figure 3G&H) while stimulated adult samples showed curling of the matrices. 
At this time point, curling was observed as well in unstimulated fetal fibroblast samples 
but not in unstimulated adult samples. Quantification, by measurement of the diameter, 
showed significantly more contraction in stimulated fetal fibroblasts at day 3 (figure 
3G).
Fetal fibroblasts produce significant higher levels of TGF-β1
Unstimulated fetal fibroblasts have significant higher gene expression of α-SMA and 
TGF-βi, higher protein levels of α-SMA and FnEDA, and show more contraction compared 
to adult fibroblasts. Altogether, unstimulated fetal fibroblasts have myofibroblast-
associated characteristics similar to TGF-β1 stimulated adult fibroblasts. Since we have 
shown before that fetal skin has high levels of TGF-β, we examined TGF-β1 levels in 
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Figure 3: Fetal fibroblasts have myofibroblast-associated characteristics in artificial skin 
substitutes. 
A&B) Quantification of protein levels of α-SMA and soluble FnEDA in unstimulated (-) and 
stimulated (+) adult and fetal fibroblasts over time. Graph represent mean ± SEM with n=3 per 
group. Two-way RM ANOVA was used to calculate significant differences, * p< 0.05 or ** p< 0.01 
 means the indicated group differed from the unstimulated adult fibroblasts at that time point. 
C-F) IHC of the solid FnEDA network in cultured matrices containing C) unstimulated adult 
fibroblasts, D) stimulated adult fibroblasts, E) unstimulated fetal fibroblasts or F) stimulated fetal 
fibroblasts. White bar indicates 100 μm. The IHC results show the solid FnEDA network which 
differs from the soluble FnEDA levels depicted in 3B. G) Measurement of matrix contraction. 
Again, graph represents mean ± SEM with n=3 per group, *** p< 0.001 vs. unstimulated adult 
fibroblasts at that time point calculated by two-way RM ANOVA. H) Examples of matrices 
seeded with fetal fibroblasts at day 3, arrowheads point at unstimulated samples that slightly 
curl at the edges while arrows point at stimulated samples that are severely contracted. 
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supernatants at 3, 7 and 10 days of culture. Levels of total TGF-β1 were significant higher 
in supernatants of fetal fibroblast compared to adult fibroblasts. This was regardless of 
the treatment as no differences were observed between unstimulated and stimulated 
samples (figure 4). At day 10, TGF-β1 concentrations in the unstimulated fetal fibroblast 
supernatants were even reaching the optimal treatment levels of 5 ng/mL. Since culture 
medium was refreshed two or three times a week, this shows that TGF-β1 production 
increased over time in fetal fibroblast cultures. This increase in TGF-β production over 
time was not observed in adult fibroblast cultures (figure 4). 
Discussion
More insight into TGF-β signaling during fetal wound healing might unravel mechanisms 
to control this signaling pathway. In this study, we stimulated adult and fetal fibroblasts 
with TGF-β1 and examined myofibroblast differentiation. The main finding of this 
study is that fetal fibroblasts are able to differentiate in myofibroblasts, despite their 
scarless healing capacities. Strikingly, in vitro cultured fetal fibroblasts in unstimulated 
conditions even show enhanced myofibroblast differentiation and TGF-β production, 
which is not observed in adult fibroblasts.
The high levels of α-SMA, FnEDA and TGF-β1 observed in fetal fibroblast cultures 
appear to be incoherent with scarless healing, but are observed by others as 
well.  High TGF-β1 production in fetal fibroblast cultures is already described by 
three other groups [30-32]. Furthermore, significantly higher levels of α-SMA in fetal 
fibroblasts compared to adult fibroblasts were reported by Moulin et al. [8]. Also 
in a study by Rolfe et al. levels of α-SMA and FnEDA in stimulated fetal fibroblasts 
were twice as high as levels in stimulated adult fibroblasts [10]. Furthermore, Glim 
et al. observed higher basal levels of α-SMA in fibroblasts derived from a scarless 
healing environment -the oral mucosa- compared to dermal fibroblasts [33]. 
Remarkably, all these studies show high TGF-β1 or α-SMA levels but interpretation of 
the data varies. We have illustrated this in figure 2, where different interpretations could 
be made due to differences in data processing i.e. higher quantitative expression versus 
A
Figure 4: Fetal fibroblasts 
produce high levels of TGF-β1. 
Quantification of TGF-β1 levels 
in culture supernatants, graph 
represents mean ± SEM of 3 adult 
and 3 fetal donors in unstimulated and stimulated conditions at 
different time points. Significance 
was calculated using a two-way RM 
ANOVA, samples were compared to 
the unstimulated adult fibroblast 
group at that time point, ** p<0.01 
and *** p< 0.001.
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higher fold change. As the in vitro culture of fibroblasts is an oversimplified model, it is 
hard to verify the biological relevance of the different interpretations and translation to 
the in vivo situation is difficult.
Despite the simple culture model, some of our findings reflect the situation in the healthy 
fetal skin. First, the high levels of TGF-β1 observed in the fetal cultures are in accordance 
with the significant higher levels of TGF-β we observed in the fetal skin [4]. Second, FnEDA 
is an important protein during development and it is highly expressed in developing tissues [34, 35]. Altogether, healthy fetal skin has characteristics of a fibrotic environment, 
which correlates with the theory that wound healing is a revival of the developmental 
program of the skin [36-38]. Consequently, the difference between scarless healing and 
detrimental scarring appears to be quantity and timing rather than absolute presence 
of fibrosis-associated factors. Hence, not only the presence of fibrosis-associated factors 
should be studied but also the timing and persistence of these factors.
Regardless of the pro-fibrotic environment, no α-SMA positive fibroblasts can be observed 
in the healthy fetal skin [39, 40] and levels of myofibroblast-associated genes, like CTGF, 
PAI-1, TGF-βi, are significant lower [4]. Since our current study shows that in vitro 
cultured fetal fibroblasts differentiate in myofibroblasts, the question remains why 
the pro-fibrotic environment in the healthy fetal skin does not provoke myofibroblast 
differentiation. More insight into mechanisms that prevent myofibroblast differentiation 
in the healthy fetal skin could lead to methods to control myofibroblast differentiation 
during adult wound healing. In this regard, it would be interesting to study the role of 
keratinocytes, as we have shown earlier that cells in the fetal epidermis contain high 
levels of phosphorylated Smads [4]. Therefore, keratinocytes rather than fibroblasts 
appear to be the main TGF-β responsive cells in the fetal skin. 
Nonetheless, more advanced and biological relevant culture models are necessary to 
study the processes in fetal skin in more detail. An in vitro wound healing model for 
fetal and adult skin, as described by Coolen et al. [39], would be suitable. Although this 
model needs optimization as no myofibroblast differentiation was observed, even not 
in the adult samples. Addition of growth factors or immune cells to this in vitro wound 
healing model is a promising method to optimize this model.
In conclusion, this study shows that in vitro cultured fetal fibroblasts are able to 
differentiate in myofibroblasts and produce a pro-fibrotic environment. This pro-fibrotic 
environment correlates with the situation in healthy fetal skin since fibrosis-associated 
markers like TGF-β and FnEDA are also important in skin development. More insight 
into the regulation of these factors during development and wound healing is necessary 
to be able to distinguish between their regenerative and their fibrotic properties.
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Abstract
Myofibroblast persistence after wound closure leads to fibrosis, while the fibrotic 
environment induces myofibroblast differentiation in return. Consequently, a vicious 
circle between myofibroblasts and environment exists that needs to be broken. The 
link between cells and the environment is formed via focal adhesions (FA) and integrin 
receptors. Myofibroblast have supermature FA which induce pro-adhesive signaling 
and an adhesive phenotype. In contrast, fetal fibroblasts from a scarless environment 
have a migratory phenotype. 
The aim of this study was to delineate the migratory phenotype of the fetal fibroblasts and 
to identify integrin receptors that induce this phenotype. Furthermore, we investigated 
whether interference with these integrin receptors modifies adult fibroblasts behavior. 
We show that fetal fibroblasts have lower gene expression of pro-adhesive molecules, 
reduced adhesion and improved migration. This migratory fetal phenotype is intrinsic, 
since it is retained despite changes in ECM coatings or substrate stiffness. In addition, 
we show that this phenotype has lower levels of α1-, α3-, α4-, α5β1, and αVβ5. Finally, 
the effects of blocking α1-, α2-, and αVβ5 integrins were investigated. Only blocking of 
α1- integrin significantly reduced adhesion and improved migration in adult fibroblasts, 
while it did not affect fetal fibroblasts. Therefore, blocking α1-integrin reverted adult 
fibroblasts towards a fetal-like migratory phenotype, and appears to be an interesting 
option to treat fibrosis.
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Introduction
During wound healing, fibroblasts migrate into the wound and contribute to wound 
closure by remodeling of the extracellular matrix (ECM) and secretion of cytokines. 
Myofibroblasts are the contractile phenotype of the fibroblast, and these contractile cells 
play an important role in closure of the wound. However, if myofibroblasts persist in 
the wound bed, fibrosis occurs due to enhanced contraction, excessive ECM production 
and cytokine secretion [1]. Although myofibroblasts generate the fibrotic environment, 
the environment can also affect myofibroblast persistence. Fibrotic tissue is stiffer than 
healthy skin and contains high levels of TGF-β. Since myofibroblast differentiation is 
induced by TGF-β together with matrix stiffness, the fibrotic environment stimulates 
myofibroblast differentiation and persistence [2]. Thus, a fibrotic environment results in 
myofibroblast persistence while myofibroblasts further induce a fibrotic environment, 
leading to a vicious circle that needs to be broken.
Cells can sense their environment and respond to it via FA, which link the cellular 
cytoskeleton to the ECM. FA consist of transcellular integrin receptors and an intracellular integrin adhesome [3, 4]. In mammals, 18 α-integrin subunits and 8 β-integrin subunits 
are known, that can associate in 24 distinct integrin receptors. These receptors can be 
divided into several subfamilies based on their affinity for ECM ligands, for example 
α1β1, α2β1, α10β1 and α11β1 are clustered together in the collagen receptor family 
[5]. Intracellular, integrin receptors bind to the adhesome, which forms a link with 
the cytoskeleton and is a dynamic complex of more than 180 FA-proteins including 
protein tyrosine kinase 2 (PTK2) and paxilin (Pax) [4]. As the integrin adhesome is a 
dynamic complex, FA are constantly assembled and disassembled and these processes 
activate several signaling pathways and influence cell behavior [6, 7]. Thus, FA are the link 
between the cellular cytoskeleton and the ECM and play an essential role in cell-matrix 
interactions.
As a result of the essential role of FA in cell-matrix interactions and the negative role of 
cell-matrix interactions on myofibroblasts persistence, affecting FA could also influence 
myofibroblast behavior. Myofibroblasts have been shown to have a special type of 
FA, the so-called supermature FA, which is characterized by the presence of different 
FA-proteins and integrins. For example, vinculin, Pax, αVβ3- and α5β1-integrin are 
associated with these supermature FA [8, 9]. A recent study that deleted αV-integrins from 
myofibroblasts showed that this resulted in inhibited fibrosis in several organs [10]. The 
authors did not study the mechanism of action, but proposed the reduced fibrosis was 
a result of inhibited TGF-β activation. Indeed, αV- integrins are associated with TGF-β 
activation and blocking αVβ5 has been shown to inhibit latent TGF-β activation [11, 12]. 
However, different mechanisms of action can exist, besides the activation of TGF-β, 
in which integrins and FA influence myofibroblast differentiation and fibrosis. More 
insight into these mechanisms of action could lead to therapeutic methods to break the 
vicious circle of myofibroblast persistence.
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Two processes that are strongly regulated by FA are cellular adhesion and migration 
which are controlled via the Rho-family pathway [13, 14]. Accordingly, FA size has 
been shown to be a reliable predictor of fibroblast migration speed [15]. Curiously, 
fetal fibroblasts that are derived from a scarless healing environment have a higher 
migration rate than neonatal fibroblasts [16, 17]. Moreover, these fibroblasts also have low 
expression of collagen receptors compared to adult fibroblasts [18]. These data show that 
migration and FA differ between fetal and adult fibroblasts. Differences in FA are also 
observed between dermal fibroblasts and gingival fibroblasts, derived from the scarless 
environment of the oral mucosa. Gingival fibroblasts have lower gene expression of two 
central FA-proteins -Pax and PTK2-, and also have reduced adhesion [19]. In contrast, 
sclerotic fibroblasts, derived from a fibrotic environment, have high gene expression of 
Pax and an enhanced ability to adhere [20]. Altogether, these data show that fibroblasts 
from different environments have divergent adhesive and migratory capacities. Fibrotic 
fibroblast have an adhesive phenotype while ‘scarless’ fetal and gingival fibroblasts have 
a migratory phenotype. Dissimilarities in integrin receptors and gene expression of FA-
molecules indicate that these phenotypes are caused by differences in FA composition 
and maturation. 
Overall, FA regulate fibroblast adhesion and migration and these processes are altered in 
fibroblasts from scarless healing or fibrotic environments. The aim of this study was to 
identify integrin receptors that induce the migratory fetal phenotype. Subsequently, the 
identified integrin receptors were tested for their ability to modify adult fibroblast adhesion 
and migration. Factors that can revert adult fibroblasts towards the fetal phenotype 
are promising for therapies to disrupt the vicious circle of myofibroblast persistence. 
Materials and Methods
Fibroblast culture
Human adult fibroblasts were derived from skin of patients undergoing abdominoplasty 
(ages ranged from 17 to 54 years) and fetal fibroblasts from skin of the limbs of aborted 
fetuses (gestational ages ranged from 15 to 22 weeks). For all tissues, informed consent 
was given according to national and institutional guidelines. In total, fibroblasts from 
9 adult and 13 fetal donors were used. Enzymatic fibroblast isolation from the dermis 
was performed as described before [21]. Fibroblasts were cultured in fibroblast culture 
medium (FBM); Dulbecco’s Modified Eagle’s Medium (Gibco,Thermo Fisher Scientific, 
Waltham, MA) with 10% fetal calf serum (FCS)(Hyclone, Thermo Fisher Scientific), 1mM 
1-glutamine, 100 ug/mL streptomycin and 100 IU/mL penicillin (Gibco, Thermo Fisher 
Scientific). At 80% confluence, fibroblasts were passaged by trypsinisation. Fibroblasts 
between passage 3 and 7 were used for experiments.
RNA isolation and Quantitative Real-time polymerase chain reaction (Q-PCR)
Fibroblasts were cultured in 6-well plates for 24h and subsequently lysed with Trizol 
(Life Technologies, Thermo Fisher Scientific). RNA isolation was performed as described 
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[22]. Shortly, RNA was precipitated with chloroform, washed with isopropanol and 70% 
ethanol, and diluted in Diethylpyrocarbonate (DEPC) treated water. After quantification 
of mRNA, conversion into cDNA was done using a Reverse Transcription System Kit 
(Promega, Madison, WI) following manufacturer’s instructions. Q-PCR was performed 
on a Step One Real-Time PCR System (Life Technologies, Thermo Fischer), primers were 
synthesized by Invitrogen (Life Technologies). Primer design was based on National 
Center for Biotechnology Information (NCBI) and sequences were as given in given in 
table 1. Gene expression was corrected for input by three references genes and fold 
change was calculated as the differences between adult and fetal [23].
Culture plates and coatings
All adhesion assays were performed in 96-wells culture plates, except for substrate 
stiffness adhesion assays which were done in Easy Coat Softwell plates (Matrigen, Brea, 
CA). Migration assays were performed on μ-Slides (Ibidi GmbH, Martinsried, Germany) 
with Culture-Inserts (Ibidi). Human collagen Type-I (Col1)(C5483), collagen Type-III 
(Col3)(C4407) or fibroblast-derived fibronectin (FN)(F2518) (all from Sigma Aldrich, 
Saint Louis, MO) were dissolved and stored according to manufacturers’ instructions. 
Coating mixtures were prepared with DMEM in, prior assessed, concentrations of 10 µg/
mL Col1 and Col3 or 5 µg/mL FN. Plates or μ-slides were coated for 3-4 h at 37˚C and 
washed twice with DMEM before use.
Cell adhesion assay
A slightly adapted protocol from Geijtenbeek et al [24] was used as follows. Cells were 
labeled for 30 min at 37°C with Calcein-AM (Life Technologies, Thermo Fisher); 2.5 µg 
in 100 µL phosphate buffered saline (B. Braun medical BV, Oss, The Netherlands) per 
106 cells. Cells were washed and resuspended in FBM. Approximately, 20.000 cells/well 
were seeded in 96-well plates and allowed to adhere at 37°C for the indicated times. 
Subsequently, plates were washed gently with Hank’s Balanced Salt Solution (HBSS) 
(Gibco, Thermo Fisher) with 0.5% FCS until all non-adherent cells were removed. 
Adherent cells were lysed with lysis buffer; 50 mM Tris in MilliQ (EMD Millipore, 
Billerica, MA) with 0,1% sodium dodecyl sulfate (SDS). Fluorescence was measured with 
Table 1 Forward sequence Reverse sequence EF1a (ref) TCGGGCAAGTCCACCACT CCAAGACCCAGGCATACTTGA GAPDH (ref) CCATGTTCGTCATGGGTGTG GGTGCTAAGCAGTTGGTGGTG Pax CCAGTGCCAAAACTTCCAGTG TTGTTGGGGAAGCTGTAGACG PTK2 AGCTCAGCTCAGCACAATCC GTGGCCTGTCTTCTGGACTC Rac1 ATGTCCGTGCAAAGTGGTATC CTCGGATCGCTTCGTCAAACA RhoA CCAAGATGAAGCAGGAGCCG CACTCCATGTACCCAAAAGCG YWHAZ (ref) AGCAGAGAGCAAAGTCTTC GCTTCTTGGTATGCTTGTTG  
Table 1: Primer sequences 
Primer sequences as used in this experiment. Primer design was based on National Center for 
Biotechnology Information (NCBI).
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a BMG Fluorstar Galaxy (MTX Lab Systems, Vienna, VA). Values are the mean of triplicate 
wells and percentages of adherence were calculated by comparison with control wells 
that were not washed. All experiments were, at least, independently repeated at three 
different time points and with at least three different cell isolates per group.
Cell migration assay
Approximately 5.000 cells/well were seeded onto μ-Slides with Culture-Inserts and 
allowed to attach for 24h at 37˚C. Upon start of the experiment, Culture-Inserts were 
removed and medium was refreshed with FBM in the presence of absence of blocking 
antibodies. Migration was measured with an IX81 motorized inverted microscope 
(Olympus Life Science Solutions, Tokyo, Japan). Cell migration was recorded for at least 
15h with 1 photo/15 min. Per well, cell migration was assessed at two locations and per 
location, migration speed of three, randomly selected cells was measured using cellR 
software (Olympus). Based on the cellR measurements, velocity was calculated as total 
distance (mm) / time (h) and directionality was calculated as linear distance (mm)/ 
total distance (mm) [25].
Integrin quantification
To quantify integrin levels an α/β-integrin-mediated Cell Adhesion Array (EMD 
Millipore) was used according to manufacturer’s instructions. Shortly, cell suspension 
was prepared, plates were incubated with 100,000 cells/well for 1h at 37˚C, washed 
three times with Assay Buffer, incubated with Cell Stain Solution for 5 min, washed with 
MilliQ and lysed with Extraction Buffer. Absorbance was determined at 570 nm on a 680 
Microplate reader (Bio-Rad Laboratories, Hercules, CA). The α-kit contained wells with 
monoclonal mouse-anti-integrin α1- α2-, α3-, α4-, α5-, αV- and αVβ3 antibodies while 
the β-kit contained β1-, β2-, β3-, β4-, β6-, α1β5 and αVβ5 antibodies. Negative wells 
with a goat-anti-mouse antibody were taken along as blanks to quantify background 
levels. 
Blocking antibodies
Mouse-antibodies against α1 (FB12 clone), α2 (P1E6 clone) (both from EMD Millipore) 
or αVβ5 (P1F6 clone, Abcam) were used in a, prior assessed, optimal concentration of 1 
μg/mL. All dilutions were made with FBM upon use. All experiments with α1- and α2- 
blocking antibodies were done on Col1 coated plastic, while uncoated plastic was used 
for the αVβ5-antibody.
Results
Fetal fibroblasts have lower gene expression of pro-adhesive molecules
Sclerotic fibroblasts have enhanced gene expression of Pax [20], while gingival fibroblasts 
have reduced gene expression of PTK2 and Pax [19]. Since fetal fibroblasts are also 
derived from a scarless environment, gene expression of PTK2 and Pax was measured. 
Significant lower expression of both these pro-adhesive genes was observed in fetal 
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fibroblasts compared to adult fibroblasts (figure 1). Further, since FA regulate the Rho-
family pathway and this pathway controls cell adhesion and migration, gene expression 
of two members of the Rho-family pathway was measured i.e. Ras-related C3 botulinum 
toxin substrate 1 (Rac1), which is involved in early cell adhesion and cell spreading [26] 
and its counter protein Ras homolog gene family, member A (RhoA) which is involved in FA maturation [27]. Fetal fibroblasts had significant lower expression of both Rac1 and 
RhoA (figure 1). 
Fetal fibroblasts have reduced adhesive capacities regardless of substrate
Since fetal fibroblasts have reduced gene expression of several pro-adhesive molecules 
compared to adult fibroblast, we assessed the adhesive capacities of these fibroblasts. 
First, adhesion of fetal and adult fibroblasts to culture plastic was determined. Adhesion 
to plastic is dependent on the presence of serum proteins from the FCS, mainly plasma 
FN and vitronectin (VN), on the plastic [28]. At all time points, adhesion was reduced in 
fetal fibroblasts compared to adult fibroblasts and the differences were significant at 30 
and 60 min (figure 2A). 
As has already been mentioned, integrins have different affinities for ECM proteins. 
Since the fetal skin has a distinct composition of the ECM compared to the adult skin 
[29], adhesion to several ECM coatings was assessed, i.e. Col1 and Col3 and a fibroblast-
derived form of FN (figure 2B). Coating with Col1, which is less abundant in the fetal skin 
[30], resulted in significantly improved adherence in both fibroblasts. In contrast, coating 
with Col3, which is more evident in the fetal skin and early granulation tissue [29, 31], did 
not affect adhesion. Finally, FN is lacking in healthy adult skin [29] but the cellular FN is 
highly present during wound healing and the special EDA-splice variant is associated 
with myofibroblast differentiation [32]. Therefore, coating of fibroblast-derived FN was 
used which resulted in improved adhesion. Although Col1 and FN coatings improved 
adhesion, fetal fibroblast still adhered significantly slower to these coatings compared 
to adult fibroblasts (figure 2B).
Figure 1: Fetal fibroblasts have 
lower gene expression of pro-
adhesive molecules.
Fibroblasts were cultured for 24h 
on plastic, mRNA was isolated and 
Q-PCR was done. For all isolates (n=6 
per group), mRNA expression was 
adjusted for three reference genes 
and fold increase was calculated by 
setting average adult fibroblast mRNA 
expression on 1, graph represent 
mean ± 95% confidence interval 
(CI), Mann-Whitney U statistical tests 
were used to calculate significance, 
* = p< 0.05, ** = p< 0.01. 
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Finally, matrix stiffness also affects cell adhesion and stimulates myofibroblast differentiation [2, 33]. To assess if substrate stiffness might differentially affect fibroblasts 
adhesion, softwell plates with a variable elastic modulus were used. Reduced adhesion 
was observed for the softer bottoms (low elastic modulus) for both fibroblasts with 
again lower adhesion for the fetal fibroblasts (figure 2C).
Fetal fibroblasts migrate faster regardless of ECM substrate
Besides adhesion, the Rho-family pathway is also involved in migration, and reduced 
adhesive capacities are associated with improved migration kinetics. Therefore, time 
lapse microscopy was used to measure migration speed of fibroblasts on plastic or on 
coated plastic. Fetal fibroblasts showed significantly faster migration compared to adult 
fibroblasts [16]. Moreover, the different ECM coatings, i.e. Col1, Col3 and FN, did not affect 
migration speed (figure 3). 
Reduced Rac1 activity switches migration from random to directed migration, by 
suppressing peripheral lamellae formation and increasing fibroblast polarity, a process 
that is independent of chemotaxis [25]. As differences in gene expression of Rac1 were 
observed between fetal and adult fibroblasts, the migratory directionality of these 
fibroblasts might also differ. Therefore, directionality of single fibroblasts was calculated 
by dividing the linear distance of their movement in a specific time period by the total 
distance of their movement in the same time period. On plastic, adult fibroblasts migrated 
with an average directionality coefficient of 0.56 ± 0.09 (SD) and fetal fibroblasts of 
0.54 ± 0.12 (SD). Also on coated plastic, no differences in directionality were observed 
indicating that the fibroblasts migrated in random motion.
Fetal fibroblasts have lower levels of several integrin receptors
As integrins play an important function in adhesion and migration [14], and fetal 
fibroblasts showed reduced adhesion but improved migration, levels of 6 α-subunits, 
5 β-subunits and 3 integrin receptors were quantitatively measured with an α/β-
integrin-mediated Cell Adhesion Array (figure 4). Both fibroblast types had detectable 
levels of all α-subunits, but of the β- subunits, only the β1-subunit was expressed above 
the background levels. Overall, lower levels of all the assessed integrins were measured 
in fetal fibroblasts compared to adult fibroblasts, although some of the differences were 
only small. Yet, significant lower levels of α1-, α3- and α4-subunits and of α5β1- and 
αVβ5-integrins were detected (figure 4).
Blocking α1-integrin redirects adult fibroblast adhesion and migration
Based on the observed integrin profiles, three integrins were selected to study the effects 
of blocking on fibroblast adhesion and migration. First, blocking αV-integrin has already 
been suggested as treatment option, because this subunit is associated with fibrosis and 
TGF-β activation [10-12]. Of the αV-subunits measured in our assay, only αVβ5-integrin 
was significantly different and, for that reason, this receptor was selected. Blocking of 
αVβ5 resulted in reduced adhesion to plastic with an average reduction of -18.0% ± 
8.3 (mean ± SD) in adult fibroblasts and -14.9% ± 4.6 in fetal fibroblasts (figure 5A). 
Proefschrift_27jan2016_JAK_versie3b.indd   84 27-1-2016   21:44:08
501871-L-bw-Walraven
4
Fetal fibroblasts and their migratory phenotype
85
Figure 2: Fetal fibroblasts have reduced adhesive capacities regardless of substrate.
Adhesion assays were performed as described in the materials and methods. Adhesion (%) was 
calculated by setting cell input at 100%. A) Fibroblast adhesion to plastic; B) Fibroblast adhesion 
to coatings (30 min at 37˚C); The data of A&B are the results of at least three independent 
experiments at different time points, with at least six different cell isolates per group, graphs 
show mean ± 95% CI, Mann-Whitney U statistical tests were used to calculate significance, * = p< 
0.05, ** = p< 0.01. C) Fibroblast adhesion to Softwell plates with variable elastic modulus of 0.2 
till 50 kPa (15 min at 37˚C); graphs represent mean ± standard error of the mean (SEM) (n=3).
Figure 3: Fetal fibroblasts migrate faster regardless of ECM substrate.
Fibroblast migration on plastic or coated plastic, migration experiments were done as described 
in the materials and methods. All data are the results of independent experiments performed at 
different time points (with a minimum record time of 15h), with at least six different cell isolates 
per group, graphs show mean ± 95% CI , Mann-Whitney U statistical tests were used to calculate 
significance, * = p< 0.05, ** = p< 0.01. 
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Blocking did not significantly affect migration, i.e. average improved migration of adult 
fibroblasts was 5.4 μm/h ± 3.2 and of fetal fibroblasts -3.2 μm/h ± 7.3 (figure 5B). 
Since blocking of αVβ5 did not affect migration and also affected fetal fibroblasts 
adhesion, αVβ5-integrin appears not to be involved in the migratory fetal phenotype. 
Therefore, α1- and α2-subunits were selected and tested. Both these subunits only 
associate with the β1-subunit, forming integrin receptors that have high affinity for 
Col1. Blocking of α1-integrin in adult fibroblasts resulted in altered adhesion and 
migration to collagen coated plates (figure 5B). Adhesion was reduced with -7.7% ± 3.9 
and migration increased with 4.8 μm/h ± 2.6. However, blocking did not significantly 
alter adhesion or migration in fetal fibroblasts (resp. -0.9% ± 3.8% and 0.9 μm/h ± 3.3). 
Blocking of α2-integrin resulted in statistically reduced adhesion in both fibroblasts 
(adult -19.6% ± 9.7 and fetal -19.1% ± 5.2) but did not affect migration (adult 2.6 μm/h 
± 4.5 and fetal 1.4 μm/h ± 5.8) (figure 5). 
Discussion
Fibroblasts from different environments have contrastive adhesive and migratory 
capacities, fibroblasts from a fibrotic environment have an adhesive phenotype while 
fetal and gingival fibroblasts from a scarless environment have a migratory phenotype. 
The aim of this study was to identify integrins that induce the migratory fetal phenotype 
and to block these integrin receptors to modify adult fibroblast adhesion and migration. 
Methods to shift the phenotype of fibroblasts towards a scarless-associated migratory 
phenotype are promising targets to break the vicious circle of myofibroblast persistence. 
Our data show that fetal fibroblasts have a migratory phenotype that is characterized 
by lower gene expression of pro-adhesive molecules, reduced adhesion and improved 
migration. This migratory phenotype correlates with literature and with the theory 
that fibroblast from a scarless healing environment have a migratory phenotype while 
fibroblasts from a fibrotic environment have an adhesive phenotype. 
Moreover, our study shows that this migratory phenotype is intrinsic. Changes in ECM 
coatings did not affect migration speed and, while some ECM coatings or alterations in 
substrate stiffness did affect fibroblast adhesion, the observed effects were similar for 
both fetal and adult fibroblasts. For example, Col1 coating improved average adhesion 
with 25% in both fetal and adult fibroblasts, i.e. the average fetal adhesion improved 
from 46% to 71% while adult adhesion improved from 67% to 92%. Therefore, the 
migratory phenotype of the fetal fibroblast retains despite alterations in environment. 
This does correlate with the conclusion of Sandulache et al. that fetal fibroblasts have a 
hyperactive migratory phenotype that is only subtly affected by substrate changes [17].
In addition, this study quantified integrins and showed that fetal fibroblasts have 
significantly lower levels of several collagen- and fibronectin-binding integrins such as 
α1-, α3-, α4-, α5β1, and αVβ5. These low levels can be an explanation for the reduced 
adhesion on both plastic and ECM coatings since fetal fibroblasts have lower expression 
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Figure 4: Fetal fibroblasts have lower levels of several integrin receptors.
Integrin adhesion profiles in arbitrary units (a.u.) were quantified with an α/β-integrin-mediated 
Cell Adhesion Array as described in the materials and methods section. Graphs show the mean ± 
SEM of 6 cell isolates per group, retrieved from three independent experiments at different time 
points, Mann-Whitney U statistical tests were used to calculate significance, * = p< 0.05, ** = p< 0.01. 
Figure 5: Blocking α1-integrin redirects adult fibroblast adhesion and migration.
A) Effects of blocking antibodies on adhesion. B) Effects of blocking antibodies on migration. 
Blocking experiments were performed as described in the materials & methods. All experiments 
with the α1- and α2- blocking antibodies were done on Col1 coated plastic, while uncoated 
plastic was used for the αVβ5-antibody. Graphs show the mean ± SEM of 6 cell isolates per 
group, y-axis shows adhesion (%) or migration (mm/h), untreated (-) and treated (+) samples 
are shown. The data are acquired in at least three independent experiments at different time 
points. Two-way ANOVA followed by Bonferroni posttests was used to calculate significance for 
the treatment, * = p< 0.05.
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of receptors that have affinity for collagens (i.e. α1-) and for FN and VN (i.e. α4-, α5β1 
and αVβ5)[5]. 
Further, as the goal of this study was to identify integrin receptors that induce the 
migratory phenotype, antibodies were used to assess the effects of α1-, α2- and αVβ5 
integrins on adhesion and migration. Interestingly, blocking with the α1-antibody 
modified both adhesion and migration of adult fibroblasts while it did not affect 
fetal fibroblasts. Therefore, α1-integrin blocking switched the phenotype of the adult 
fibroblast towards a fetal-like migratory phenotype. This is in contrast to the other 
blocking antibodies that similarly reduced adhesion in both fibroblasts but did not 
affect migration. These results suggest that the α2β1 and αVβ5 integrins do not induce 
the differential phenotype. Accordingly, this might make α1-integrin blocking an 
interesting target option to treat fibrosis.  
Finally, by quantifying integrins on fetal and adult fibroblasts, our study has shown 
that the subunit that is already linked to fibrosis, i.e. αV-, is present in similar levels 
on fetal and adult fibroblasts subtypes. Besides, blocking of αVβ5-integrin similarly 
altered adhesion and migration in both fibroblasts. Together, these data demonstrate 
that αV-integrins do not influence the migratory fetal phenotype. Therefore, our study 
proves that, besides the activation of TGF-β, there is a differential mode of action in 
which integrins affect fibrosis. Based on our data we propose a mechanism in which α1-
integrin enhances a specific kind of fibroblast adhesion that negatively affects wound 
healing and induces fibrosis.
In conclusion, our study shows that fetal and adult fibroblasts have differential adhesive 
and migratory phenotypes. These phenotypes are intrinsic as they are retained despite 
changes in culture-environment. Furthermore, differential integrin profiles, with low 
expression of collagen- and fibronectin binding integrins result in a more migratory 
phenotype. Indeed, blocking of these integrins in both fetal and adult fibroblasts 
reduced adhesion. However, blocking of α1-integrin resulted in significantly reduced 
adhesion and improved migration in adult fibroblasts but did not affect fetal fibroblasts. 
Therefore, treatment with α1-blocking antibodies redirects the phenotype of adult 
fibroblasts towards a more fetal-like migratory phenotype. This makes α1-integrin an 
interesting target for therapies to reduce myofibroblast persistence and fibrosis.
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Abstract
Ongoing scar contraction after wound closure is part of a pathological scarring process 
that is called hypertrophic scarring. Myofibroblasts are key players in hypertrophic 
scarring as these cells produce excessive amounts of extracellular matrix and are highly 
contractile. Scar contraction is a complication that negatively affects the patient’s range 
of motion (ROM) and quality of life. An effective non-surgical method to prevent scar 
contraction is splinting, which is done by bracing the contraction in a fixed position. 
However, no consensus exists on the optimal splinting protocol with regard to method 
of bracing or treatment duration. Furthermore, the molecular mechanisms that might 
underlie the positive effects of splinting upon scar contraction are not known yet.
The goal of this study was to assess the effects of splinting on myofibroblast 
differentiation or de-differentiation in order to identify the best splinting protocol to 
reduce contractures. Differences in expression of myofibroblast-associated genes were 
investigated between fibroblasts from different human tissues to assess their intrinsic 
fibrotic profiles, i.e. ‘healthy’ adult dermal fibroblasts, ‘scarless’ fetal dermal fibroblasts, 
and ‘scarring’ adult eschar fibroblasts. Eschar fibroblasts had higher expression of 
myofibroblast-associated genes compared to the other fibroblasts groups, but the 
differences were not significant. Stretch reduced gene expression of α-smooth muscle 
actin (α-SMA) and production of scarring-associated transforming growth factor-β1 
(TGF-β1) in all fibroblasts. However, the stretch programs did not have uniform effects 
on expression of the other myofibroblast-associated genes. Altogether, this study does 
not give conclusive evidence for the beneficial effects of splinting on scar contraction. 
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Introduction
Ongoing scar contraction after wound closure is a pathological process that is part 
of hypertrophic scarring. Pathological scar contraction negatively affects the ROM of 
affected joints and the patients’ quality of life. Consequently, contractures at joint sites 
often require reconstructive surgery to restore mobility [1-3]. 
Currently, the most common non-operative method to treat contractures is splinting [4, 5]. 
Common splinting treatments are either static splinting -the contracture is braced 
in a fixed position- or dynamic splinting -a combination of static splinting with ROM 
exercises-. Splinting treatments are considered safe and efficacious methods to reduce 
scar contraction as multiple studies have reported an improvement in ROM [6-8]. However, 
treatments vary widely between different clinics since there is no consensus on the 
splinting protocol with regard to splinting method or treatment duration. Besides, 
the effectiveness of splinting is debated as strong evidence from large prospective 
randomized trials is lacking [5]. Such trials are necessary to properly compare the 
different methods of splinting, but differences in burn wound etiology, posttraumatic 
treatment and patient compliance make the execution of such studies difficult [5,8]. In addition, there is no insight into the cellular and molecular mechanisms that underlie 
the effects of splinting on scar contraction. 
Scar contraction is part of hypertrophic scarring, a pathological process in which 
‘normal’ wound healing derails and processes that are essential during the first stages 
of wound healing continue after wound closure. A cell that plays an important role in 
this derailment of wound healing is the myofibroblast, which differentiates from the 
fibroblast. Myofibroblast differentiation is characterized by the formation of stress 
fibers due to recruitment of α-SMA to the cytoskeleton [9]. Myofibroblasts produce high 
amounts of extracellular matrix and cross-link the collagen via the hydroxyallysine route. 
Eventually, this results in irreversible accumulation of collagen, increased mechanical 
tension and TGF-β activation [10, 11]. Although all these processes are necessary to close 
the wound during the first stages of wound healing, continuation of these processes 
after wound closure results in hypertrophic scarring and scar contraction. 
The rationale behind splinting techniques is to apply mechanical forces opposite to the 
contractile forces to prevent scar contraction. However, myofibroblasts are stimulated 
by mechanical tension and, therefore, splinting forces could induce myofibroblast 
differentiation. Consequently, the application of splinting could improve scar contraction 
instead of reducing it.  In vitro data support this idea, as fibroblast populated collagen 
gels subjected to mechanical loads showed an induction of myofibroblast phenotype 
[12, 13]. In addition, the application of mechanical tension to in vitro cultured scar tissue 
resulted in an induction of myofibroblasts as well [14]. 
Eschar fibroblasts are derived from burn wound tissue and are thought to be the key 
players in the onset of hypertrophic scarring and scar contraction in these wounds [15]. 
Therefore, this study assessed the scarring-associated profile of eschar fibroblasts and 
compared it to ‘healthy’ dermal fibroblasts and ‘scarless’ fetal fibroblasts [16]. Further, 
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the aim of this study was to determine whether mechanical stretch could alter the 
scarring-associated profile of eschar fibroblasts towards the healthy fibroblast profile. 
As no consensus exists on splinting protocol, we used two different stretch programs 
that simulated splinting therapies, either static splinting or dynamic splinting. 
Altogether, the ultimate goal of this study was to identify cellular and molecular 
mechanisms that underlie the positive effects of splinting on scar contractures.
Materials and methods
Fibroblast isolation and culture
Fibroblasts were isolated from human adult or fetal skin or from burn wound tissue 
(i.e. eschar tissue), isolation was performed as described before [17]. Adult skin was 
donated by patients undergoing abdominoplasty (6 donors, ages ranged between 16 
to 70 years), eschar tissue was donated by patients undergoing burn wound surgery (6 
donors, age range between 26 to 49 years), and fetal skin was obtained from the limbs 
of aborted fetuses (8 donors, gestational ages ranged between 15 to 20 weeks). For all tissues informed consent was given according to national and institutional guidelines. 
Cells were cultured in fibroblast culture medium (FBM); Dulbecco’s Modified Eagle’s 
Medium (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) with 10% FCS (Hyclone, 
Thermo Fisher Scientific), 1mM 1-glutamine, 100 ug/mL streptomycin and 100 IU/
mL penicillin (Gibco, Thermo Fisher Scientific). Upon 80% confluence fibroblasts 
were passaged by trypsinization. Fibroblasts in passage 3 were used for the stretch 
experiments.
Flexcell®
Collagen 1 coated bioflex® plates (Flexcell International Corp, Hillsborough, NC, USA) 
were seeded with approximately 12,500 cells/cm2 and fibroblasts were left to adhere 
overnight (ON). Directly before start of the experiment FBM was refreshed. Plates 
were placed in a Flexercell® FX4000 apparatus (Flexcell International Corp) inside 
an incubator (37˚C, 95% humidity, 5% CO
2
). Control plates were placed in the same 
incubator but not subjected to stretch. Cells were subjected to multiaxial stretch, 
either static stretch (10% elongation for 24h) or stretch regime (10% elongation for 
10h followed by 2h of mechanical loading with a sinusoidal pattern, baseline-10% 
elongation, at a frequency of 1Hz, this 12h program was repeated twice) (figure 1). 
Directly after the 24h stretch programs cell culture supernatant was collected and cells 
were lysed in Trizol (Life Technologies, Thermo Fisher Scientific).
Quantitative Real-time polymerase chain reaction (Q-PCR)
RNA was isolated from Trizol samples with chloroform treatment as described before 
[18]. RNA was dissolved in Diethylpyrocarbonate (DEPC) treated water, quantified on a 
nanodrop and reverted to cDNA with a Reverse Transcription System Kit (Promega, 
Madison, WI). Primers were designed, synthesized and used as described before [18]. 
Primer sequences are given in table 1. Q-PCR was performed on a Step One Real-
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Time PCR System (Life Technologies, Thermo Fischer). Relative gene expression was 
calculated with the ddCt method as normalized ratios between target genes and the average of three reference genes, while fold change was calculated as the difference 
between paired stretch and no stretch samples [19].
TGF-β Elisa
A TGF-β1 Emax ImmunoAssay System (Promega, Madison, WI) was used to quantify 
levels of TGF-β1 in cell culture supernatants. To measure total levels of TGF-β1, pH 
of cell culture supernatants was lowered under 3.0 (10 min, RT) and subsequently 
restored to pH 7.0. The assay was performed following manufacturer’s instructions 
and a 680 Microplate reader (Bio-Rad Laboratories, Hercules, CA) was used to measure 
absorbance at 450 nm.
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Figure 1: Flexcell® and stretch programs. 
A) Flexcell 4000 apparatus including computer and pump. B) Culture plate insert inside culture 
hood. C) Schematic representation of Flexcell® mechanism, due to vacuum the membrane with 
cells is stretched around the loading block (lb). D) Stretch programs used in this study.
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Statistical analysis
Graphpad Prism 4 (Graphpad, La Jolla, CA, USA) was used to perform statistical analyses. 
Two different analyses were used. Significance of gene expression between fibroblasts 
groups was calculated with Kruskal-Wallis, followed by Dunn’s Multiple Comparisons 
test. Significance of the effects of stretch within fibroblasts groups was calculated with a 
Wilcoxon-signed rank test which compared ddCT-values of two related samples (stretch 
and no-stretch) and assessed whether their population mean ranks differ. This test was 
used to calculate significance within every fibroblast groups. Every figure and table 
indicates which of either test was used.
Results
Myofibroblast-associated gene expression in fibroblasts from different origin
To assess the scarring-associated profiles of the different fibroblast types, we studied 
gene expression of several myofibroblast-associated genes. First, we chose α-SMA as 
this is a well-known myofibroblast marker and recruitment of α-SMA to stress fibers is involved in contraction [20]. Although eschar fibroblasts had slightly higher overall 
expression of α-SMA compared to adult and fetal fibroblast, the differences were not 
significant (figure 2A). 
Second, upregulation of collagen production [21] and Lysyl Hydroxylase 2b (LH2b)-
mediated hydroxyallysine crosslinking of the collagen [10] are distinct features of the 
myofibroblast. A slightly higher gene expression was observed for collagen-I (col1a) and 
collagen-III (col3) in eschar fibroblasts compared to adult and fetal dermal fibroblasts 
(figure 2B-D). Furthermore, significant higher expression of LH2b was observed in 
eschar fibroblasts compared to adult and fetal dermal fibroblasts (figure 2D). 
Table 1 Primer Sequence 5’-3’ Reverse Sequence 5’-3’ Collagen 1a  AGAAAGGGGTCTCCATGGTG AGGACCTCGGCTTCCAATAG Collagen 3  CCAGGAGCTAACGGTCTCAG TGATCCAGGGTTTCCATCTC CTGF TGTGCACCGCCAAAGATG CAGACGAACGTCCATGCTG EF1a (Ref)  TCGGGCAAGTCCACCACT CCAAGACCCAGGCATACTTGA FnEDA CCCTAAAGGACTGGCATTCA CATCCTCAGGGCTCGAGTAG GAPDH (Ref)  CCATGTTCGTCATGGGTGTG GGTGCTAAGCAGTTGGTGGTG LH2b TTAAAGGAAAGACACTCCGATCAGAGATGA AATGTTTCCGGAGTAGGGGAGTCTTTTT PAI-1  AGTGAAGATCGAGGTGAACGA GACTGTTCCTGTGGGGTTGT TGF-βi  ATGACCCTCACCTCTATGTACC CACAGTTCACAGTTACAATCCCA YWHAZ (Ref)  AGCAGAGAGCAAAGTCTTC GCTTCTTGGTATGCTTGTTG  
Table 1: Primer sequences. 
Primer sequences design was based on NCBI data. The genes that are marked as (Ref) are used 
as reference genes.
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Figure 2: Intrinsic differences in gene expression in fibroblasts from different origin. 
Box-and-whiskers plots (represents medians, hinges and end points) of ddCt-value in fibroblast 
from different groups (number of samples per group is indicated under x-axis). Significance was 
calculated with Kruskall-Wallis followed by Dunn’s Multiple Comparison test, * means p< 0.05 
between those groups.
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Third, an extracellular matrix molecule that is required for myofibroblasts 
differentiation is extra domain A splice variant of fibronectin (FnEDA), and the gene 
for FnEDA is upregulated in myofibroblasts [11,22]. FnEDA gene expression in eschar 
fibroblasts was higher compared to adult and fetal dermal fibroblasts (figure 2F). 
Finally, we studied three other myofibroblast-associated genes, i.e. connective tissue 
growth factor (CTGF), Plasminogen Activator Inhibitor-type 1 (PAI-1), and TGF-β 
induced (TGF-βi). CTGF and TGF-βi are shown to be upregulated during myofibroblast 
differentiation and fibrosis [23-26]. CTGF was slightly higher expressed in eschar 
fibroblasts compared to adult and fetal dermal fibroblasts (figure 2E). PAI-1 controls 
proteolytic activity and overexpression of this gene is associated with excessive 
collagen accumulation and myofibroblast differentiation [27, 28]. Gene expression of PAI-
1 was lower in fetal fibroblasts while gene expression of TGF-βi was lower in adult 
dermal fibroblasts compared to the other groups (figure 2G&H).
Effects of mechanical stretch on myofibroblast-associated gene expression 
To assess the effect of stretch on myofibroblast differentiation, we determined fold 
changes in myofibroblast-associated gene expression in fibroblasts that were subjected 
to mechanical stretch. A two-dimensional Flexcell® model was used to perform two 
different multi-axial stretch programs as depicted in figure 1. A static stretch program 
was used to mimic static splinting therapies and a stretch regime program was used to 
mimic dynamic splinting therapies. 
Both stretch programs significantly reduced α-SMA expression in the fetal fibroblast 
group (figure 3A). Although the reduction of α-SMA expression levels in eschar 
fibroblast was the lowest, this was not statistically significant, probably due to the 
small group size (n=4). Furthermore, stretch increased the expression of Col1a and 
Col3 genes in the adult fibroblasts, although these increases were highly variable and 
not statistically significant (again n=4) (Figure 3B&C). 
The expression of LH2b, CTGF and PAI-1 showed a slight increase due to mechanical 
stretch except for LH2b and CTGF in eschar fibroblasts and PAI-1 in adult fibroblasts, 
but again this was not statistical significant (figure 3D,F,H). Finally, gene expression of 
FnEDA and TGF-βi remained the same (Figure 3E&G).
Figure 3: Fold changes in gene expression.
Box-and-whiskers plots of fold changes in gene expression between no stretch and stretch 
samples, on the left the effects of static stretch, on the right the effects of a stretch regime. Fold 
change was calculated per cell isolate by relating ddCt-values of the treated sample to ddCt of the 
control sample. Sample group and number of samples per group are indicated on the x-axis, from 
left to right: F is fetal fibroblast; A is adult dermal fibroblast; E is eschar fibroblast. Significance 
was calculated with a Wilcoxon-signed rank test, * p<0.05, *** p<0.00 1.
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TGF-β1 production in fibroblasts from different origin and fibroblasts under 
stretch
Effects of stretch on fibroblasts can be direct via mechano-sensitive responses, 
or indirect via the activation of growth factors. As TGF-β is an important growth 
factor in myofibroblast differentiation and all genes in this study are targets of 
TGF-β signaling [18], we measured levels of total TGF-β1 in cell culture supernatants.
Higher TGF-β1 levels were observed in the supernatants of fetal fibroblasts compared 
to supernatants of adult dermal or eschar fibroblasts but there were no significant 
differences (figure 4A). Static stretch decreased the levels of TGF-β1 in all fibroblasts 
populations and this decrease was statistically significant in the fetal fibroblast group 
(figure 4B). In contrast, the stretch regime did not have such an effect on TGF-β1 levels.
Discussion
The goal of this study was to evaluate the effects of splinting therapies on scar 
contractures at the cellular level. Therefore, we studied the effects of two different 
mechanical stretch programs on myofibroblast differentiation and de-differentiation. 
Insight into the effects of these stretch programs on myofibroblasts could be useful to 
design effective splinting protocols. 
We used fibroblasts from a scarring environment -eschar fibroblasts- and determined if 
these fibroblasts have a more pronounced myofibroblast-associated profile compared 
to adult dermal fibroblasts and fetal fibroblasts. Although eschar fibroblasts had higher 
expression of all assessed myofibroblast-associated genes, most of the results were 
highly variable and differences between the fibroblast groups were small (table 2). 
A
B
Figure 4: TGF-β1 levels in fibroblasts 
from different locations and stretch-
affected fold changes. 
A) Box-and-whiskers plots (represents 
medians, hinges and end points) of 
TGF-β1 levels in pg/mL in cell culture 
supernatants of fetal, adult, and eschar 
fibroblasts (number of samples per group 
is indicated under x-axis). Samples did not 
differ significantly as was calculated with a 
Kruskall-Wallis test. B) Box-and-whiskers 
plots of fold changes in TGF-β1 levels in 
supernatants, levels of TGF-β1 in stretched 
samples were related to levels in the similar 
no stretch control. Sample group and 
number of samples per group are indicated 
on the x-axis, from left to right: F is fetal 
fibroblasts; A is adult dermal fibroblasts; 
E is eschar fibroblasts. Significance was 
calculated with a Wilcoxon-signed rank 
test, ** p<0.01.
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Further, culture supernatants of eschar fibroblasts did not have higher levels of the 
fibrosis-associated TGF-β1 compared to supernatants of adult dermal fibroblasts. 
However, supernatants of fetal fibroblasts had higher TGF-β1 lev els, although the 
differences were not significant. The high levels of TGF-β1 in fetal fibroblast cultures are 
in accordance with our previous study (chapter 3), which also showed that the higher 
levels of TGF-β1 in supernatants of fetal fibroblast become more apparent over time.
Overall, the high within-group variations and the small differences in fold change (table 2) 
lead us to the conclusion that no biological significant differences are observed between 
fibroblasts from different origin. However, a study by Van den Bogaerdt et al. showed 
that expression of α-SMA, Col1 and LH2b was significant higher in scar fibroblasts 
compared to adult dermal fibroblasts. Besides, the high expression in scar fibroblasts 
correlated with the high expression in scar tissue compared to adult dermal skin [10]. As 
eschar tissue is collected in relatively early stages of scarring, i.e. approximately two 
weeks after the burn injury, it might be that the eschar fibroblasts in our study did not 
have a fully developed hypertrophic phenotype yet. Besides we studied gene expression 
after 24h which is an earlier time point compared to the Van den Bogaerdt-study were 
gene expression was assessed upon sub-confluence of the fibroblast cultures.
In this study we determined the effects of two different mechanical stretch programs on 
myofibroblast-associated gene expression. Application of stretch resulted in a reduction 
of α-SMA expression and TGF-β1 levels in all fibroblasts. These results correlate with a 
study by Blaauboer et al, who showed that α-SMA and TGF-β gene expression in lung 
fibroblasts decrease under cyclic stretch [29]. However, most other groups report no 
change or an increase in α-SMA expression or TGF-β1 levels upon cyclic stretch (table 
3). Like in clinical trails, differences in experimental set-up make comparison between 
studies difficult and could have caused the different findings. For example, most studies 
used cyclic stretch while we have used static stretch or a combination of static and cyclic 
stretch. In addition, most studies used longer incubation periods. Therefore, differences 
in study design and stretch method could underlie the variations in study results. 
In our study, the stretch programs only had small effects on the expression, as average 
fold changes were mostly between 0.5 and 2.0 (figure 3). Further, fold changes for all 
Table 2: Fold change compared to adult dermal fibroblasts (mean ± SD) 
Gene Adult Fetal Eschar 
α-SMA 1.05 ± 0.38 1.34 ± 0.66 1.83 ± 0.79 Col1 1.26 ± 0.84 1.23 ± 0.95 2.05 ± 1.30 Col3 1.30 ± 0.71 1.50 ± 0.90 1.99 ± 1.31 LH2b 1.14 ± 0.61 1.34 ± 0.79 3.07 ± 1.43 FnEDA 1.03 ± 0.28 0.82 ± 0.21 1.45 ± 0.46 CTGF 1.04 ± 0.36 1.21 ± 1.03 2.86 ± 1.83 PAI-1 1.13 ± 0.60 0.72 ± 0.37 1.22 ± 0.57 TGF-βi 1.02 ± 0.24 2.35 ± 1.24 1.86 ± 1.01  
Table 2: Fold changes in gene expression. 
The average ddCt of the adult fibroblast group was set to 1 and fold change was calculated per 
sample. Table shows the mean fold change per group and the standard deviation of the fold 
change per group. 
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myofibroblast-associated genes were also highly variable regardless of the fibroblast 
type or the stretch program. Again, the results correlate with the variable data in 
literature. Several factors are known to alter the influence of mechanical stretch on 
cells and could have caused these variations. First, cells with a relaxed cytoskeleton are 
less responsive to mechanical forces [30]. Since fibroblasts have a relaxed cytoskeleton 
and myofibroblasts have not, stretch will have a less pronounced effect on fibroblasts 
compared to myofibroblasts. As we used primary fibroblasts derived from human 
tissue, the percentage of myofibroblasts varied between the individual fibroblast 
isolates. Therefore, stretch will have affected different percentages of cells within the 
different fibroblast isolates. Second, the confluence of in vitro cultures also affects 
the mechanosensitivity of cells [31]. Thus, differences in proliferation rate between the 
individual fibroblast isolates or the different fibroblast populations have influenced the 
results as well. Third, integrin receptors play an essential role in mechanotransduction 
[32-34]. We have shown that the integrin profiles differ between fetal and adult fibroblasts 
(chapter 4). Therefore, differences in response to stretch between fetal and adult 
fibroblasts could have been caused by the different integrin profiles of the fibroblast 
populations. 
Altogether, differences in myofibroblast percentage, proliferation and integrin receptor 
profiles between the primary cell cultures could have caused the variable results 
in our study. Although longer culture periods could give more pronounced results, 
the highly variable and contradictory data in literature show that there is a need for 
relevant mechanotransduction models. Improvements in this area are optimization 
of data acquisition, for example the possibility to microscopically visualize the cells 
during the stretch, and optimization of environment, for example models that more 
closely resemble the biological microenvironment or models with controllable cell-
environment interactions. Such improvements are necessary to enable further insight 
in the complicated effects of mechanical stretch on cell behavior.
In conclusion, mechanotransduction influences cell behavior in multiple, complicated 
ways. The highly variable data of in vitro studies indicate that in vivo splinting therapies 
also have variable and diverse effects on scarring. Due to inter-patient variations, for 
example in burn wound etiology, some patients might benefit from splinting therapies 
while others will not. Therefore, better insight in the complicated effects of mechanical 
stretch on cell behavior is needed to improve and fine-tune protocols for splinting 
therapies.
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Table 3 Species Source Gene Protein Time Stretch Reference 
α-SMA Human Cardiac = = 72h Cyclic [35] Human Dermal = / >  24h / 48-96h Cyclic [31] Human Dermal Scar > > 6-12h Cyclic [36] Human Gingiva =   24-72h Cyclic [37] Human Lung  <  48h Cyclic [29] Col1a Human Cardiac > / =  24h / 72h Cyclic [35, 38] Rat Cardiac >  24h Cyclic / Static [39,40]  Rat Cardiac =  24h Static [41] Human Dermal  > > 24-48h Cyclic / Static [12, 42]  Human  Dermal =  0-24h Static [43] Human Gingiva =  = 24-72h  Cyclic [37, 44] Human Ligament > > 24-48h Cyclic [45-47] Human Lung  <  48h Cyclic [29] Human Keloid > / =  3-6h / 24h Static [43] Human Tendon >  4h Cyclic [48] Chicken Tendon >  6h Cyclic [49] Col3 Human Cardiac =  72h Cyclic [35] Rat Cardiac >  24h Static [41] Human Ligament >  48h Cyclic [47] Human Lung  <  48h Cyclic [29] Human Gingiva  = 24-72h Cyclic [44] CTGF Human Gingiva = / >  24h / 72h Cyclic [37] Fn Rat Cardiac >  24h Static [41] Human Ligament  > 24h Cyclic [45] Human Lung  =  48h Cyclic [29] EDA-Fn Human Lung  =  48h Cyclic [29] LH2b Human Lung  =  48h Cyclic [29] TGF-β1 Human Cardiac  > / < 24h / 72h Cyclic [35, 50] Rat Cardiac  > 24h Static / Cyclic [39, 41]  Human Dermal  = / > > 0-48h Static / Cyclic [42, 43] Human Dermal Scar > > 6-12h Cyclic [36] Human Gingiva >  24-72h Cyclic [37] Human Ligament  > 24h Cyclic [46] Human Lung  =  48h Cyclic [29] Human Keloid = / >   3-6h / 24h Static [43] Human Tendon >  4h Cyclic [48]  
Table 3: Overview of Flexcell® studies 
Overview of studies that assessed the effects of stretch on myofibroblast-associated gene 
expression in fibroblasts. Effect on gene or protein expression, > increase; < decrease; = no 
difference; if multiple time points or stretch programs were used, / indicates different results 
between those variables.
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Abstract
The lack of immune cells in mid-gestational fetal skin is often mentioned as a key factor 
underlying scarless healing. However, the scarless healing ability is conserved till long 
after the immune system in the fetus is fully developed. Therefore, we studied human 
second-trimester fetal skin and compared the numbers of immune cells and levels of 
chemokine from fetal skin with adult skin.
By using immunohistochemistry, we show that healthy fetal skin contains significant 
lower numbers of CD68+-macrophages, Tryptase+-mast cells, Langerin+-Langerhans 
cells, CD1a+-dendritic cells, and CD3+-T cells compared to adult skin. Staining with an 
early lineage leukocyte marker, i.e. CD45, verified that the number of CD45+-immune 
cells was indeed significantly lower in fetal skin but that sufficient numbers of immune 
cells were present in the fetal lymph node. No differences in the vascular network were 
observed between fetal and adult skin. Moreover, significant lower levels of lymphocyte 
chemokines CCL17, CCL21 and CCL27 were observed in fetal skin. However, levels of 
inflammatory interleukins such as IL-6, IL-8 and IL-10 were undetectable and levels of 
CCL2 were similar in healthy fetal and adult skin.
In conclusion, this study shows that second-trimester fetal skin contains low levels 
of immune cells and leukocyte chemokines compared to adult skin. This immune cell 
deficiency in healthy second-trimester fetal skin may result in reduced inflammation 
during wound healing and could underlie the scarless healing capacities of the fetal 
skin. 
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Introduction
Fetal skin heals without scarring or fibrosis and this intrinsic capacity is independent of 
the intrauterine environment. Differences in growth factor profiles, in the structure of 
the skin and in immune cell profiles are known for fetal skin compared to adult skin [1, 2]. 
Yet, it is still unknown how these differences are involved in scarless healing. 
The immune system plays an important role in wound healing, but, an excessive immune 
response and prolonged inflammation result in fibrosis. Improved healing is reported 
in animals lacking a subset of immune cells [3] or in humans that used anti-inflammatory mediators [4, 5]. Strikingly, other studies have shown that wounds in scarless healing fetal 
skin lack a full blown immune response and infiltrate of immune cells [6]. Furthermore, addition of immune cells to fetal wounds resulted in scarring [7]. Similarly, scarless-
healing oral mucosa has low numbers of immune cells in both the healthy and healing situation [8]. Together, these data support that the immune system has a key role in 
keeping the delicate balance between wound healing and fibrosis and suggest that a 
reduced immune cell infiltrate may play an important role in scarless wound healing. 
Interestingly, diminished immune responses in fetal wound healing appear not to 
be a result of an immature immune system. In humans, haemopoiesis starts already 
during embryogenesis in the yolk sac and the splanchnopleura, and continues during 
early fetal development in the liver [9]. The first blood cells that are attracted to the 
liver are macrophages that are derived from the yolk sac, where macrophages-like 
cells appear at 5.5 weeks gestation [10, 11]. From the 6th  till the 9th week of gestation, the 
first lymphocytes migrate from the fetal liver to colonize the thymus [12]. In the fetal 
thymus these so-called thymocytes develop into T-cells that migrate to the peripheral 
lymphoid organs, during week 14 of gestation [13]. At 15 weeks gestation these T-cells 
express the CD3-receptor and the number of T cells in the blood gradually increases 
[14, 15]. Progenitors of B-cells, so-called pre-B cells, can be identified in the fetal liver at 
7 weeks gestation, in the peripheral blood at 12 weeks gestation, and the number of 
B-cells in the spleen and peripheral blood is comparable to that in adults at week 22 [16]. 
The number of CD34+ hematopoietic progenitor cells in the fetal blood is even 4.9-fold 
higher at 17-24 weeks gestation compared to 37-41 weeks gestation [17]. Furthermore, 
the second trimester fetal immune system is capable of eliciting an immune response 
and thus appears to be functionally mature as well [18-21].
Altogether, these data indicate that the fetal immune system contains functional immune 
cells far before the second trimester while the transition from scarless to scarring is 
considered to take place after the second trimester of pregnancy [22]. Therefore, we 
studied the immune system and its chemokines in scarless second-trimester fetal skin 
and compared the number of immune cells and levels of chemokines with scarring 
adult skin.
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Materials and methods
Tissue samples
Healthy skin and lymph node tissue was collected from fetal and adult donors. Informed 
consent was given according to institutional and national guidelines. Adult skin was 
obtained from donors undergoing abdominoplasty. Fetal skin and lymph node tissue 
were derived after legal termination of pregnancy, and gestational age was estimated 
by last menstrual period. Collected tissues were snap-frozen and stored at -80°C until 
sectioning. Six adult skin samples (27-56 years), one adult lymph node sample (age 
unknown), five fetal skin samples (18-22 weeks gestational age), and two fetal lymph 
node samples (20 and 21 weeks gestational age) were used for IHC. Further, ten adult 
(16-56 years) and ten fetal (18-22 weeks) skin samples were used for a luminex assay.
Immunohistochemistry (IHC)
Cryosections of 5 µm were cut from the frozen tissues, mounted on slides (KP Frost 
slides, Klinipath, Duiven, The Netherlands), air-dried and fixed in acetone (10 min, 
room temperature (RT)). Slides were blocked with normal goat serum for 10 min at RT 
and incubated overnight (ON) at 4°C with primary antibodies (table 1). All antibodies 
were diluted in 1% [w/v] bovine serum albumin (Sigma-Aldrich, Zwijndrecht, The 
Netherlands) in MilliQ, and negative control slides were incubated in absence of the 
Primary 
Antibody Clone Source Host Dilution Secondary 
αSMA 1A4 Abcam Mouse 1:100 555 1 CD1a OKT6 ATCC Mouse undiluted 555 1 CD3 Hybridoma ATCC Mouse 1:100 555 1 CD19 HIB19 EBioscience Mouse 1:100 647 3 CD20 L26 EBioscience Mouse 1:25 Directly labeled CD31 JC70A Dako Mouse 1:50 555 1 CD40 LOB76 ABD Serotec Mouse 1:50 647 2 CD45 D9M8I Cell Signaling Rabbit 1:200 555 4 CD68 EBM11 Dako Mouse 1:100 555 1 Langerin 10E2 ATCC Mouse 1:1000 555 1 MR 19.2 BD Pharma Mouse 1:100 Strep-555 5 Tryptase G3 Millipore Mouse 1:1000 647 2 
Secondary 
Ref Reactivity Labeled Source Host Dilution Lot.  1 Anti-mouse AF-555 Invitrogen Goat 1:500 A21424 2 Anti-mouse AF-647 Invitrogen Goat 1:500 A21236 3 Anti-mouse(IgG2a) AF-647 Invitrogen Goat 1:500 A21241 4 Anti-Rabbit AF-555 Invitrogen Goat 1:500 A21429 5 Anti-Strep AF-555 Invitrogen Goat 1:500 S32355  
Table 1: Primary and secondary antibodies used for IHC. 
The numbers in the primary data table (last column) indicate the secondary antibody used (first 
column). Manufacturers information: Abcam (Cambridge, UK), ATCC (Manassas, VA), EBioscience 
(Hatfield, UK), ABD SeroTec (Kidlington, UK), Cell Signaling (Leiden, The Netherlands), BD 
Pharma (Breda, The Netherlands), and Invitrogen (Thermo-Fisher, Waltham, MA).
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primary antibody. Slides were thoroughly washed with phosphate buffered saline and 
incubated with appropriate secondary antibodies (table 1) for 1h at RT. DAPI (Life 
Technologies, Thermo Fisher Scientific, Waltham, MA) was used to envision nuclei and 
slides were mounted in Vinol (Dako, Glostrup, Denmark); 88% hydrolyzed polyvinyl 
alcohol.
Analysis 
All IHC stainings were photographed with a Zeiss fluorescence microscope (Zeiss, 
Sliedrecht, The Netherlands). Three pictures of random parts of the fetal skin, or, the 
upper and lower adult dermis were taken. The adult skin was divided in an upper 
(epidermis and papillary dermis) and lower (reticular dermis) part as it is thicker than 
fetal skin. Localization and quantification of specific staining was evaluated with NIS-
elements software (Nikon, Amstelveen, The Netherlands). Immune cells were quantified 
by measuring co-localization of positive staining with DAPI and the number of positive 
cells was corrected for surface area. The Chalkley method was used to quantify blood 
vessel density in the different areas of the skin as previously described [23].
Luminex
Luminex samples were prepared as was previously described [24]. In short, frozen 
skin samples were lysed and homogenized in MILLIPLEX MAP Lysis Buffer (Millipore, 
Billerica, MA, USA). A Bio-Plex Human Chemokine Pro Assay (Bio-Rad, Veenendaal, The 
Netherlands) with coupled magnetic beads was used to measure levels of CCL2/ MCP-1, 
CCL17/TARC, CCL21/6Ckine, CCL27/CTACK, CXCL8/IL8, CXCL12/SDF-1α+β, IL-6, and 
IL-10. The assay was executed following manufacturer’s instructions and samples were 
measured in duplo on a Bioplex 200 system (Biorad). Protein levels were measured 
in pg/mL and these concentrations were corrected for the total protein levels (mg/
mL) of the sample, which were previously quantified by means of a BCA assay (Life 
Technologies).
Results
Immune cells
Macrophages
Significant lower levels of CD68+-macrophages were observed in fetal skin compared 
to both the upper and lower part of the adult skin (Figure 1A&B). Besides CD68 as 
a general macrophage marker, we also used markers to broadly discriminate two 
different macrophage-subsets that play important roles in wound healing and fibrosis, 
i.e. early macrophages (M1-phenotype) and alternative macrophages (M2-phenotype). 
M1-macrophages appear during the early stage of wound healing and secrete pro-
inflammatory cytokines, while M2-macrophages appear during the late, proliferative 
stage and secrete anti-inflammatory cytokines [25]. Discrimination of M1- and M2-
macrophages was done by double staining of CD68 with CD40 or mannose receptor 
(MR), respectively. Quantification of double-positive cells resulted again in lower 
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quantification in fetal skin for both markers (Figure 1C-F). Although the absolute 
amount of MR+CD68+-cells was lower, the percentage of CD68+ cells that co-expressed 
MR was higher in fetal skin compared to adult skin i.e. 80% ± 8 (mean ± SD) against 
60% ± 8 in the lower dermis and 54% ± 20 in the upper dermis. No double CD68+CD40+-
cells were observed in the fetal skin, so the absolute amount and the percentage of M1-
macrophages was lower in fetal skin, i.e. 0%± 0 against 4% ± 4 in the lower dermis and 
9% ±5 in the upper dermis.
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Figure 1: Fetal skin contains lower numbers of CD68⁺ macrophages. 
A, C, E) CD68⁺-, CD68⁺CD40⁺- and CD68⁺MR⁺- macrophages in adult upper skin and fetal skin. 
CD68-staining (red), double staining (green), indication of the basements membrane (white 
dotted line). B, D, F) Box-and-whiskers plots (represents median, hinges and end points) 
of quantified stainings of 6 adult and 5 fetal donors. Y-axes represent the counted number of 
immune cells divided by the total area of the slide (measured by DAPI staining). N0 indicates 
no positive cells were observed in any of the samples in this group, and significance could not 
be calculated for those groups. Mann-Whitney tests with Bonferroni correction were used to 
calculate significance, * p≤(0.05/3), ** p≤(0.01/3).  
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Figure 2: Fetal skin contains lower numbers of several immune cells. 
A, C, E, G) Tryptase⁺ mast cells, CD1a⁺ dendritic cells, Langerin⁺ Langerhans cells, CD3⁺ T-cells in 
adult upper skin and fetal skin. Positive staining is red, nuclei are blue and the white dotted line 
indicates the basements membrane. B, D, F, H) Box-and-whiskers plots of the quantified staining 
in 6 adult and 5 fetal donors. N0 indicates no positive cells were observed this group at all, thus, 
significance could not be calculated for those groups. Quantification and statistical analyses were 
done as described in figure 1. 
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Mast cells, dendritic cells and Langerhans cells
The number of Tryptase+- mast cells was significant lower in the fetal skin compared 
to adult skin (Figure 2 A&B). CD1a+ dendritic cells were observed in the upper part of 
the adult skin, and no positive staining was observed in the adult reticular dermis at all 
(Figure 2C). Scarce positive staining was observed in the fetal skin and the differences 
were significant between fetal and upper adult skin (Figure 2D). Langerin+-Langerhans 
cells were very specifically observed in the adult epidermis and were absent in the 
reticular dermis (Figure 2H). Again, fetal skin had significant lower levels of Langerin+-
cells compared with adult skin (Figure 2 G&H).
T-cells and B-cells
T-cells were identified by expression of the general T-cell marker CD3. The highest levels 
of CD3+-cells were observed directly under the adult epidermis while only a single T-cell 
was observed in some samples of the lower adult dermis and the fetal skin (Figure 2G). 
The levels of CD3+ cells differed significantly between adult upper and lower skin, and 
between adult upper and fetal skin (Figure 2H). Both, CD19 and CD20 were used as 
markers for B-cells but no positive staining was observed in any of the skin samples 
(data not shown).
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Figure 3: Fetal and adult skin have comparable blood vessel density. 
A, C) CD31⁺ blood vessels , αSMA⁺ blood vessels in adult upper dermis and fetal dermis. Positive-
staining (red), nuclei (blue), indication of the basements membrane (white dotted line). B, D) 
Box-and-whiskers plots (6 adult and 5 fetal donors) of blood vessels quantified by Chalkley 
method. Significance was calculated by Mann-Whitney tests with Bonferroni correction.
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Blood vessels
Two differential markers were used to stain blood vessels in the skin, i.e. CD31 as 
endothelial marker and α-SMA as smooth muscle cell marker. Using the Chalkley-
method, more CD31+ blood vessels were observed in fetal skin but the differences 
were not significant compared to adult skin (Figure 3 A&B). Also for α-SMA+-vessels no 
significant differences were measured between fetal and adult skin (Figure 3D).  
CD45
As the immune system in the fetus is developing, fetal immune cells might not yet 
express all of the lineage markers that were assessed in this study. Therefore, we used a 
general leukocyte marker that is already expressed at young gestational age, i.e. CD45, to stain all immune cells in fetal and adult skin [21].  Significantly lower levels of CD45+-
cells were observed in the fetal skin compared to adult skin (Figure 4A&B). To verify 
that the human second-trimester fetus indeed has immune cells that express CD45, we 
also stained lymph node sections with CD45. This resulted in positive staining in both 
adult and fetal lymph node tissue. Moreover, we used fetal skin and lymph node tissue 
that was harvested from the same donor and observed only few cells in this skin sample 
while the lymph node sample was full of CD45+-cells (Figure 4C).  
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Figure 4: Fetal skin contains lower numbers of CD45⁺ immune cells. 
A) CD45⁺ immune cells in adult upper dermis and fetal dermis. B) Box-and-whiskers plot of CD45 
staining in 6 adult and 5 fetal donors, levels were quantified as described in figure 1. p-values 
were calculated by Mann-Whitney tests with Bonferroni correction, * p≤(0.05/3). C) CD45⁺ 
immune cells in adult and fetal lymph nodes, the middle sample is from the same fetal donor as 
the fetal skin sample in A. Positive-staining (red), nuclei (blue).
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Chemokines
Migration of leukocytes into the skin is dependent on several chemokines. In this 
study, we compared the concentrations of some of these chemokines in healthy fetal 
and adult skin. First, CCL2 was studied, as this chemokine is a potent chemoattractant 
for monocytes, dendritic cells, T-cells and mast cells and high levels of CCL2 in fetal 
skin have already been reported [21]. No differences in CCL2-levels were observed 
between fetal and adult skin, both had average levels of 3.9 pg/mg tissue (Figure 5A). 
Moreover, low levels of inflammatory IL-8 and high levels of immunosuppressive IL-
10 are reported in fetal skin while data on IL-6 are controversial [21, 26, 27]. The levels of 
IL-6, IL-8, and IL-10 were measured but were all below detection levels in adult and 
fetal skin (lower limit detection levels were 0.88 pg/mg, 0.63 pg/mg and 1.63 pg/mg 
respectively). Further, the main T-cell chemoattractants during skin homeostasis are 
CCL17 and CCL27 [28, 29]. Fetal skin contained significant lower levels of both CCL17 and 
CCL27 (figure 5 B&C). Finally, CCL21 and CXCL12 are expressed by endothelial cells and 
involved in leukocytes extravasation from the blood [30, 31]. Both these chemoattractants 
are expressed in high levels in the developing fetal thymus [32, 33]. CCL21 was measured 
in significant lower levels in fetal skin (Figure 5D) while CXCL12, a chemoattractant for 
progenitor cells, was undetectable in both fetal and adult skin (minimum detection level 
was 10.38 pg/mg).
A B
C D
Figure 5: Fetal skin contains lower levels of lymphocyte chemoattractants. 
Quantification of CCL2-, CCL21-, CCL17- and CCL 27-levels in healthy adult and fetal skin samples 
(n=10 per group). Protein levels are in pg/mg tissue. Box-and-whiskers plots of 10 adult and 10 
fetal donors, p-values were calculated by Mann-Whitney tests, *** p≤0.001.
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Discussion
In this study, we compared the levels of immune cells and chemokines between fetal 
and adult skin. We show that fetal skin at this gestational age is immune deficient, as it 
contains significantly lower numbers of CD68+-macrophages, Tryptase+-mast cells, CD1a+-dendritic cells, Langerin+-Langerhans cells and CD3+-T cells compared to adult skin. Our 
data are consistent with reports of other groups that show low numbers of leukocytes in fetal skin [34, 35]. In accordance with the data of Coolen et al and Schuster et al [36, 37] no 
significant differences in the vascular network were observed between fetal and adult 
skin. Furthermore, staining with early lineage marker CD45, showed significantly lower 
levels of CD45+-cells in fetal skin compared to adult skin while fetal lymph nodes at this 
gestational age contained sufficient levels of CD45+-cells comparable to adult lymph 
nodes. Altogether, these data show that immune cells are present in the human fetus and 
that there is a sufficient vascular network to transport them to the skin. Therefore, the lack 
of immune cells in second-trimester fetal skin appears to be a result of deficient homing 
rather than an overall deficiency of immune cells. 
Indeed, fetal skin contains significantly lower levels of CCL17, CCL21, and CCL27 compared 
to adult skin. As these chemokines are potent chemoattractants for T-cells and dendritic 
cells, the low chemokine levels can be linked to the low number of these cells in the fetal 
skin. Furthermore, chemokines such as IL-6, IL-8, and IL-10 are often mentioned as 
markers that orchestrate the reduced fetal inflammatory response [21]. Yet, levels of these 
interleukins were undetectable in the homeostatic fetal or adult skin. Curiously, chemokine 
levels measured in this study significantly differ from previous reported levels measured 
in supernatants [21, 34]. This raises the question if chemokine levels in supernatants from 
ex-vivo cultured skin do resemble chemokine levels in healthy skin. As those supernatant 
studies have shown high levels of inflammatory mediators such as IL-6 and CCL2, it appears 
these models might more closely resemble the wounded or inflammatory situation. 
Finally, our data show that of the few macrophages that were present in fetal skin a 
relatively high percentage co-expressed CD68 and MR, while no co-expression of CD68 
and CD40 was observed. Therefore, it appears that fetal macrophages have more of an 
anti-inflammatory M2-phenotype. Curiously, another study observed high percentages 
of tolerance-inducing regulatory T-cells in fetal skin compared to adult skin [35]. Both, 
anti-inflammatory M2-macrophages and regulatory T-cells, are known to produce anti-
inflammatory cytokines such as IL-10 and Transforming Growth Factor-β. Indeed, we 
recently showed that levels of Transforming Growth Factor-β are significant higher in the 
healthy fetal skin compared to adult skin [24]. Therefore, it might be that the low numbers 
of immune cells that are present in fetal skin further induce an immunosuppressive anti-
inflammatory environment. 
In conclusion, immune cell deficiency in second-trimester fetal skin is not the result of an 
immature immune system. In this study, we show that the absence of lymphocytes in the 
fetal skin goes together with low levels of chemoattractants such as CCL17, CCL21 and 
CCL27. Our data indicate that healthy fetal skin lacks signals for immune cell homing and 
that this could result in a diminished immune reaction upon wounding.
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Summary
The main aim of my thesis is to unravel the cellular and molecular mechanisms involved 
in scarless fetal wound healing. Insight into these scarless healing mechanisms can 
lead to strategies to control and improve adult wound healing. 
Fetal skin has the intrinsic ability to heal without scarring. Differences between fetal 
and adult skin that influence wound healing are known with regard to extracellular 
matrix (ECM) molecules, fibroblasts characteristics, inflammatory response, and levels 
of growth factors. However, most data on differences between fetal and adult wound 
healing come from a wide range of animal models which makes it difficult to compare 
the results or to translate the results to the human situation. Therefore, the exact 
mechanisms that result in scarless healing are still unknown. 
Altogether, three different cellular and molecular processes were studied in my thesis. 
First, data about the role of transforming growth factor-β (TGF-β) in fetal wound 
healing were summarized and verified because this field of research is extensive and translation of results from animal models to the human situation is shown to 
be problematic in this area [1, 2]. Second, aspects of the relation between fibroblasts 
and their environment were studied because the environment plays an important 
role during fibroblast-to-myofibroblast differentiation and wound healing. Third, 
we studied the immune system and chemokines in fetal and adult skin to verify the 
immune status of the healthy fetal skin. Finally, the goal of this chapter is to discuss 
the findings on these three mechanisms and give indications for future research and 
clinical implications.
TGF-β
The role of TGF-β in fetal wound healing is dual. On on e hand, this growth factor 
has an important role during fetal development [3, 4]. On the other hand, it also has 
a detrimental role during scarring as it improves myofibroblast differentiation and 
fibrosis [5, 6]. In chapter 1, current literature on fetal wound healing and the canonical 
TGF-β signaling pathway was discussed. In chapter 2, gene expression and protein 
levels of components of the canonical TGF-β pathway were quantified in healthy 
fetal and adult skin. In contrast to what was suggested in literature [7, 8], we showed 
that fetal skin is able to store and activate TGF-β as it contains latent TGF-β binding 
protein-1. Furthermore, we were the first to quantitatively measure protein levels of 
TGF-β isoforms, TGF-β Receptor-II and intracellular Smads in fetal skin. We showed 
that fetal skin has higher concentrations of all three TGF-β isoforms and higher levels 
of (phosphorylated) intracellular Smads, indicating activated intracellular TGF-β 
signaling. Further, differences in gene expression did not always reflect protein levels, 
e.g. gene expression of both TGF-β Receptor-II and TGF-β1 were lower in fetal skin 
while protein levels were equal or even higher in fetal skin. Our findings show that 
several post-transcriptional processes influence the production and activation of 
TGF-β components and demonstrate the complexity of the TGF-β signaling pathway.
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Despite high levels of TGF-β isoforms and activated intracellular Smads, fetal skin had 
significant lower expression of TGF-β target genes like connective tissue growth factor 
(CTGF), plasminogen activator inhibitor-1 (PAI-1), and TGF-β induced (TGF-βi). The 
activated TGF-β signaling combined with the low expression of fibrosis-associated 
genes in the fetal skin shows that the effects of TGF-β signaling differ between fetal and 
adult skin. Processes involved in these differences could be nuclear Smad shuttling, 
transcriptional processes or interaction with other signaling pathways. Overall, 
chapter 1 and 2 give an overview of TGF-β signaling in human fetal and adult skin 
which shows that all components of the TGF-β pathway are present in healthy fetal 
skin, but that active TGF-β signaling in the fetal skin does not result in high expression 
of fibrotic genes.
According to literature, fetal fibroblasts are able to differentiate in myofibroblasts [9-
11]. However, data on the exact response of fetal fibroblasts to TGF-β differ as we have 
described earlier in chapter 1. In chapter 3, we stimulated in vitro cultured fibroblasts 
with TGF-β1 to gain more insight into mechanisms in which canonical TGF-β signaling 
might affect fetal wound healing. We show that fetal fibroblasts not only differentiate 
into myofibroblasts but that they also have the capacity to produce high levels of 
fibrosis-associated proteins. These findings correlate with the in vivo situation as both 
healthy fetal skin and wounded skin have high levels of TGF-β, fibronectin [12], and 
collagen-III [13]. Our study shows that human fetal wound healing also has the potential 
to result in myofibroblast differentiation and scarring as has been shown earlier in an 
in vivo sheep model [14]. 
Together, chapter 1 till 3 of this thesis demonstrate the important role of TGF-β signaling 
in both skin development and skin repair. For example, activated canonical TGF-β 
signaling is involved in both skin development and fibrosis. At present, researchers 
in the wound healing field associate activated TGF-β signaling only with fibrosis. This 
mind-set should change as the fetal skin shows that activated TGF-β signaling is also 
necessary for proper skin development.
Fibroblast-environment interactions
Persistence of myofibroblasts during wound healing results in a vicious circle in 
which myofibroblasts generate a fibrotic environment, while the fibrotic environment 
further stimulates myofibroblast differentiation and myofibroblast persistence [15]. 
Therefore, a vicious circle between myofibroblasts and environment exists that needs 
to be broken. The relation between fetal fibroblasts and the environment was studied in chapter 4. In accordance with other studies we found that fetal fibroblasts have 
an intrinsic migratory phenotype while adult fibroblasts have an adhesive phenotype 
[16-19]. Furthermore, we showed that fetal fibroblasts have low levels of several integrin 
receptors and blocking of these receptors in adult fibroblasts reduces fibroblast 
adhesion. Blocking of α1-integrin not only reduced adult fibroblast adhesion but also 
improved adult fibroblast migration. Consequently, blocking of α1-integrin reverts 
the adhesive phenotype of adult fibroblasts towards a fetal-like migratory phenotype. 
Proefschrift_27jan2016_JAK_versie3b.indd   125 27-1-2016   21:44:33
501871-L-bw-Walraven
7
126
Therefore, therapies that block α1-integrin are promising to reduce myofibroblast 
adhesion and disrupt the vicious circle between myofibroblast and environment.
The promising effects of blocking α1-integrin are an addition to recent findings 
that blocking of the αVβ5-integrin receptor prevents fibrosis [20, 21]. However, the 
mechanisms of action appear to differ as αVβ5 is suggested to be involved in TGF-β 
activation and mechanotransduction. This hypothesis corresponds with our results as 
blocking αVβ5 had no effects on migration and reduced adhesion in both fetal and 
adult fibroblast. Therefore, blocking integrin receptors can reduce fibrosis via different 
ways: via inhibited TGF-β activation, via reduced mechanotransduction, or via reduced 
fibroblast adhesion and improved fibroblast migration. Altogether, interference with 
integrin receptors is a promising therapeutic strategy to prevent fibrosis as it affects 
myofibroblasts via different mechanisms. 
Interestingly, TGF-β is known to increase levels of integrin receptors such as α1β1 and 
αVβ5 in fibroblasts [22]. Nonetheless, in vitro cultured fetal fibroblasts had significant 
lower levels of these integrin receptors compared to adult fibroblasts (chapter 4) 
despite the higher levels of TGF-β1 in their cell culture supernatants (chapter 3 & 5). 
The lower integrin receptor levels in fetal fibroblasts included significant lower levels 
of myofibroblast-associated integrins such as αVβ5 and α5β1 [23, 24]. Therefore, high 
levels of TGF-β1 in fetal fibroblast cultures do not affect levels of integrin receptors 
but do result in enhanced myofibroblast characteristics such as high α-SMA levels and 
enhanced fibrotic protein fibronectin splice-variant EDA (FnEDA) production (chapter 
3). This finding indicates that fetal fibroblasts lack the necessary integrin receptors to 
cause contraction and activate TGF-β via myofibroblast-associated mechanisms.
It should be noted that all data in chapter 3 and 4 are from in vitro experiments and that 
the significance of these processes should be further elucidated in vivo. A first step would 
be to quantify levels of integrin receptors in the healthy skin to see if the differences 
in integrin receptor levels in the in vitro situation resemble the in vivo situation. 
Furthermore, an interesting topic to study would be the influence of hyaluronic acid 
(HA), as fetal skin contains high levels of HA [13, 25-27] and HA-receptors such as CD44 and 
RHAMM are directly linked to cellular migration and TGF-β signaling [26, 28, 29].
Fibroblasts are also sensitive for mechanotransduction [30], so the influence of mechanical 
stretch on in vitro myofibroblast differentiation was studied in chapter 5. The goal of 
this study was to finds leads for an optimal splinting protocol to reduce pathological 
scar contraction. Therefore, two stretch programs were used that matched the stretch 
therapies that are currently used in the clinic to prevent scar contraction [31]. We 
used fibroblasts derived from burn wound tissue, so-called eschar fibroblasts. These 
fibroblasts are key players in the onset of hypertrophic scarring and scar contraction 
in burn wounds [32, 33]. We assessed the scarring-associated profile of eschar fibroblasts 
and compared it to ‘healthy’ dermal fibroblasts and ‘scarless’ fetal fibroblasts. Besides 
we studied if the different stretch programs could alter the scarring-associated profile 
of eschar fibroblasts.
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Higher expression of all myofibroblast-associated genes was observed in eschar 
fibroblasts but differences between fibroblast groups were not significant and within 
group variations were high. Besides, cell culture supernatants of eschar fibroblasts did 
not have higher levels of TGF-β1 compared to adult fibroblast supernatants. In contrast, 
fetal fibroblast supernatants had higher levels of TGF-β1 which is in correlation with 
our findings in chapter 3.
Both stretch programs used in this study reduced levels of TGF-β1 and gene expression 
of α-SMA in all fibroblasts. However, the results of the stretch programs on other 
myofibroblast-associated genes were very variable and the within-group variations 
were high as well. As we show in chapter 5, these variable data correlate with literature 
since reported results of mechanotransduction on fibroblasts are also highly variable 
and contradictory. The variations in outcomes of mechanotransduction studies are 
most likely the consequences of culture methods. Sensitivity of fibroblasts to mechano-
transduction is affected by cell density, cytoskeletal tension, and integrin receptor 
profiles [34-38]. As we used primary fibroblasts, fibroblast proliferation and fibroblast-
myofibroblast ratio differ per cell isolate which will results in difference in cell density 
and cytoskeletal tension. Further, we show in chapter 4 that integrin receptor profiles 
differ between fetal and adult fibroblasts. Therefore, variations in our primary cell 
cultures have affected the influence of mechanical stretch on the cultures, resulting 
in variable effects of the two different mechanical stretch programs on myofibroblast 
characteristics. In conclusion, mechanotransduction influences cell behavior in multiple, 
complicated ways. Improved models that optimize data acquisition and enable micro-
environmental control are necessary to study the effects of mechanotransduction on 
myofibroblast differentiation.
Immune system
Another important factor involved in wound healing is the immune system. Enhanced 
immune responses after wounding are shown to worsen scarring and prolonged 
inflammation is associated with fibrosis. Several studies have shown that the fetal 
immune system is absent during wound healing [39] and scarless healing is the result of 
reduced inflammation [40, 41]. However, the capacity to heal without scarring is conserved 
till long after the fetal immune system is fully developed [42-44]. Therefore, we investigated 
immune cells and measured levels of chemokines in healthy human fetal and adult skin in chapter 6. Our study established that second-trimester fetal skin indeed contains low 
levels of immune cells. Yet, this immune cell deficiency is not the result of an immature 
immune system as matching fetal lymph nodes contain sufficient CD45⁺ immune cells. 
Nonetheless, we showed that fetal skin is also devoid of several chemoattractants. 
Therefore, the absence of lymphocytes in the fetal skin appears to be orchestrated by 
chemokines. Altogether, this study shows that low levels of immune cells and low levels 
of chemokines in the healthy fetal skin may result in reduced inflammation during fetal 
wound healing.
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Discussion and future perspectives
On first sight, scarless fetal wound healing appears to be the antipode of fibrotic wound 
healing. However, similarities exist as processes, such as activated TGF-β signaling and 
enhanced ECM production, are involved in both fetal skin development and fibrotic 
scarring. In this thesis, we show that in vitro cultured fetal fibroblasts do have several 
myofibroblast-associated features such as high levels of α-SMA and a high production 
of TGF-β1 and FnEDA (chapter 3 & 5). This is consistent with results of Cuttle et al. 
[45] who showed that collagen deposition during fetal skin development and adult skin 
repair does not significantly differ. Altogether, fetal skin development and adult skin 
repair require similar mechanisms but, given the different outcomes, control of these 
mechanisms differs between fetal development and adult wound healing.
The similarities between tskin repair and skin development have as a consequence that 
markers associated with scarring are also present during scarless healing. This duality of 
the markers results in misinterpretation and confusion as can be seen in the conflicting 
literature about fetal wound healing (chapter 1). The problem is further worsened by 
the plasticity of the fibroblast-phenotype and the diverse origin of the myofibroblast, 
resulting in an absence of fibroblast- and myofibroblast-specific markers [46]. Given 
the diverse origin of the fibroblast and the similarities between skin repair and skin 
development the change to find a specific myofibroblast marker that can distinguish 
between skin repair and skin development is small. For that reason, genetic profiling is a 
more promising approach as it can be used to gain insight into similarities and differences 
between development and fibrosis. A good example of genome-wide screening is the 
study by Larsson et al who examined idiopathic pulmonary fibrosis and showed that 
deranged β1-integrin signaling and TGF-β induced epithelial-to-mesenchymal transition 
are important mechanisms in this disease [47]. Hence, genetic profiling of developing 
skin and healing skin might shed light onto similarities and differences between skin 
development and skin repair. 
Besides the lack of relevant markers, the shortage of biological relevant wound 
healing models is another major problem in the area of fetal wound healing. Large 
differences exist between wound healing in animal skin and human skin as animal 
skin mainly heals by contraction and hypertrophic scarring does not occur. Therefore, 
all studies in my thesis were performed with material from human donors. Although 
this precluded studies into actual wound healing itself, it was possible to study healthy 
skin and simulate wound healing using in vitro models. Overall, this gained insight into 
processes that are involved in fetal skin development such as activated TGF-β signaling 
and enhanced fibroblast migration. However, like with the animal models, proper 
translation of results from in vitro models towards the in vivo situation or from healthy 
skin towards wounded skin is difficult. For example, fibrosis does not occur in fetal 
skin but in vitro culture of fetal fibroblasts resulted in fibrosis-associated conditions 
(chapter 3). This raises the question if the fibrotic-conditions are an artificial finding or 
if these fibrosis-associated conditions also occur during scarless fetal wound healing. 
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As it is impossible to answer such questions with the wound healing models that are 
currently available, development of biological-relevant and reliable in vitro models is 
necessary. 
Wound healing is a complex process that involves interactions between a broad range 
of cells, chemokines and ECM proteins. Therefore, wound healing models should 
enable these interactions as much as possible. Promising studies in this field are the 
generation of in vitro skin equivalents [48] and ex vivo culture models of human skin. An 
ex vivo model for human fetal wound healing was already described by Coolen et al [49]. 
Although reepithelialization could be studied in this model, the situation in the dermis 
did not reflect the biological situation as no myofibroblasts were present, even not in 
adult wounds. This absence of myofibroblasts is most probably caused by the absence 
of growth factors, inflammation and mechanical tension. Therefore, the application of 
tension and the addition of growth factors and immune cells to ex vivo cultured skin is 
a promising model to study in vitro wound healing. 
Finally, my thesis shows that theories about reduced TGF-β signaling and anti-fibrotic 
properties of fetal skin are incorrect or incomplete. Therefore, I will end this discussion 
by introducing a new theory about fetal wound healing (figure 1). Enhanced migration 
of fetal fibroblasts (chapter 4) and high production of TGF-β and ECM proteins (chapter 
3 & 5) result in fast wound closure in the fetal skin. Besides, the healthy fetal skin 
lacks immune cells and chemokines (chapter 6), which results in a late onset of the 
inflammatory reaction upon wounding. Therefore, wound healing in the fetal skin is fast 
and without inflammation, resulting in early wound closure and effective termination 
of the wound healing processes. In contrast, adult skin has wound healing which is slow 
and highly inflammatory, resulting in imperfect regeneration. Moreover, prolonged 
continuation or failed termination of the inflammatory-, proliferation-, and ECM 
remodeling- phases leads to derailed wound healing resulting in fibrosis (figure 1). 
In conclusion, the data in my thesis indicate that scarless wound healing is the result 
of rapid wound healing phases instead of differential wound healing processes. To be 
able to verify this theory, suitable in vitro wound healing models and interpretable 
biomarkers are needed. Discriminating between skin development and skin repair is 
necessary to gain insight into methods to control wound healing and improve scarring 
outcome. Such methods are very much needed to develop anti-fibrotic therapies for 
patients that suffer from hypertrophic scarring. 
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Figure 1: Alteration in wound healing phases. 
Schematic representation of the differences in wound healing phases between adult wound 
healing, fibrosis and fetal wound healing. The y-axis indicates the severity of every phase, the x-axis 
indicates time in a log scale, i.e. hemostasis takes hours, inflammation days, proliferation weeks 
and remodeling months. Fibrosis differs from ‘regular’ adult wound healing as the inflammatory 
response is prolonged and the proliferation and remodeling phases are more severe and fail to 
terminate upon wound closure. On the other hand, fetal wound healing differs from adult wound 
healing as it has a very mild inflammation while the proliferation and ECM remodeling phases are 
severe but start early in the wound healing resulting in fast wound closure. 
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Nederlandse Samenvatting
Onze huid heeft het vermogen om zichzelf te herstellen na een verwonding. Bij ondiepe 
wonden is dit herstel volledig terwijl er bij diepere wonden een litteken gevormd 
wordt. In 30% tot 90% van de diepe wonden ontspoort het genezingsproces en ontstaat 
een pathologisch litteken oftewel een hypertroof litteken. Naast het ontsierende effect 
veroorzaken hypertrofe littekens ook andere problemen zoals jeuk en pijn. Verder is het 
hypertrofe littekenweefsel stug en trekt het samen waardoor het de bewegingsvrijheid 
van gewrichten kan beperken. Door deze complicaties beïnvloeden hypertrofe littekens 
de kwaliteit van leven in ernstige mate en hierdoor hebben veel patiënten tevens last 
van psychische en sociale klachten.
Een van de belangrijkste processen die leidt tot hypertrofe littekenvorming is de 
zogeheten “myofibroblast persistence”. Tijdens de eerste fases van de wondgenezing 
ontstaan myofibroblasten uit gezonde huidfibroblasten onder invloed van een aantal 
factoren zoals stimulatie met groeifactoren -voornamelijk transforming growth factor-β 
(TGF-β)-, veranderingen in extracellulaire matrix (ECM) eiwitten en toenemende 
mechanische spanning. Myofibroblasten produceren grote hoeveelheden ECM eiwitten 
en veroorzaken sterke contractie wat in de vroege stadia van de wondgenezing 
bijdraagt aan het sluiten van de wond. Myofibroblast persistence betekent dat de 
myofibroblasten echter aanwezig blijven in het wondbed na sluiting van de wond en 
ECM blijven produceren en blijven contraheren. Dit proces zorgt voor littekenverdikking 
en littekencontractie en veroorzaakt uiteindelijk hypertrofe littekens.
In tegenstelling tot hypertrofe littekenvorming in de volwassen huid kan de foetale 
huid genezen zonder littekens. In de humane foetus blijft deze littekenloze genezing 
behouden tot in het derde trimester van de ontwikkeling. Verder is het een intrinsieke 
eigenschap van de foetale huid en wordt het dus niet veroorzaakt door externe factoren 
zoals het vruchtwater. De littekenloze genezing komt bij zowel mensen als bij dieren 
voor, ook al verschillen de foetale stadia tot waarin de littekenloze genezing plaatsvindt 
per diersoort. 
Uit onderzoek is gebleken dat er enkele belangrijke verschillen zijn tussen de foetale en 
de volwassen huid die mogelijk bijdragen aan de verschillen in het wondgenezingsproces. 
Ten eerste zijn er verschillen in de opbouw van de ECM. De foetale huid bevat meer 
collageen type-III, meer hyaluronzuur, meer fibrone ctine en meer glycosaminoglycanen 
maar juist minder elastine. Ten tweede zijn er verschillen in cellulaire eigenschappen 
tussen foetale en volwassen fibroblasten afkomstig uit de dermale laag van de huid. 
Foetale fibroblasten produceren meer ECM eiwitten, hebben een snellere celdeling en 
migreren sneller. Ten derde zijn er verschillen in de aanwezigheid van immuuncellen 
in de huid en de ontstekingsreactie tijdens de wondgenezing. In de foetale huid zijn 
minder immuuncellen aanwezig en de ontstekingsreactie tijdens de wondgenezing is 
ook zwakker in de foetale huid. Tot slot zijn cytokines en groeifactoren in verschillende 
concentraties aanwezig in de volwassen en foetale huid, zowel in de gezonde situatie als 
tijdens de wondgenezing. 
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Ondanks het feit dat al deze verschillen mogelijk bijdragen aan de littekenloze genezing 
in de foetale huid zijn de exacte mechanismen nog niet bekend. Inzicht in deze 
mechanismen kan leiden tot methoden om wondgenezing te verbeteren en hypertrofe 
littekenvorming te voorkomen. Het doel van mijn proefschrift was om verschillende 
cellulaire en moleculaire mechanismen te bestuderen die betrokken zijn bij littekenloze 
wondgenezing in de foetale huid. 
De eerste drie hoofdstukken van mijn proefschrift richten zich op TGF-β. Deze 
groeifactor speelt een belangrijke rol bij de ontwikkeling van de huid maar is ook 
betrokken bij myofibroblast differentiatie en hypertrofe littekenvorming. Mijn 
proefschrift begint met hoofdstuk 1 een literatuurstudie over de rol van TGF-β in 
foetale wondgenezing. Het hoofdstuk geeft een overzicht van de verschillen tussen 
foetale en volwassen wondgenezing en kan daarom ook gelezen worden als algemene 
inleiding. Verder worden canonische TGF-β signaaltransductie en de verschillen die 
er zijn in signaaltransductie tussen foetale en volwassen wondgenezing besproken. 
In hoofdstuk 2 worden de onderdelen van de canonische TGF-β signaaltransductie 
bestudeerd in de gezonde foetale en volwassen huid. In tegenstelling tot de hypothese 
dat de foetale huid een disfunctionele of verminderde TGF-β signalering heeft, laat 
deze studie zien dat de foetale huid alle onderdelen van de TGF-β signalering bevat. 
Verschillen in gen expressie, eiwit concentraties en lokalisatie van de onderdelen laten 
echter wel zien dat er mogelijke verschillen in signalering zijn tussen de foetale en de 
volwassen huid. Tot slot wordt in hoofdstuk 3 de reactie van foetale en volwassen 
dermale fibroblasten op TGF-β bestudeerd. In volwassen fibroblasten zorgt TGF-β voor 
myofibroblast differentiatie. De studie beschreven in hoofdstuk 3 laat zien dat foetale 
fibroblasten ondanks hun littekenloze eigenschappen in staat zijn te differentiëren 
in myofibroblasten. Gezamelijk laten hoofdstuk 1 tot en met 3 zien dat actieve TGF-β 
signalering niet alleen betrokken is bij littekenvorming maar ook belangrijk is voor de 
ontwikkeling van de foetale huid. Meer inzicht in de TGF-β signaaltransductie die leidt 
tot opbouw van de foetale huid kan zorgen voor therapieën die huidherstel bevorderen 
en littekenvorming tegen gaan.
Het tweede deel van dit proefschrift overlapt deels met hoofdstuk 3 omdat in deze 
hoofdstukken opnieuw foetale en volwassen fibroblasten uit de huid worden bestudeerd. 
Echter wordt in deze hoofdstukken niet gekeken naar TGF-β maar naar de relatie tussen 
de fibroblast en zijn omgeving. In hoofdstuk 4 worden adhesie en migratie van foetale 
en volwassen fibroblasten vergeleken. Uit deze studie blijkt dat foetale fibroblasten 
een pro-migratoire fenotype hebben wat gekenmerkt wordt door snelle migratie, 
langzame adhesie en lage expressie van bepaalde integrines. Integrines zijn receptoren 
die de verbinding vormen tussen de cel en zijn omgeving en een belangrijke invloed 
hebben op het gedrag van de cel. Het verschil in integrines tussen foetale en volwassen 
fibroblasten kan daarom een belangrijke rol spelen tijdens de wondgenezing. Zo laat 
hoofdstuk 4 zien dat het blokkeren van α1-integrine in volwassen fibroblasten leidt 
tot een migratoire fenotype vergelijkbaar met het foetale fenotype. In hoofdstuk 5 
wordt vervolgens gekeken naar de effecten van mechanische spanning op het gedrag 
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van dermale fibroblasten. Dit hoofdstuk is gebaseerd op de klinische vraagstelling of 
spalken van een brandwond een gunstig effect heeft op littekencontractie. Daarom 
worden in deze studie niet alleen foetale en volwassen fibroblasten bestudeerd maar 
ook litteken-fibroblasten die verkregen zijn uit brandwondweefsel, de zogeheten eschar 
fibroblasten. In vergelijking met de volwassen huidfibroblasten hebben deze eschar 
fibroblasten hoge expressie van myofibroblast-geassocieerde genen. Het toepassen van 
mechanische spanning op de verschillende fibroblasten gaf geen eenduidige resultaten 
waardoor niet te concluderen is of mechanische spanning myofibroblast differentiatie 
en myofibroblast persistence vermindert. Op basis van deze data is het daarom niet te 
voorspellen of spalken littekencontractie kan voorkomen. Voor vervolgstudies is het 
daarom raadzaam om geavanceerdere modellen te gebruiken.
Het derde deel van dit proefschrift richt zich op het immuunsysteem. In hoofdstuk 6 
worden de verschillende cellen van het immuunsysteem vergeleken tussen de gezonde 
foetale en de volwassen huid. Uit deze studie blijkt dat de foetale huid significant lagere 
aantallen immuuncellen bevat vergeleken met de volwassen huid. Deze verschillen 
worden niet veroorzaakt door een gebrek aan bloedvaten of een onderontwikkeld 
immuunsysteem. De foetale huid in onze studie bevatte een gelijke hoeveelheid 
bloedvaten vergeleken met de volwassen huid. Verder bevatten foetale lymfeklieren 
in het bestudeerde ontwikkelingsstadium grote hoeveelheden immuuncellen. De 
foetale huid bevat echter wel lagere concentraties van de chemokines CCL17, CLL27 
en CCL21. Deze chemokines zijn betrokken bij het aantrekken van immuuncellen naar 
de huid en kunnen dus het gebrek aan immuuncellen in de foetale huid gedeeltelijk 
verklaren.  Uiteindelijk kan dit gebrek aan immuuncellen in de gezonde foetale huid 
leiden tot een verminderde ontstekingsreactie tijdens de wondgenezing en hierdoor 
het genezingsproces beïnvloeden.
Gezamenlijk laten de hoofdstukken van mijn proefschrift zien dat veel processen die 
betrokken zijn bij de ontwikkeling van de foetale huid ook plaatsvinden tijdens de 
volwassen wondgenezing. Meer inzicht in deze processen is nodig om ervoor te zorgen 
dat het wondgenezingsproces niet ontspoort maar dat het leidt tot huidregeneratie 
zoals in de foetale huid. Het bestuderen van de foetale huid kan daarom leiden tot 
essentiële kennis voor het ontwikkelen van therapieën die hypertrofe littekenvorming 
tegen gaan.
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Dankwoord
Wondgenezing is een proces waar veel factoren bij betrokken zijn en ditzelfde geldt 
ook voor een promotietraject. Daarom wil ik alle mensen die mij in de afgelopen jaren 
geholpen hebben bedanken.
Zoals er zonder wond geen wondgenezing is, is er zonder promotieproject en de 
bijbehorende �inanciën geen promotie. Magda, jij bedacht dit project, schreef de 
projectaanvraag en liet mij met dit project aan de slag gaan. Je hebt mij altijd alle ruimte 
gegeven om het project naar eigen inzicht in te vullen maar je stond wel altijd voor me 
klaar als ik je nodig had. Ik wil je ontzettend bedanken voor je vertrouwen, je inzet en je 
praktische adviezen en hulp. 
De eerste fase van de wondgenezing is de vorming van een bloedstolling in het wondbed, 
dit netwerk fungeert als vangnet om bloed binnen maar ongewenste factoren buiten het 
lichaam te houden. De onderzoeksgroep van de VSBN in Beverwijk heeft mij in de eerste 
fase van mijn promotieonderzoek opgevangen en mij alles geleerd over wondgenezing, 
fibroblasten en αSMA kleuringen. Ik wil alle medewerkers en oud-medewerkers dan 
ook hartelijk bedanken voor hun hulp maar ook voor de gezelligheid tijdens de etentjes, 
bijeenkomsten en uitjes. Ook al kwam ik in de laatste jaren van mijn onderzoek steeds 
minder vaak naar Beverwijk, ik voelde me er altijd welkom en ging er altijd met veel 
nieuwe ideeën, kennis en materiaal weer vandaan.
Na de verwonding zijn de macrofagen een van de eerste cellen die het wondbed betreden. 
Rob, als echte macrofagen man heb jij ook twee kanten, je ‘good guy’ M1-kant zorgde 
altijd voor de vrolijke noot tijdens werkbesprekingen en hielp mij de zonnige kanten 
van het promovendus leven in te zien. Toch kon jij ook de ‘bad guy’ spelen en liet jij je 
M2-kant zien op de momenten dat ik doorzeurde over een mislukt experiment of een 
artikel dat erg lang bij een tijdschrift lag. Jouw nuchtere kijk op het onderzoek en de 
academische wereld zorgden voor de nodige relativering.
De neutro�ielen die het wondbed betreden nemen de aanwezige bacteriën en 
ziekteverwekkers op en voorkomen zo het ontstaan van infecties. Marjolein, ik weet niet 
of het je nu boos of trots maakt om vergeleken te worden met een neutrofiel. Wat ik 
wel weet is dat jouw vermogen om grote hoeveelheden data op te nemen en kernachtig 
samen te kunnen vatten van onschatbare waarde is voor ieder onderzoek. Ik ben blij dat 
jij er in de laatste fases van dit promotietraject bij was om mij af en toe dat duwtje in de 
goede richting te geven.
Het aangeleerde immuunsysteem is belangrijk voor het presenteren en ‘onthouden’ van 
antigenen zodat een snelle immuunresponse op gang kan komen. Als niet-moleculair 
celbioloog en niet-immunoloog heb ik op de afdeling Moleculaire Cel Biologie en 
Immunologie ontzettend veel geleerd op zowel praktisch als inhoudelijk niveau. 
Ik wil alle medewerkers en oud-medewerkers dan ook ontzettend bedanken voor 
hun interesse in mijn onderzoek, alle hulp en samenwerking en natuurlijk ook alle 
gezelligheid, borrels en uitjes. Jasper, bedankt voor het verzorgen van de lay-out!
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De groeifactoren in het wondbed zorgen voor een snellere genezing maar kunnen, in 
geval van een overmaat, ook een averechts effect hebben. Lieve kamergenootjes, jullie 
aanwezigheid in J289 zorgde voor de hoognodige gezelligheid en dit proefschrift had 
niet geschreven kunnen worden zonder jullie niet aflatende aanmoediging en natuurlijk 
de enorme hoeveelheden koffie, thee, chocolade, koekjes en snoepjes. De roomie diners 
zorgden voor de benodigde ontspanning op zijn tijd, ook al kwam er van werken 
de volgende ochtend vaak niet zo veel. Dear roomies, for the ones that still don’t 
understand Dutch, shame on you ;) Thank you for everything!
De �ibroblasten in het wondbed zorgen ervoor dat de wond de�initief gesloten wordt 
door het produceren van grote hoeveelheden extracellulaire matrix. Renske en Joyce, 
ontzettend bedankt voor jullie inzet en enthousiasme tijdens jullie stages! De data die 
jullie gegenereerd hebben zorgen voor de opvulling van dit proefschrift. Onder het kopje 
harde werkers kan natuurlijk ook Marcel niet ontbreken, dank voor alle praktische 
hulp! Ik hoop dat mijn data het wondgenezingsonderzoek bij de VSBN verder helpen. Tot slot wil ik hier ook Mirella bedanken, jouw initiatief en jouw enthousiasme hebben 
uiteindelijk geresulteerd in hoofdstuk 5 van dit boekje, een beetje een vreemde eend in 
de bijt maar ook het onderzoek waar alles mee begon. 
Dan is er nog een speciaal type �ibroblast, de myo�ibroblast. De enorme kracht van deze 
cel zorgt ervoor dat de randen van het wondbed dichter bij elkaar komen. Wendy en 
Johanneke, jullie waren de overbrugging tussen de VU en Beverwijk en ik ben ontzettend 
blij dat jullie tijdens de verdediging aan mijn zijde staan. Wendy, we hadden allebei onze 
eerste werkdag op 1 april 2011 en werden vrij snel ingewerkt in de wondere wereld 
van de fibroblast isolaties en de α-SMA kleuringen. Zonder jouw hulp op het gebied 
van celkweek en immuuncel-kleuringen was dit proefschrift nog lang niet afgeweest. 
Dank je! Johanneke, ondanks dat we elkaar niet heel veel zagen en verrassend weinig 
hebben samengewerkt was jij toch mijn PhD-zusje. Samen profiteerden we van ‘the best 
of both worlds’ door naar borrels en labuitjes in zowel Beverwijk als op de VU te gaan. 
Daarnaast was jij ook mijn vaste reismaatje tijdens alle ETRS-congressen die we over de 
jaren bezocht hebben. Bedankt en heel veel succes met de laatste loodjes!
De geproduceerde extracellulaire matrix vult het wondbed op en zorgt voor een de�initieve 
sluiting van de wond. Knowledge is the extracellular matrix of this thesis. At this point, 
I would like to thank all members of the fibroblast meeting for sharing their data and 
valuable knowledge with me and for the great meetings we have had. Further, I would like to thank the ETRS for organizing the yearly meetings. These meetings were an 
ultimate source for knowledge and inspiration while the hospitality and friendliness 
within the ETRS always amazed me. 
Dan zijn er de keratinocyten, de cellen die vanuit de randen van het wondbed over de 
wond heen groeien en een blijvende beschermende laag vormen. Lieve papa en mama 
jullie hebben mij de kansen, de mogelijkheden en de vrijheid gegeven om te worden 
wie ik ben. Woorden schieten te kort om jullie te bedanken voor alles wat jullie voor 
mij gedaan hebben. Lieve familie en vrienden, jullie liefde en aandacht waren de 
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beschermende laag tegen de stress en onzekerheid die dit project soms met zich mee 
bracht. Alle gezellige weekendjes weg, leuke activiteiten, feestjes en gezelligheid hebben 
vele mooie herinneringen achter gelaten. Ik hoop dat er in de komende jaren nog heel 
veel bij zullen komen!
Tot slot is er nog die ene factor, waar niemand precies de vinger op kan leggen, maar die 
er voor zorgt dat een wond in plaats van een litteken, gezonde mooie huid wordt. Lieve, 
lieve Michel, dank je wel dat je jouw leven met mij wilt delen. Met jou aan mijn zijde 
wordt alles ook dat belangrijke beetje mooier!
Proefschrift_27jan2016_JAK_versie3b.indd   141 27-1-2016   21:44:34
501871-L-bw-Walraven
&
Curriculum Vitae
142
Curriculum Vitae
Mariëlle Walraven was born on the 30th of November 1984 in Middelburg, The 
Netherlands. In 2003 she received her high school diploma from the Christelijke 
Scholengemeenschap Walcheren (CSW, location Elzenlaan, Middelburg). Subsequently, 
she started with the study Technical Medicine (Twente University, Enschede) and, 
after her BSc degree, continued with the master Reconstructive Medicine (Twente 
University, Enschede). In the last two years of her MSc degree she performed 
internships at the departments of Orthopaedic Surgery (UMCU, Utrecht), Cardiology 
(MST, Enschede), Nephrology (LUMC, Leiden) and Urology (Radboud UMC, Nijmegen). 
At the Urology department she also performed her graduation project under 
supervision of dr. Paul Geutjes and Prof. dr. Wout Feitz. During this project Mariëlle 
developed, characterized and evaluated a tubular construct for urinary derivations.
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